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Abstract
Tuberculosis is a major threat to human health. About one third of the world's population is 
latently infected with Mycobacterium tuberculosis. In these cases the bacillus is in a state of 
low metabolic activity, making eradication difficult with conventional chemotherapy, 
which targets actively metabolizing organisms. The mechanisms by which M. tuberculosis 
reactivates to cause disease are currently unknown but a better understanding could greatly 
improve the treatment of tuberculosis. Resuscitation-promoting factor is a protein first 
identified in the supernatant of stationary phase cultures o f Micrococcus luteus. It is active 
in picomolar concentrations, increasing the number of culturable M. luteus cells from 
dormant populations and shortening the lag phase of growth of small inocula. 
Bioinformatic searches reveal over 40 examples of rpf-like genes in the high G -C  cohort of 
Gram-positive bacteria, including M. tuberculosis, which contains five rp f  gene 
orthologues. The work presented here investigated aspects of the M. tuberculosis Rpfs. 
Improvements in solubility of recombinant mycobacterial (A/, tuberculosis and M. 
smegmatis) Rpfs were achieved by manipulating induction times and temperatures during 
protein expression and by using new hosts and vectors and producing novel fusion proteins. 
New assays were devised to measure the biological activity o f  recombinant Rpfs, using 
ATP bioluminescence of M. luteus cultures. A phage display library for M. tuberculosis 
was constructed, in an attempt to identify a protein receptor for Rpf. Rpf expression in 
human infection was investigated for the first time, using immunocytochemistry. Anti-Rpf 
antibodies were applied to human tissue sections infected with M. tuberculosis. Rpf was 
found to be located within epithelioid giant cells and in the immediate vicinity of acid-fast 
bacilli in necrotic centres. The presence of Rpf in human tuberculosis infection 
demonstrated in this work suggests that Rpfs may have a role in controlling dormancy of 
the bacilli in human disease.
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CH A PTER  I
INTRO DUCTIO N
17
1.1 Tuberculosis and latency -  the clinical problem
Tuberculosis (TB) is recognised as one o f  the major threats to human health. 
Approximately 8 million active cases o f  TB are diagnosed every year and there are over 
3 million deaths. Furthermore it is estimated that about 1.9 billion people (about one 
third o f  the world's population) are latently infected. The term latency has been used by 
the Centers for Disease Control in the United States and the American Thoracic Society 
to refer to the clinical state where an individual is infected with M  tuberculosis, but has 
no clinical disease (American Thoracic Society 2000). These individuals are tuberculin 
reactive but have no active disease either on chest radiography or elsewhere. Most 
people exposed to M. tuberculosis mount a cell-mediated immune response which 
prevents the progress o f  the disease, and limits the organisms to the site o f  entry into the 
lung tissue and local lymph nodes (Ghon focus). However total elimination o f  the 
bacilli is very slow and unless the infection is treated, latent infection is believed to be 
the typical outcome. The organisms may then reactivate after many years and lead to 
active disease. On conservative estimates, 5-10% o f  latently infected immunocompetent 
individuals will develop active TB over their lifetimes: for those co-infected with HIV 
the figure rises to 5-10% per year o f  life. The adoption o f  a latent infection state makes 
sense for the organism: it is able to exist in a large proportion o f  the individuals in a 
group whilst ensuring its own transmission and continuation by causing overt disease in 
a few. M. tuberculosis is therefore well adapted to the human host, as pointed out by 
Bentrup & Russell (2001). It is this 'human reservoir' which poses the biggest problem 
o f  all to TB control.
The exact physiological and metabolic state o f  the tubercle bacillus in latent infection is 
not known for certain. It is postulated that the anaerobic and acidic conditions within 
closed lesions in the lung reduce bacterial metabolism. The organisms in this state are
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known as 'persisters'. It is not known whether these cells are metabolising very slowly 
or whether metabolism is entirely halted. The term ‘persistence' has been defined as ‘a 
phenomenon whereby microorganisms which are drug-susceptible when tested outside 
the body are nevertheless capable o f  surviving within the body despite intensive therapy 
with the appropriate antimicrobial drug' (see the review by McKinney. 2000). There 
appear to be different subpopulations o f  persisters, as described by Hu & Coates (2003): 
they all survive the immune response ('immune persisters') but some are also refractory 
to drug treatment (‘antibiotic persisters'). Immune persisters grow well on solid media 
but antibiotic persisters cannot (Hu et al 2000). The presence o f  persisters leads to the 
lengthy treatment required for TB: current therapy for active disease depends on the use 
o f  at least three drugs (rifampicin, isoniazid and pyrazinamide) for a minimum o f  six 
months. This strategy emerged as a result o f  a series o f  clinical trials conducted by the 
MRC and its international collaborators (see Fox et al 1999). Isoniazid, which inhibits 
mycobacterial cell wall synthesis, exerts its major activity against rapidly dividing cells. 
This is demonstrated clinically by a rapid fall in sputum viable counts and quickly 
renders the patient non-infectious (East African/British Medical Research Council 
1973). Rifampicin and pyrazinamide have some activity versus persisters and are the 
best clinical sterilising agents (East African/British Medical Research Council 1973). 
Despite this, attempts to reduce duration o f  therapy below six months have failed. The 
long duration o f  therapy leads to problems in adherence and completing the correct 
course o f  treatment. This in turn may lead to the development o f  drug-resistant forms o f  
disease resulting from serial monotherapy.
The presence o f  persisters is, therefore, fundamental to the problem of treating active 
TB satisfactorily. Eradicating latent infection effectively also requires treatments which 
can target them. Novel therapies which could do this might thus have the two-pronged
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benefit o f  reducing length o f  treatment in active cases, and eradicating latent TB. One 
way o f  achieving this would be to activate the persistent organisms so that they become 
responsive to conventional chemotherapeutic agents. In order to do this a better 
understanding o f  the mechanisms o f  persistence, dormancy and reactivation is required.
1.2 Dormancy
1.2.1 Definition
The persisters which occur in tuberculous infection are often rather loosely referred to 
as 'dormant*. This is a term used to refer to microorganisms themselves, rather than to a 
clinical state. The most obvious example o f  a dormant bacterial cell is the bacterial 
spore, in which there is a reversible shutdown o f  metabolic activity. Different authors 
consider the term dormancy to describe a wide range o f  different states and there is no 
overall consensus on a definition. It has often been used to describe cells in different 
states that have simply reversibly lost the ability to proliferate (see Kell & Young 2000). 
Wayne chose the term 'non-replicating persistence* to describe the state o f  the bacilli in 
his model o f  dormancy in M. tuberculosis (Wayne & Hayes 1996). Wayne's model, and 
non-replicating persistence, are described in Chapter 5, section 5.2. Barer (2003) defines 
dormancy as 'a  reversible state o f  low metabolic activity in a unit that maintains 
viability*. Given that the phenomenon of  dormancy necessarily requires the concept o f  
resuscitation. Kell and Young arrived at the following definition: 'In a state o f  low 
metabolic activity and unable to divide or form a colony on an agar plate without a 
preceding resuscitation phase* (Kell & Young 2000). This is the definition which has 
been used for the purpose o f  all work in this thesis.
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1.2.2 Site and physiology' o f  dormant organisms
Following inhalation, the bacilli enter the pulmonary alveolar macrophages and 
proliferate within them. The organism survives by disrupting phagosome acidification 
and preventing phagosome-lysosome fusion. Some bacilli may escape from infected 
macrophages and cause a transient bacteraemia with dissemination o f  viable bacilli to 
other parts o f  the body. Once infected, the chance o f  developing active disease is 
greatest immediately following infection, declining exponentially thereafter. Within the 
first year after infection, in immunocompetent individuals, the incidence o f  clinically 
significant disease is approximately 1.5% and the cumulative risk o f  disease during the 
first five years is 5-10% (Chiba & Kurihara 1979). However in the majority the 
infection is subsequently controlled by T cell and macrophage responses (see Parrish, 
Dick & Bishai 1998 for a review) and latent tuberculosis infection is the result.
The exact location o f  the dormant tubercle bacillus within the host is uncertain. 
Classically it was believed to reside in the macrophages in the tuberculous granuloma 
and healed pulmonary lesions (see Bishai 2000 for a brief review). These encapsulated 
and sometimes calcified lesions could protect the bacillus from the immune response 
and the anaerobic, acidic and lipid-rich environment might trigger a dormant state. 
However a significant proportion o f  cases o f  post-primary tuberculosis arise in organs 
other than the lungs, making it highly likely that the dormant bacilli reside in extra- 
pulmonary sites also, presumably having been seeded during the early bacteraemic 
phase o f  the primary infection described above. In 1927, Opie and Aronson prepared 
human tissue homogenates from unaffected portions o f  the lung from necropsy 
specimens and found that they contained viable M. tuberculosis infectious for guinea 
pigs -  strongly suggesting that latent organisms exist in apparently normal tissue. A 
study by Hemandez-Pando and colleagues (Hernandez Pando et al 2000) found
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evidence o f  M. tuberculosis DNA by in-situ and conventional PCR in 15 o f  47 lung 
specimens taken from Mexican and Ethiopian patients who died o f  causes other than 
TB. The DNA was found to be present not only in macrophages, but also in type II 
pneumocytes, endothelial cells and fibroblasts. There was no histologic evidence o f  the 
presence o f  A7. tuberculosis, either as histologic lesions or as visible acid-fast bacilli. 
There is other experimental evidence to suggest that acid-fast bacilli may not always be 
present in latent tuberculous infection. The Cornell model is an in vivo mouse model o f  
dormancy in M. tuberculosis (McCune et al 1957a and 1957b). This model involves 
infecting mice with M. tuberculosis and then treating them with isoniazid and 
pyrazinamide for twelve weeks. On withdrawal o f  treatment, microscopy o f  tissue 
sections revealed that no acid-fast bacilli were visible, and cultivable tubercle bacilli 
could not be recovered from the tissues, even by passing tissue extract into other 
animals - a situation known as the 'sterile state'. However a few weeks later disease 
reappeared in the infected animals. More recently de Wit et al used PCR to detect the 
presence o f  DNA in the organs o f  sterile state Cornell model mice (de Wit et al 1995). 
Substantial amounts o f  DNA were present despite failure to obtain positive cultures. 
The presence o f  DNA could represent dead bacilli, free DNA or dormant forms. 
However studies using RT-PCR showed that mRNA transcripts and rRNA are present 
in sterile state mice in the Cornell model, implying that these non-culturable bacilli are 
transciptionally active (Hu et al 2000, Pai et al 2000).
Thus the absence o f  visible acid-fast bacilli on microscopy certainly does not seem to 
preclude their presence in the tissues in some form. This has prompted some to consider 
the possibility o f  a non-acid-fast form o f  M. tuberculosis (eg 'ghost cells' -Canetti 1955, 
Seiler 2003). M. tuberculosis does possess genes homologous to sporulation regulatory 
genes o f  actinomycetes. This may explain the ability o f  M. tuberculosis to survive for
such long periods in latent infection due to the putative induction of  a ‘spore-like state'. 
Others argue that where acid-fast bacilli are not visible in infected tissues this may 
simply be down to the lack o f  sensitivity o f  microscopy, and that just because M. 
tuberculosis possesses sporulation regulatory gene homologues does not mean they are 
activated (Orme 2001). Isoniazid significantly reduces the risk o f  reactivation in latent 
tuberculosis, but it acts only on actively metabolising bacilli (as a cell wall agent) - this 
observation does not support the presence o f  a totally metabolically inert spore-like 
state. A further discussion o f  the location and activity o f  dormant tubercle bacilli is 
found in the introduction to Chapter VII.
1.2.3 M olecular changes in dormancy
The molecular changes leading to dormancy are also beginning to be unravelled. 
Transcriptional regulators such as sigma factors are likely to have an important role in 
bacterial adaptive responses. SigF  is an alternate sigma factor found in M. tuberculosis 
and is similar to sporulation sigma factors in Bacillus subtilis. It has been found to be 
induced in M. tuberculosis by a number o f  stresses including anaerobic conditions, 
oxidative stress, antibiotic stress and nutrient depletion (Michele, Ko & Bishai 1999). It 
is therefore believed that sigF  may control genes which are important for mycobacterial 
persistence within the host, including during chemotherapy. The fact that expression can 
be induced both by anaerobiasis and antibiotic treatment lends support to the idea that 
dormancy and persistence may be very closely related. It is not certain whether the 
expression o f  SigF  indicates a stress response or the presence o f  a sporulation cascade. 
Electron microscopy o f  tubercle bacilli exposed to hypoxia shows thickening o f  the cell 
wall and analysis o f  the cultures by SDS-PAGE identified the presence o f  a 16kDa 
alpha-crystallin (Acr) protein (Cunningham & Spreadbury 1998). This protein was 
strongly associated with the cell envelope, reminiscent o f  a sporulation-like response.
and the authors suggested that it might play a role in stabilizing cell structures during 
long-term survival in granulomas. The acr gene is strongly induced by hypoxic 
conditions and is required for growth in macrophages (Yuan et al 1998).
Although M. tuberculosis is usually considered a strict aerobe, it can survive in 
anaerobic conditions (Wayne 1976) and to this end it is able to use fatty acids as a 
carbon source: the glyoxylate shunt is upregulated (Wayne & Lin 1982). This shunt 
requires the enzyme isocitrate lyase (ICL), and it has been found that persistence o f  M. 
tuberculosis in mice is facilitated by ICL, with disruption o f  the icl gene causing 
attenuation o f  bacterial persistence and virulence in the mice (McKinney et al 2000). 
Under anaerobic conditions the organism also switches to nitrate respiration, with a 
marked increase in nitrite production accompanying anaerobic persistence (Wayne & 
Hayes 1998).
A detailed review o f  the molecular changes identified in dormancy is beyond the scope 
o f  this introduction, which will concentrate mainly on Resuscitation Promoting Factors, 
but changes such as those briefly described all suggest that the metabolism and surface 
structure o f  A/, tuberculosis are profoundly influenced by the environmental conditions.
1.3 Resuscitation promoting factors.
Some aspects o f  dormancy have been briefly reviewed in this introduction. It will be 
apparent that much remains to be elucidated about the nature o f  dormancy, its causes 
and also about what causes organisms to come out o f  the dormant state. One very 
intriguing area pertaining to the latter question is that o f  the resuscitation-promoting 
factors (Rpfs). Since the Rpfs are the subject o f  this study, the literature surrounding 
them will now’ be reviewed in some detail.
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1.3.1 Discovery• o f  R p f
M icrococcus luteus is a high G^C Gram-positive organism that may be isolated from 
mammalian skin, soil and water. In 1994 Kaprelyants et al published a study in which it 
was found that dormant (ie after a prolonged stationary-phase) cells o f  M. luteus in 
liquid medium could be stimulated into growth by adding supernatant from stationary 
phase cultures o f  the same organism. This was evidenced using the most probable 
number method, which showed an increase in apparently viable cells o f  1000-100 000- 
fold in cultures with the added supernatant, compared to those without it. It was 
concluded that the spent culture supernatant contained a factor which stimulated the 
growth o f  dormant cells (Kaprelyants et al 1994, Mukamolova et al 1995).
It was established that the active component o f  the supernatant was heat-labile, 
nondialyzable, and trypsin-sensitive (Mukamolova et al 1998). It was purified to 
homogeneity by ion-exchange chromatography. The peak resuscitation activity 
corresponded to a protein with a molecular mass o f  16-17kDa, named resuscitation- 
promoting factor (Rpf). It was found to be active in the picomolar range and increased 
the number o f  culturable M. luteus cells from dormant populations by three orders o f  
magnitude. In view o f  the low concentrations necessary for activity a nutritional role for 
R pf was discounted. Primers designed from microsequence data were used to amplify a 
147bp fragment from M. luteus D \A .  When this fragment was cloned and used as a 
hybridization probe it detected a 1.4kbp fragment, corresponding to a gene denoted rp f  
(Mukamolova et al 1998).
Data from bacterial genome sequencing projects have now revealed the existence o f  
over 40 examples o f  rpf-like genes in the high G+C cohort o f  Gram-positive bacteria, 
including streptomycetes, corynebacteria and mycobacteria (Mukamolova et al 1998,
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Kell & Young 2000, Ravagnani, Finan & Young 2005). Most organisms contain several 
representatives (unlike M. luteus which only has one). Recombinant M. luteus R pf has a 
wide spectrum o f  activity - it stimulates the growth o f  several other high G-+-C Gram 
positive organisms, including M ycobacterium tuberculosis, Mycobacterium smegmatis 
and Mycobacterium avium  (Mukamolova et al 1998). An Rpf domain has even been 
identified in a large mycobacteriophage (Pedulla et al 2003).
1.3.2 Structure o f  R p f and possible modes o f  action
The rpf-gene encodes a product o f  total length 223 amino acids. Bioinformatic analysis 
suggests it has two functional domains. At the N-terminus, the first 41 amino-acid 
residues are predicted to be a secretory signal peptide, which is removed during protein 
processing to give the 182 amino-acid mature protein, sequestered on or in the bacterial 
cell wall. At the C-terminus, a LysM module is found, which probably promotes its 
association with the peptidoglycan o f  the cell envelope (Bateman & Bycroft 2000). The 
Rpf domain also contains two highly conserved cysteine residues believed to lie in close 
proximity and to form a disulphide bridge (Ravagnani, Finan & Young 2005). All the 
rpf-WkQ genes share extensive sequence similarity over a 70aa segment, known as the 
'R p f  domain' (Figure 1.1). A truncated form o f the protein consisting only o f  the 'R p f  
domain* is fully active and the C-terminus LysM module is not required for biological 
activity (Mukamolova et al 2002a).
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Figure 1.1 Multiple sequence alignment o f  the conserved region o f M. luteus R pf 
and the five R pf orthologues o f  M. tuberculosis. Conserved residues are in red and 
residues in green represent those absolutely conserved in all known R pf orthologues.
Rv0867c (RpfA) EWDQVAR CESGGNWS INTGNGYLGGLQFTQS TWASH 91
R vl009  (RpfB) I WDA I AGCEAGGNWAINTGNGYYGGVQFDQGTWEAN 332
Rv 1884c (RpfC) NW DAVAQ CESGGNW AANTGNGK YGGLQFKPA TWAAF 117
Rv2389 (RpfD) DW DA I AQC ESGGNWAANTGNGLYGGLQI SQATWDSN 98
Rv2450c (RpfE) NW DA I AQCESGGNWS INTGNGYYGGL RFTAGTWRAN 145
Rpf TWD R LAEC’ESNGTWD I NTGNG FYGGVQFTLS SWQAV 88
Rv0867c (RpfA) GGGEFAPSAQLASREQQ I AVGERVLATQGRGAWPVCG 140
R vl009  (RpfB) GGLRYAPRADLATREEQIAVAEVTRLRQGWGAWPVCA 362
Rv 1884c (RpfC) GGVG - - - NPAAASREQQ I AVANRVLAEQGLDAWPTCG 166
Rv2389 (RpfD) GGVG - - - SPAAASPQQQ I EVADNIMKTQG PGAWPKCS 147
Rv2450c (RpfE) GGSG - - - SAAN ASREEQ I RVAENVLRSQGI RAWPVCG 172
Rpf GGEG - - - YPHQASKAEQI KRAEI LQDLQGWGAWPLCS 137
R pf was considered in 1998 to be the first autocrine or paracrine factor identified which 
stimulated the resuscitation o f dormant bacteria (Mukamolova et al 1998); it was 
considered to have the properties o f  a cytokine because it also stimulated the growth o f 
viable cells and was thought likely to have a role in the normal control o f  cell 
multiplication. The high potency o f Rpfs, and the fact that there is an optimum 
concentration for activity, above which they are inactive (a phenomenon seen in studies 
o f  ligand-receptor interactions) seemed to support the suggestion that Rpfs bind to 
specific protein receptors. Over the last twelve months however evidence has been 
mounting that the Rpfs may have a different mode o f  action, namely, as muralytic 
enzymes. Alignments show a 30% homology between the R pf domain and the c-type 
lysozyme family (Cohen-Gonsaud et al 2004). The conserved residues are glutamate at 
position 35, glycine at positions 46 and 104, and tryptophan at positions 64 and 108. All
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deletions appear to be sited in relatively unimportant parts o f loops, and although the 
cysteine residues are not conserv ed in lysozyme, the disulphide bridges are. Hence, the 
R pf domain has a lysozyme-like fold. The molecular structure o f the common R pf core, 
or R pf domain, as determined by NMR spectroscopy, was recently published. (Cohen- 
Gonsaud et al 2005). This confirmed the resemblance o f  Rpf to glycoside hydrolases 
and the presence in Rpf o f a cleft equivalent to the oligo-saccharide binding site cleft o f 
c-type lysozymes. Using NMR, binding o f the R pf domain to trimers o f the 
polysaccharide NAG was demonstrated in the form o f chemical shift changes for 
residues o f the putative binding groove. The experiments suggested that the same 
binding mechanism is present in c-type lysozymes as in Rpf. The need for an active site 
glutamate was confirmed by producing a mutant R pf which lacked this residue: the 
resuscitation activity o f the mutant protein was completely suppressed. Hence, although 
the overall sequence conservation between R pf and c-type lysozymes is low, the need 
for an active site glutamate and a binding pocket that undergoes rearrangement in the 
presence o f a polysaccharide strongly suggest that the function o f Rpfs may be to cleave 
oligosaccharide in the cell wall. Another publication from Mike Y oung's group 
supports this view (Ravagnani, Finan & Young 2005). In this work, the R pf proteins 
were classified into several subfamilies by in silico  analysis o f the accessory domains. 
The RpfB subfamily has very similar domain structures and genomic contexts to a 
group o f proteins o f  unknown function in the low G+C Gram positive bacteria (which 
do not contain Rpfs). In these proteins, the R pf domain is replaced by another 
completely different domain designated Sps (stationary phase survival). Forty-six Sps 
domains have been identified. Organisms containing sps-like genes include Bacillus 
anthracis, Bacillus cereus, Listeria monocytogenes, Enterococcus faecalis, Clostridium  
botulinum, Clostridium tetani and Clostridium perfringens. The Sps domain was found 
to be associated with other domains known to be present in muralytic enzymes (eg
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SH3b and LysM). The sequence similarity between the C-terminal region o f the Sps 
domain and that o f  the Gram-negative lytic transglycosylase MltA also supports this 
association. Mike Y oung's group have subsequently shown that M. luteus R pf has 
murein hydrolase activity in zymograms (M ukamolova et al 2006). This has led to their 
suggestion that the walls o f dormant organisms may contain inert peptidoglycan which 
could be likened to a 'cocoon ', requiring the muralytic enzymes to cleave certain 
residues so that growth and cell wall expansion can resume. It is still possible that cell­
cell signalling might be involved, perhaps mediated by a small molecule released as a 
result o f the cleavage o f peptidoglycan by Rpf.
1.3.3 Activity o f  R p f
Once the gene encoding the R pf had been identified, it was cloned and expressed in E. 
coli (M ukamolova et al 1998). The recombinant protein was found to have the 
following activity:
i. it promoted the resuscitation o f dormant cells o f  M  luteus, in a similar manner 
to the culture supernatant used in the first experiments. Activity is greatest when 
the proteins are used in picomolar concentrations; activity is lost at both higher 
and lower concentrations.
ii. it shortened the apparent lag phase (ie as estimated by optical density o f  the 
culture medium) o f M. luteus in batch culture.
iii. it enabled small inocula o f washed cells to grow in minimal media, that could 
not grow in the absence o f Rpf.
R pf was also able to stimulate the growth o f washed Mycobacterium smegmatis cells in 
Sauton's medium (a relatively minimal medium). The cells could not grow in the 
absence o f Rpf. Similarly, R pf stimulates the growth o f M  tuberculosis, M ycobacterium
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avium, Mycobacterium bovis BCG and Mycobacterium kansasii in Sauton's medium, as 
evidenced microscopically after Ziehl-Neelson staining o f 50 ul culture after 14 days.
R pf has been described as an essential secreted growth factor (M ukamolova et al 
2002a). As well as being essential for growth o f washed cells o f M. luteus inoculated at 
low density into a minimal medium, incorporation o f  anti-Rpf antibodies into the 
culture medium at the time o f  inoculation also prevented bacterial growth. Addition o f  
recombinant R pf as well as anti-R pf antibodies to the medium abolished this inhibition. 
Furthermore, attempts to disrupt the r p f  gene failed except in the presence o f a second 
functional plasmid-located copy o f  the gene. An r p f  null mutant could not be 
constructed, even when recombinant R pf was added to the growth medium. On the 
other hand, Hartmann (Hartmann et al 2004) studied Coiynebacterium glutamicum  
which contains two rpf-gene homologues. In this organism, strains with deletions o f 
both these genes could be constructed, indicating that the two genes were not 
collectively essential for C. glutamicum. However the double mutant displayed slower 
growth and a prolonged lag phase after transfer o f long-stored cells into fresh medium.
1.3.4 Onset o f  transcription and appearance o f  R p f in cultures
Isolation o f  mRNA at various times in the M. luteus bacterial growth cycle revealed that 
transcripts o f  R pf became detectable by RT-PCR within 30 min o f inoculation o f the 
medium with M. luteus cells. Within 1 hour o f  inoculation, transcripts were abundant, 
and they remained so throughout the lag phase. From early mid-log phase onwards the 
transcript abundance began to decline, until they were undetectable in late stationary 
phase. To measure the accumulation o f  R pf itself in the medium, ELISAs were used, 
which revealed that R pf was not detectable until about 5 hours after inoculation, by 
which time almost two doublings had occurred. R pf accumulated in the culture medium
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during early mid-exponential phase and declined afterwards, reaching zero at 50 hours 
post-inoculation. Hence there was a delay between the onset o f rp f  transcription and the 
appearance o f  R pf in the culture supernatant. The probable explanation for this was 
given by examining the bacteria by confocal microscopy after labelling with anti-Rpf 
antibodies. R pf was present on the bacterial cell surface in mid-exponential phase: in 
samples taken much earlier during the growth cycle R pf was present on a higher number 
o f  cells (-30% ). Many o f the protein molecules may have remained cell-associated, to 
be released later into the culture medium. This event might represent a signal, 
anticipating onset o f a period o f less active growth in preparation for stationary phase, 
or, the action o f R pf might be mediated whilst still attached to the cell surface.
1.3.5 Rpfs in M. tuberculosis
Homology searches revealed that M. tuberculosis contains five rp f  gene orthologues. 
All show extensive sequence similarity to the N-terminal (signalling) domain o f  R pf 
(See Figure 1.1). Two o f the proteins, RpfA (Rv0867c, 407 aa) and RpfD (Rv2389c, 
154aa) are predicted to be secreted. RpfA is a com paratively large protein in which the 
Rpf-like sequence is followed by a long series o f proline and alanine-rich repeats at 
residues 146-320. RpfB (RvT009, 362aa) seems to have a membrane anchor at the N- 
terminus and its Rpf-like domain at the C-terminus. It is thought to be anchored to the 
outer surface o f the cell membrane by an N-terminal prokaryotic membrane lipoprotein 
lipid attachment site. The status o f the products o f the other two genes, RpfC (Rv 1884c, 
176aa) and RpfE (Rv2450c, 172aa), is less clear though they are probably also 
m embrane-associated or secreted (M ukamolova et al 2002b). Like R pf from M.luteus, 
all five probably have extra-cytoplasmic functions. Figure 1.2 shows the postulated 
functional regions o f the rpf-like gene products from M. tuberculosis, as a schematic
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comparison. The gene and amino acid sequences o f each protein, and their molar 
extinction co-efficients, are shown in Appendix i.
Figure 1.2 Diagrammatic representation o f  all five M. tuberculosis Rpfs, showing 
predicted molecular weights and number o f  amino acid residues. Adapted from 
Mukamolova et al 2002b and Ravagnani, Finan & Young 2005.
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RpfC MW 12,110 176 aa
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The five genes are scattered around the M. tuberculosis genome. This protein family 
may show functional redundancy, or, the different signalling molecules may be 
produced under different conditions or for different specific purposes. All five knock­
out mutants for each one o f RpfA-E o f  M  tuberculosis are viable (Downing et al 2004, 
Tufariello et al 2004): the cells grew as well as wild type in aerated liquid medium, 
although a slightly lower final cell density was reached and colonies were slightly 
smaller on agar. However, mutants o f  M. tuberculosis lacking three o f  the r p f  genes 
{rpfA, rpfB  and rpfC  or r p f A, rpfC  and rpfD) were significantly attenuated in a mouse 
infection model, and w ere unable to resuscitate spontaneously in culture (Downing et al 
2005). In D ow ning's first (2004) published study, global gene expression profiling 
showed that loss o f rpfC  affected the expression o f the largest number o f genes (118 
genes up-regulated and 91 down-regulated). The authors suggest that this relatively 
large number may indicate a shift in metabolism or a response to shock: several genes 
indicating a shock response were up-regulated including sigB, sigE, and four genes 
encoding heat shock proteins. There was significant overlap in the differential gene 
expression profile o f  the rpfC  mutant with those o f the RpfB, rpfD  and rpfE  mutants; the 
expression profile o f the rp f A mutant was notably less similar. Recently, Rickman et al 
have shown that RpfA expression is regulated by a transcription factor belonging to the 
cAMP receptor protein family. Deletion o f Rv3676, which encodes this transcription 
factor, causes growth defects both in laboratory culture and in a mouse model (Rickman 
et al 2005).
The rp f  genes have been isolated from M. tuberculosis DNA, cloned and expressed in E. 
coli (M ukamolova et al 2002b, Zhu et al 2003). RpfA, RpfC, RpfD and RpfE were all 
found to decrease the apparent lag phase o f M. luteus (similarly to Rpf) w'hen used in 
subpicomolar concentrations. RpfB w^as not tested in this context. RpfA and RpfC were
the most potent: RpfA showed activity at fM concentrations (equivalent to just a few 
molecules per cell), whilst RpfC caused the greatest reduction in apparent lag phase 
(from 216h to 80h). As with Rpf, there appears to be an optimum concentration range 
for activity, above and below which there is reduced activity or none at all. The proteins 
appear to lose biological activity during storage.
The five M. tuberculosis Rpfs were also tested on cells o f M. bovis BCG, which 
contains five r p f  gene homologues very similar to those o f  M. tuberculosis. When 
actively growing cells w ere used, the R pf proteins did not stimulate bacterial growth. 
However, in common with M. tuberculosis, cells o f M. bovis BCG lose culturability 
during extended stationary phase (Sun et al 1999, Lim et al 1999, Shleeva et al 2002); 
see Chapter 5. Use o f  such late stationary phase cells showed that all five proteins, used 
in pM concentrations, enabled dormant cells to grow that could not grow in their 
absence (M ukamolova et al 2002b). In the experiments on M. luteus, as stated 
previously, it was possible to produce a state in which cells could not grow’ without the 
addition o f  Rpf, by washing the cells and then inoculating them at low' density in 
minimal medium. W ashing presumably removes secreted R pf associated with the cell 
envelope. However it was not possible to reproduce this effect with M. tuberculosis and 
M. bovis, supporting the belief that one or more o f  the Rpfs produced by these 
organisms is membrane bound (specifically, RpfB).
To investigate the expression o f  the five genes, mRNA corresponding to each was 
detected by RT-PCR using RNA extracted from in vitro growing cultures o f  M. 
tuberculosis and M. bovis BCG (M ukamolova et al 2002b). All five were expressed in 
both organisms under these conditions. RpfC appeared much more highly expressed 
than the others (unpublished data). However, mRNA corresponding to the genes could
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not be detected in cultures o f M. bovis BCG during stationary phase, or from cells 
which had been starved for 5 months. These R pf genes are thus expressed in actively 
growing cells, but not in non-growing cells (or they are below the limit o f detection). 
R pf proteins were also detected in the supernatants o f actively growing cultures o f M. 
tuberculosis and M. bovis BCG, using anti-Rpf antibodies. As with the M. luteus 
experiments, use o f confocal microscopy o f  M. bovis BCG incubated with anti-Rpf 
antibodies and a secondary FITC-labelled antibody showed that Rpf-like proteins could 
be detected on the bacterial cell surface. About 30% o f the cells in early logarithmic 
phase cultures showed fluorescence. None was seen in stationary phase cultures. 
Adding anti-Rpf antibodies to the culture medium inhibited the growth o f both M  bovis 
BCG and M. tuberculosis; this effect could be abolished by also adding Rpf.
1.3.6 Effect o f  R p f expression in vivo
As stated earlier, recombinant proteins appear unstable with storage and the number o f 
biologically active molecules in each batch o f  protein may vary w idely. Because o f this 
attempts have been made to examine the effect o f R pf expression in vivo (M ukamolova 
et al 2002b, Shleeva et al 2004). In M ukam olova's experiment, a plasmid expressing 
r p f  under the control o f a M. smegmatis promoter w as introduced into M. smegmatis. 
When these bacteria were subjected to inoculation at low density into a nutrient-poor 
medium (Sauton's) the apparent lag phase was reduced in the Rpf-expressing strain 
compared to a control. The effect was not visible at a high inoculation density. Shleeva 
found that dormant cells o f M. smegmatis harbouring plasmids expressing rp f  
resuscitated spontaneously in Sauton's medium after an apparent lag o f 3 days. Control 
cells with the same plasmids but lacking r p f  failed to resuscitate spontaneously, as had 
been observed with the wdld-type.
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1.3.7 Clinical relevance o f  R p f
The study o f the M. tuberculosis Rpfs may have great clinical relevance. It has been 
demonstrated that M. tuberculosis cells isolated from murine macrophages, which could 
not be cultured under normal conditions, could be resuscitated using R pf in liquid 
medium (Biketov et al 2000). This has implications for the laboratory diagnosis o f 
tuberculosis, where cultures may be falsely negative or very slow-growing because o f 
failure o f  growth o f organisms which have become dormant or metabolically inactive. 
Addition o f R pf or Rpf analogues to culture media might lead to more sensitive and 
rapid culture o f slow-growing mycobacteria -  for a preliminary study see Freeman et al 
2002. From a therapeutic point o f view, cells in a low state o f metabolic activity are less 
susceptible to drug treatment, so to resuscitate them might be to render them easier to 
treat with conventional drug treatments. Rpfs might be used as an adjunct to 
conventional treatment and thus result in a shorter course o f chemotherapy. Conversely, 
where there is a high risk o f reactivation o f tuberculosis, for example in HIV infection, 
suppression o f  R pf expression or activity might be able to prevent the disease becoming 
active again. Finally, Micrococcus luteus R pf and RpfE have been used in mice to 
produce an immune response against infection with M. tuberculosis (Yeremeev et al 
2003). IgGl and IgG2 responses were elicited, as well as T-cell proliferation and the 
production o f gam ma interferon, IL-10, and IL-12. The levels o f protection obtained, as 
evidenced by survival times and mycobacterial multiplication in organs, was 
comparable to that obtained using short-term culture filtrate components such as Ag85B 
and ESAT-6, or by using a low dose (10'' cfu) o f  BCG: although lower than the level 
achieved by vaccination with 104-  106cfu o f BCG.
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1.4 Aims of the project
The original aim o f  this project was to investigate the effects o f the mycobacterial Rpfs 
on the antimicrobial susceptibility o f  dormant cultures o f M. tuberculosis. It was 
postulated that the resuscitation o f  dormant cultures o f  the organism, using Rpfs, would 
simultaneously increase their susceptibility to anti-tuberculosis drugs, which is known 
to be reduced in the dormant state. However, difficulties with the stability and solubility 
o f the Rpfs, and the measurement o f  their activity, precluded this. Hence the first part o f 
the project, described in chapters 3-5, concentrated on resolving these problems by 
improving the expression and solubility o f  recombinant Rpfs, and developing assays for 
measuring their activity, to pave the way for future work. Chapter 6 is an account o f the 
attempt to identify a protein receptor molecule for Rpfs in A/, tuberculosis, using the 
technique o f phage display. Chapter 7 describes the location o f Rpfs in M. tuberculosis- 
infected human tissue sections, as identified by immunocytochemistry.
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CH APTER II
M ATERIALS AND M ETHODS
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2 M aterials and M ethods
All chemicals were obtained from Sigma and BDH, unless stated otherwise in the text. 
Media and solutions are listed in Appendix //.
2.1 Cloning experiments
2.1.1 DNA extractions from  Escherichia coli
Strains for DNA extraction were taken from the -80°C  freezer and cultured overnight in 
Luria-Bertani broth (LB) or Nutrient Broth 2 (NB2) containing the appropriate 
concentration o f  antibiotic, in 2 x 2 ml glass test tubes or in sterile plastic universals on 
a shaking incubator at 37°C. The following day DNA was extracted using the Qiagen 
QIA Prep Spin Miniprep kit. following the m anufacturer's instructions.
2.1.2 DNA extractions from  M. tuberculosis
This was carried out in the containment level 3 laboratory. A loopful o f cells o f  H37Rv 
from a Lowenstein-Jensen slope was transferred into a sterile 1 ml microcentrifuge tube 
containing 400pl o f TE buffer. This was heated at 80°C for 20 min to kill the cells, then 
cooled to room temperature. 50 pi o f lOmg/ml lysozyme were added, the suspension 
vortexed briefly and incubated for 1 hour at 37°C. 75 pi 10% SDS./proteinase K solution 
was added, the tube inverted, and incubated for 10 min at 65°C. 100 pi o f 5 M NaCl was 
added, then 100 pi o f CTAB/NaCl solution (prewarmed at 65°C for 5 min). The liquid 
was vortexed until it became white, then incubated for 10 min at 65°C. 750 pi 
chloroform/isoamyl alcohol was added, the tube mixed by inversion and centrifuged at 
room temperature for 5 min at 12,000 g.
The rest o f the procedure was carried out outside the containment level 3 laboratory. All 
the aqueous supernatant was transferred, in 180 pi aliquots, to a fresh 1 ml
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microcentrifuge tube, using a pipette. Next 450 pi ice-cold isopropanol was added to 
precipitate the nucleic acids and the tube rolled carefully by hand. It was then placed at 
-20°C for 30 min, before microfuging for 15 min at 10,000 g. Most o f  the supernatant 
was removed, and the pellet washed with 1 ml ice cold 70% ethanol, and inverted 
gently. This was microfuged at 10,000 g for 5 min, and the supernatant discarded 
carefully. The pellet was allowed to air-dry at room temperature and resuspended in 50 
pi TE buffer, overnight at 4°C.
2.1.3 M easurement o f  DNA concentrations
This was done with the PicoGreen dsDNA Quantitation kit (M olecular Probes), as per 
the m anufacturer's instructions.
2.1.4 PCR for genes rpfD and Rv0328
Primers were designed for the rpf-D  gene that did not include the N-terminal signal 
sequence. The primers were designed to have an Ndel site at the N-term inal/5' end 
(primer sequence CGC ATA TGG ACG ACA TCG ATT GGG ACG CC, restriction 
site underlined) and an Xhol site at the C-term inal/3' end (primer sequence CTC GAG 
ATC GTC CCT GCT CCC CGA ACA A). The sequence for amplification had a length 
o f  315 bp. The reaction was carried out with 5 pi M. tuberculosis DNA (concentration 
50 pg/ml) both in the presence and absence o f Q solution (Qiagen) in a total reaction 
volume o f 50 pi. 1 pi Taq polymerase was added after heating to 95°C for a 'hot start'.
Primers for Rv0328 wrere designed with an Ndel site at the 5 'end (primer sequence 
ATA TCA TAT GCA ACA GCA ACG CAC A) and a H indlll site at the 3' end (primer 
sequence ATA TAA GCT TCA CCG CAA CTG CGA CGT). The reaction was carried
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out as for the rpf.D gene PCR but without Q solution and without using 'hot start'. The 
PCR protocol w as:
5 min @ 95°C
30 cycles: Denaturation: 95 ° C for 30 s
Annealing: 60 °C  for 90 s 
Extension: 72 °C  for 120 s 
Final extension: 72°C for 10 min
2.1.5 TO P 0 2.1 % cloning reaction
This was done according to the m anufacturer's instructions (Invitrogen).
2.1.6 Restriction endonuclease digestions
Enzymes for digestions, and their respective buffers, were obtained from New England 
Biolabs (NEB). Buffers were used at a concentration o f 10% o f the total reaction 
volume (v/v), which was usually 20 pi. Digestions were carried out in 1.5 ml 
microcentrifuge tubes. Where BamHl was used bovine serum albumin (NEB) was also 
added to the reaction mix (0.2 pi) Each digestion reaction was incubated at 37°C for 90- 
120 min, then examined by agarose gel electrophoresis.
2.1.7 Agarose gel electrophoresis
This followed the standard method for a 1% agarose gel in TAE buffer. 1 g agarose was 
dissolved in 100 ml TAE buffer by heating in a microwave oven. The agarose was 
cooled to about 50°C. then ethidium bromide (0.5 pg/ml) was added. The mixture was 
then poured into a taped gel tray containing the appropriate comb. After cooling, the 
solid gel in the tray was transferred to a horizontal gel tank filled wdth TAE. DNA 
samples containing 10% (v/v) loading buffer w^ere loaded into the wells left after
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removal o f the comb and the tank was connected to a power supply. This was run 
constantly at 10-15 V/cm, and the DNA was left to migrate through the gel towards the 
positive pole. The ethidium bromide-stained DNA was visualised under ultraviolet light 
(302 nm). Where small DNA fragments were to be visualised a 2% gel was used.
2.1.8 Extraction o f  DNA from  agarose gel
For this procedure, the desired band o f  DNA was excised from the agarose gel with a 
clean scalpel under ultraviolet light, then extracted from the gel using the QIAEX II 
Agarose Gel Extraction Kit (Qiagen), following the m anufacturer's instructions.
2.1.9 Treatment with calf-intestinal alkaline phosphatase
On occasion digested DNA was treated with calf-intestinal alkaline phosphatase (CIP) 
prior to ligation. 1 pi calf-intestinal CIP (NEB). 1 pi 10 x buffer (NEB) and 8 pi 
distilled water were added to 30 pi o f digested DNA and incubated at 37°Cfor 1 h. The 
enzyme was removed from the reaction mixture by passing through a QIA quick 
column (Qiagen), before setting up the ligation itself as above.
2.1.10 Ligation reactions
T4 DNA li gase (NEB) was used with 10 x T4 DNA ligase buffer (NEB). 1 pi o f  T4 
DNA ligase and 1 pi buffer were used with the required DNA in a 10 pi total volume 
reaction. The reaction was performed in a 1.5 ml microcentrifuge tube and incubated 
overnight on the bench.
Alternatively in some cases Ready-To-Go1 M T4 DNA ligase (Amersham Biosciences)
was used. 20 pi o f DNA solution was added to the tube, which was incubated at room
temperature for 3-5 min, then gently mixed by pipetting. The tube was incubated at
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room temperature for a further 30-45 min, then the ligase was inactivated by heating to 
70°C for 10 min.
2.1.11 Preparation o f  competent E. coli host cells
5 ml o f nutrient broth was inoculated with the E. coli host cells and grown on a shaker- 
incubator at 37°C for 3-4 hours until the OD60U was about 0.6. 1.5 ml o f the culture was 
pelleted in a microcentrifuge tube (14 0000 rpm for 5 min) and then resuspended by 
pipetting in 0.75 ml o f an ice-cold solution o f 0.075 M CaCT 15% glycerol. The cells 
were pelleted again and gently resuspended in 0.15 ml o f  the same solution. They were 
then used immediately, or stored at -70° C.
2.1.12 Transformation o f  competent cells
200 pi o f the competent cell suspension was mixed with 1 pi DNA. using a cold pipette 
tip. This mixture was left on ice for 10 min and then heat-shocked at 42°C for 90 s. 
SOB (800 pi) was added and the mixture was shaken at 37°C for 90 min. 0.1 -  0.2 ml 
aliquots o f the transformed cells were plated onto selective antibiotic plates with a plate 
spreader and incubated at 37°C overnight.
2.1.13 Blue-white selection o f  XL2-Blue strain (Novagen)
This method was used in the selection o f XL2-Blue cells transformed with pET-43.1b 
containing the Rpfsmcg gene insert and o f DH5a cells transformed with the TOPO 2.1® 
vector containing the rpfD  gene insert or the Rv0328 gene insert.
50 pi, 100 pi and 200 pi aliquots o f  the transformed cells were plated onto LB plates 
containing ampicillin (50 pg/ml). 40 pM  5-bromo-4-chloro-3-indolyl-p-D- 
galactopyranoside (X-Gal) and 0.4 mM isopropvl p-D-thiogalactopyranoside (IPTG).
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The plates were incubated overnight at 37°C. White colonies were picked o ff and 
subcultured onto LB plates containing 50 pg ampicillin/ml and re-incubated for 6 h. 
These subcultured colonies were then incubated in broth overnight on a shaker. Next 
day, a subculture from each broth was made on LB/Ap50, streaking to obtain single 
colonies.
2.1.14 Sequencing o f  cloned gene inserts
This was done by thermal cycle sequencing, using the ABI 310 system, a capillary 
electrophoresis-based sequencer using laser fluorescence detection o f Big Dye 
terminators. Sequencing was carried out following the m anufacturer's instructions.
2.1.15 Storage o f  expression hosts and clones
All hosts and clones were frozen in 20% glycerol and stored at -70°C .
2.2 Protein expression
2.2.1 IPTG induction
10 ml Nutrient Broth E (NBE, Lab M) or NB2 (Oxoid) containing 50 pg ampicillin/ml 
in a 100 ml conical flask, was inoculated with the desired bacterial strain from the - 
70°C freezer, and cultured on a shaker-incubator at 37°C overnight. The following 
morning, 1.5 ml o f the culture w as removed and centrifuged for 1 min at 13,000 rpm in 
a microcentrifuge tube. The supernatant was discarded, to remove any P-lactamase that 
had accumulated in the overnight cultures.
500 ml conical flasks containing 150 ml NBE/NB2 and 50 pg ampicillin/ml were 
prepared. The cell pellet after centrifugation w as resuspended in 1 ml o f  this broth and 
then inoculated into the 500 ml flask. The bacteria w-ere cultured on a shaker-incubator
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at 37°C until the culture had reached an OD6oonm o f between 0.7 and 0.9 (about 4 h). At 
this point, 1 mM IPTG was added and the incubation continued for a further 3 h. In the 
case o f RpfC and RpfD, which have low levels o f  expression in these hosts and vectors, 
300-ml cultures were used rather than 150-ml cultures. They were also incubated for 6 h 
after the addition o f  IPTG, whilst the other Rpfs only required incubation for 3 h. In 
some other experiments, the concentration o f IPTG and the length and temperature o f 
induction were varied to improve solubility and where this was done it is indicated in 
the text.
2.2.2 Harvesting the induced cells
At the end o f  the induction, the cultures were centrifuged for 10 min at 6000 rpm. The 
cells were then resuspended in 50 ml 20mM Tris-HCl pH 8 and centrifuged again. The 
supernatant was discarded and the cell pellets stored at -20°C .
2.3 Protein extraction and purification
2.3.1 Sonication
When using urea, the frozen induced cell pellet was resuspended in 5 ml binding buffer 
containing 8 M or 6 M urea, and sonicated using a MSE sonicator. Sonication was 
carried out on ice, using six 30 s periods o f  sonication with 30 s interv als between them. 
The suspension was then left on ice for between 20 min and 1 h for the urea to dissolve 
the proteins, then four further 30 s bursts o f sonication, with 30 s intervals between 
them, were applied.
When urea was not being used, the frozen pellets were re-suspended in binding buffer 
without urea and kept on ice at all times to limit the action o f  proteases. Sonication was 
carried out using the same equipment settings but for shorter bursts to prevent heating
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the sample: between 6 and 20 x 15 s bursts were used with 30 s intervals in between 
each burst. Microscopic examination w as employed to determine the extent o f  bacterial 
disruption.
In both cases, the suspension was then decanted into 1.5 ml microcentrifuge tubes and 
centrifuged at 14,000 rpm for 30-40 min (in a centrifuge refrigerated to 4°C where urea 
w'as not used). The supernatant was removed w'ith a syringe and the end o f a pipette tip 
and filtered through a 5 pm filter ready for protein purification.
2.3.2 Protein purification by metal-ion chelation column chromatography 
This procedure w as initially carried out using in-house sepharose columns. Later in the 
course o f the project commercially available nickel columns were used (Quick-900 
columns, Novagen).
2.3.2.1 Protein purification using in-house sepharose columns
When urea was used, all the buffers except for the charge buffer and the strip buffer 
contained 8 M urea. When urea was not used, extraction and purification was performed 
keeping temperatures at 4°C throughout. The steps up to purification were done on ice 
and using a refrigerated centrifuge, and the whole purification procedure was carried out 
in a 4°C cold room.
Columns were prepared by adding 2 ml resin (iminodiacetic acid immobilized on 
Sephadex 6B Fast Flow', suspended in 20% ethanol- Sigma) to a chromatography 
column (Sigma). The resin was allowed to settle. The columns were then rinsed twice 
wdth 10 ml deionised w'ater, to w^ash out the alcohol, and then charged with 10 ml 
charge buffer (containing nickel). When this had eluted, the column was equilibrated
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with 10 ml binding buffer. After this the base o f  the column was blocked and 2 ml 
binding buffer was added. The surface was gently pipetted up and down to create a flat 
surface after re-settling (the end o f  the pipette tip was cut in order not to disturb the 
beads too much). Then the remaining binding buffer was allowed to drain off.
The filtered supernatant (crude extract) containing the cell protein was then applied to 
the column, and the unbound fraction collected. About 20 pi o f the crude extract was 
also kept aside for later analysis by SDS-PAGE. The column was washed with 20 ml 
binding buffer. 50 ml w ash buffer containing 60 mM imidazole was then applied to the 
column and a sample o f the bulk eluate collected (wash fraction). A few; ml o f elution
buffer w'ere applied and 1 ml fractions were collected in 5 or 6 numbered
microcentrifuge tubes (elution fractions). The column was then washed with 8 ml strip 
buffer and a sample o f the bulk eluate collected again (strip fraction). Finally, 10 ml o f 
deionised water was passed through the column, followed by 10 ml o f 20% ethanol. The 
columns were stored at 4°C with 3 ml o f 20% ethanol in them.
2.3.2.2 Protein purification using Quick-900 columns (Novagen)
Later in the course o f the project commercially available nickel columns were used 
(Quick-900 columns, Novagen), instead o f in-house sepharose columns. The buffers 
used contained 6 M rather than 8 M urea and the m anufacturer's instructions were 
followed.
2.3.3 Estimation o f  purified protein concentration
The concentration o f protein in each o f  the elution fractions was tested by one o f  two 
methods -  either by measuring the A 280nm in a spectrophotometer, against a blank o f 
elution buffer, and using this in conjunction with the molar extinction coefficient
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(Appendix /), to calculate the concentration; or by using a modified Bradford assay, 
available as Coomassie Plus Protein Assay kit (Pierce) and following the 
manufacturer's instructions.
2.3.4 Large scale expression, extraction and purification o f  RpfE  
Eight litres o f culture o f the E coli host were set up for induction, in a yeast-peptone 
induction medium. Ampicillin 50 pg/ml was added, plus 1 ml glucose per 100 ml 
culture to suppress protein production until IPTG was added.
Sixteen 500 ml flasks were set up. Each was inoculated with a 1:100 dilution o f 
overnight culture o f clone AD11 -  rpfE in vector pET-15b.tev and host Origami B 
(DE3) pLysS (see Appendix Hi for a table o f clones used). IPTG 0.1 mM was added 
when the OD6oo was 0.7 -  0.9. The flasks were incubated at 25°C for a further 4 ‘A 
hours. The cultures were spun down and washed with PBS. Extraction was done on the 
deposit from 2 1 culture volumes at once and 2 ml lysis (binding) buffer was used per lg  
pellet. 1 tablet o f  Protease Inhibitor Cocktail (Roche) was added per 50 ml lysis 
suspension. The suspension was sonicated on ice using 12 bursts o f 30 s with 30 s 
interv als. Sonicated suspension was spun down at 20 000 rpm for 1 h.
The cell extract was loaded onto an A K T A 1V1 fpicim chromatography system 
(Amersham Biosciences) and run down two 5 ml HiTrap nickel-chelating HP
TYlcolumns (Amersham Biosciences). Subsequently, the imidazole concentration in the 
buffers was increased at discrete intervals by mixing binding and elution buffer.
5 ml aliquots which corresponded with protein peaks were saved and kept at 4°C.
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Desalting was performed on the same equipment using HiPrep 26/10 50ml desalting 
columns™  (Amersham Biosciences) and binding buffer.
The equipment was supported by the Unicom V3.00 software operating system.
2.3.5 TEV protease cleavage o f  His-tag from  RpfE expressed from  pET-15b. tev 
Recombinant TEV (rTEV) protease was obtained from Invitrogen in concentration 
10 u/pl. The reaction mix consisted of:
1 pi rTEV protease per 20 pg protein.
1% v/v DTT (0.1 M)
0.1% v'/v EDTA (0.5 M)
The mixture was incubated on a roller at 16°C. Small aliquots were taken off hourly for 
the first 3 h and then after overnight incubation. Once removed the reaction was stopped 
in each aliquot by heating in a hot-block at 80°C for 10 min. Each sample then was then
T VIconcentrated using Vivaspin filter-concentrators (Vivascience). rTEV protease was
T \ 1separated from R pf by passing through a HiTrap nickel-chelating FPLC column as 
before.
2.3.6 SDS-PAGE (Sodium Dodecyl Sulphate-Poly aeiylam ide Gel Electrophoresis)
The equipment used was the BioRad Mini-PROTEAN 3™ system. Acrylamide was 
obtained from National Diagnostics, TEMED and ammonium persulphate (APS) from 
Sigma. A 12.5% separating gel was made as follows:
Acrylamide 3.275 ml
Tris-HCl pH 8.8 1.86 ml
H20 2.725 ml
TEMED 15 pi
APS 10 pi
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The separating gel was overlaid with H2O to obtain a flat surface and allowed to 
polymerise for at least 20 min. Stacking gel was made as follows (equivalent to a 7.5% 
gel):
Acrylamide 0.5 ml
Tris-HCl pH 6.8 0.75 ml
H20 1.7 ml
TEMED 20 pi
APS 15 pi
When the separating gel had polymerised, the water was drained off, the stacking gel 
was applied, the comb inserted and this was allowed to polymerise for at least another 
25 min. When polymerised, the comb was removed from the stacking gel and the gel 
placed in the gel tank, which was filled with running buffer. The gel was loaded with 
samples o f volume 10-15 pi in sample buffer (25% v/v). which had been boiled for 5 
min, and a protein marker (NEB) in one well. The gel was run at 200 V for about 60 
min, and then stained by incubating overnight at 48°C with Brilliant Blue G-colloidal 
stain (Sigma) with 20% methanol.
2.3.7 Immimo-blotting
SDS-PAGE gels run for the purpose o f  immuno-blotting were run with a prestained 
MW marker (NEB). After separating the proteins by SDS-PAGE, the gel w;as washed 
with distilled water to remove SDS, and the stacking gel removed and discarded. The 
BioRad Mini-PROTEAN 3 1M equipment was set up according to the m anufacturer's 
instructions. From negative to positive, the blotting apparatus consisted o f  a synthetic 
porous pad, four pieces o f  filter paper (W hatman), the SDS-PAGE gel, a cellulose
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nitrate transfer membrane (W hatman), four more pieces o f filter paper, and another 
porous pad. All components were first soaked in transfer buffer. Bubbles were removed 
by rolling a glass pipette over the filter papers. The blotting apparatus was immersed 
completely in transfer buffer in an electrophoresis tank and run at 20 V in a 4°C cold 
room overnight.
The membrane was removed carefully, using gloves and tweezers, and placed in 
blocking buffer at 37°C for 30 min. This buffer was tipped off, and fresh blocking 
buffer containing the primary antibody was added. The membrane was incubated for 2 h 
at 37°C. then washed with TBS containing 0.2% Tween 20 (3 washes o f 5-10 min each, 
on a 'belly dancer' shaker). Blocking buffer containing 1/20,000 dilution o f the 
secondary antibody was added and the membrane incubated for 30 min at 37°C, before 
washing again in TBS three times. A SIGMA FAST 5-Bromo-4-chloro-3-indolyl 
phosphate/nitro blue tetrazodium (BCIP/NBT) tablet (Sigma) was dissolved in the dark 
in 10 ml distilled water and added to the membrane. This was incubated in the dark until 
the bands becam e visible (about 10-20 min) and then the reaction was stopped by 
discarding the solution and adding water.
2.4 Establishing dormant cultures of Mycobacterium bovis BCG
The strain o f  M. bovis BCG used was the Glaxo strain (a derivative o f the Pasteur 
strain). Two types o f culture were set up: glass test tubes with air-tight PTFE seals, and 
500 ml glass Erlenmeyer flasks w'ith airtight rubber bungs as seals.
M. bovis BCG was cultured in Sauton's medium. Differences in viability between cells 
are more readily apparent in this minimal medium. Use o f a rich medium may mask the
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effect o f addition o f R pf to cultures. In both the tube and the flask models, the vessels 
contained one fifth o f their volume o f Sauton's medium, supplemented with ADC.
The same culture o f BCG was used to inoculate both the tubes and the flasks. This was 
a six-dav old turbid culture, grown from a frozen stock in Sauton's medium at 37°C.
2.4.1 Tubes
2.4.1.J Tubes- culture and sampling
A final dilution o f 10"6 o f the BCG culture in Sauton's medium was prepared, calculated 
to contain approximately 2 cfu/ml o f organisms. 3 ml aliquots were distributed into 
tubes. The tubes were incubated at 37°C in a rack and were not shaken. The pellet o f 
BCG was visible at the bottom o f the tube from a few days onwards. Each time a 
sample was taken, a tube was shaken to suspend the cells, opened, the sample taken and 
the rest o f the culture discarded.
2.4.1.2 Tubes -  estimation o f  viable count
At various intervals, samples were taken and serially diluted in Sauton's medium. 
Samples (100 ul) o f  each dilution were spread on agar plates containing either Sauton's 
medium or M iddlebrook medium. Colony counts were performed in order to obtain an 
estimate o f the viable cfu/ml at different times.
2.4.2 Flasks
2.4.2.1 Flasks -  culture and sampling
A 10° dilution o f the 6 day-old BCG culture in Sauton's medium was inoculated into 
100 ml fresh Sauton's medium in a 500 ml Erlenmeyer flask, to give a final dilution o f 
10°. The resulting culture was calculated to contain approximately 20 cfu/ml. The flask 
was incubated on a shaking platform, at 70 rpm and 37°C. Sampling was done after
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wiping the top o f the rubber septum with alcohol, using a sterile needle inserted through 
the septum.
2.4.2.2 Flasks -  estimation o f  viable count
The sample was serially diluted in Sauton's medium and 100 pi o f each dilution was 
spread on agar plates containing either Sauton's medium or M iddlebrook medium. 
Colony counts were performed in order to obtain an estimate o f the viable cfu/ml at 
different times. Estimation o f cfu/ml was carried out in the same way on day 0 to 
determine the starting inoculum.
2.4.2.3 Flasks -  estimation o f  M ost Probable Number
On some occasions MPN tests were also performed. This test gives an indication o f  the 
number o f  cells present which can grow in liquid medium (not necessarily the same as 
the number that can grow when plated directly on agar). MPN is recognised to give a 
higher viable count than plating on agar. Additionally, R pf could be added to the liquid 
medium to give counts both in the presence and in the absence o f  Rpf, whereas it has no 
activity when incorporated into agar. Where there was a higher count using R pf than 
without, dormant but rescusitatable cells were considered to be present. MPN 
determinations were performed in Sauton's medium as described in 2.5.2.2
2.5 Protein Activity Testing
2.5.1 Protein activity testing measuring optical density o f  M. luteus cultures 
As M. luteus grows far more rapidly than either M. bovis BCG or M. tuberculosis, 
attempts were made to use the effect o f  R pf on the optical density (OD) o f M. luteus 
cultures to assess its activity. M. luteus strain NCIMB 13267 ('Flem ing strain' 2665)
was used. M. luteus was grown overnight in 10 ml Nutrient Broth E at 30°C with
continuous shaking. This provided a culture containing approximately 109 cfu/ml. Cells
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were collected from 1 ml by centrifugation and resuspended in 1 ml Lactate Minimal 
Medium (LMM).
The rest o f the procedure was carried out in a laminar flow cabinet to avoid 
contamination. The suspension was passed through a needle 10-15 times to break up 
clumps o f cells and then serially diluted in microcentrifuge tubes to obtain a suspension 
o f about 10“ cfu/ml.
Freshly prepared R pf was diluted 100-fold in LMM. It was then passed through a 0.2 
pm filter that had been washed first with 20 ml LMM. Serial dilutions o f the filter- 
sterilised R pf were then made, to obtain pM- fM concentrations.
In a microtitre plate, wells were inoculated with 145 pi o f each dilution o f R pf from pM 
to fM. Six replicate rows were inoculated. The wells around the edge o f the plate were 
filled with LMM alone, to combat the 'edge effect' o f evaporation.To each o f the other 
wells were added 5 pi o f the M. luteus cell suspension. The final concentration o f M. 
luteus in the wells was ~3 x 10“ cfu/ml. A control microtitre plate was inoculated in 
parallel, using elution buffer instead o f Rpf. The plates were incubated at 30°C on a 
shaker and read daily, up to 5 days, looking initially for a deposit o f cell aggregates in 
wells, which is usually followed by development o f a turbid cell suspension, indicating 
growth, in the wells.
2.5.2 Protein activity testing using M. bovis BCG cultures
Evidence o f activity o f fresh R pf was sought either by performing an activity test, 
analagous to the one used for M. luteus, using different concentrations o f R pf on 
dormant cultures o f BCG, or by carrying out Most Probable Num ber (MPN)
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experiments on dormant cultures both with and without Rpf. The former method has the 
advantage that the most active concentration o f R pf can be determined. The latter 
method is easier to interpret as it has a better-defined end-point, and data for plotting 
growth curves can be obtained, but owing to the numbers o f tubes required and space 
limitations in the incubator, only a few different protein concentrations/samples can be 
tested at any one time. All testing o f activity on BCG was carried out in a Class 2 safety 
cabinet in a Containment Level 2 laboratory. Details o f how dormant BCG cultures 
were obtained are described in 2.4.
2.5.2.1 C' oncentration-activity te s t ' m ethod
Dormant M. bovis BCG cells were used. 1 ml o f a 10"“ dilution o f the cells was 
inoculated into each o f 6 tubes containing 9 ml Sauton's medium, thus producing a 
dilution o f 10° in each tube.
Freshly prepared R pf was sterilised by passing a 100-fold dilution in Sauton's medium 
through a 0.2 pm filter, which had been flushed with 20 ml Sauton's medium. It was 
then serially diluted, and different dilutions were added to 5 o f the 6 tubes o f BCG. No 
R pf was added to the 6th tube, which acted as a control. The final dilutions o f R pf 
ranged from nM to fM. The contents o f each tube were then mixed and pipetted into a 
rack o f tubes in 2 ml aliquots, to provide 5 replicates o f each concentration o f Rpf, and 
the controls. The tubes were incubated at 37°C. They were read daily and tubes in 
which visible growth was seen were recorded as positive. Growth appeared as a white 
pellet at the bottom o f the transparent tube. Results were recorded daily until all the 
tubes contained visible growth.
2.5.2.2 M ost Probable Num ber method
For this test, different dilutions o f dormant BCG cultures were used with the same 
dilution o f R pf in each tube (as opposed to different concentrations o f R pf in the same 
dilution o f BCG, as described in 2.5.2. J). The MPN tests were performed in Sauton's 
medium as follows:
'M aster-m ix':
10° dilution: 22.5 ml Sauton's medium + 2.5 ml dormant BCG culture at 10'2 dilution
lCT4 ** “ " ’* *’ " at 10° dilution
10° *’ ** " " ** " at 1 O’4 dilution
10'6 ” " " ” ** '* at 10° dilution
10'7 ** ** ” " " '* at 1 O'6 dilution
10‘8 " ** *’ ” ** " at 1 O'7 dilution
Samples (2 ml) o f each 'M aster-m ix' were incubated in 5 replicate clear plastic tubes at 
37°C for up to 6 weeks. These contained no Rpf. To the remaining 12.5 ml o f  each 
'Master-mix* were added 0.125 ml o f the appropriate dilution o f filter-sterilised Rpf. 
The required dilution o f Rpf depended on the calculated concentration o f the stock. 
Normally a final concentration o f -3 0  pM was aimed for in the MPN experiments. 
Samples (2 ml) o f each o f the 'M aster-m ixes' + R pf were incubated in 5 replicate clear 
plastic tubes along with the controls. The tubes were all incubated at 37°C and read 
daily until no additional tubes showed new growth over a period o f 10 days. This was 
taken as the end point o f the experiment. The results were interpreted using published 
MPN tables (Appendix v).
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2.5.3 Protein activity testing using ATP-bioluminescence o fM . luteus cultures
2.5.3.1 (h'ernight \4. luteus cultures ('overnight te s t ')
This technique was applied to assay changes in bacterial counts in the presence and 
absence o f recombinant Rpf. As a positive control, Rpf in the supernatant o f stationary- 
phase M. luteus cultures was used.
LMM was inoculated with an overnight culture o f  M. luteus ( O D 6oo = 2.0) in nutrient 
broth to give a thousand-fold dilution (equivalent to ~~106 cfu/ml in a 50 ml total 
volume). This was divided into 4 ml aliquots. To each aliquot was added 40 pi freshly- 
produced R pf to give dilutions o f  R pf between pM and pM. For the negative control, an 
equal volume o f  a 10° dilution o f  elution buffer was used. For the positive control, 2 ml 
sterile filtered supernatant o f a stationary phase culture o f M. luteus in LMM was added 
to 2 ml o f the inoculated LMM. Each tube was set up in duplicate. The tubes were 
incubated overnight at 37°C on a shaker-incubator. After 16-18 h the tubes were 
removed and the cultures spun down. The pellet was resuspended in 50 pi o f 0.1 M 
Tris/0.004M EDTA buffer, pH 7.75. This suspension was added to a boiling 450 pi 
volume o f the same buffer. The sample w as then heated to 100°C again for 2 min, then 
spun down at 1 OOOg for 1 min. The supernatant was removed and kept on ice prior to 
measurement o f  ATP-bioluminescence in a luminometer, using the ATP 
Bioluminescence Assay Kit CLS II (Roche) as per the m anufacturer's instructions.
ATP concentration was calculated as follows: for each experiment, using ATP standards 
a standard curve was drawm, on a log-log graph, to correlate bioluminescence w ith ATP 
concentration. The ATP concentrations in the cultures could then be read off the graph.
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2 .53 .2  Four hour M. luteus cultures ('rapid te s t ')
A modification o f the test in 2.5.3.1 was developed in order to get an activity test result 
on the day o f  production o f  the protein, rather than the day after. In this more rapid test, 
the initial overnight culture o f M. luteus ( O D 6(xr~ 2.0) was the same, but instead o f 
diluting it 1000-fold it was only diluted down to an O D 6oo o f 0.1. The diluted cells were 
then aliquoted as described in 2.5.3.1 but only cultured for 4 h at 37°C before ATP was 
extracted.
2.6 Phage display
2.6.1 Construction o f  phage display library'
Since a relatively large quantity o f  M. tuberculosis DNA would be required to construct 
a phage library, broth cultures were set up. 200 ml o f 7H9 broth w as inoculated wdth a 2 
ml culture o f  M. tuberculosis H37Rv, and incubated at 37°C for 6 weeks. The culture 
was spun down and DNA extraction was carried out as described in 2.1.2.
Aliquots o f the DNA w^ere cut with the blunt-ended restriction enzymes H aeIII, Rsal, 
Alul, and ///n C H 4 U  (NEB). To obtain DNA fragments in the size range required, 
digests w?ere done using various concentrations o f DNA and enzyme, and digestion was 
continued for various time periods. The aim was to find a concentration o f DNA, 
restriction enzymes and lengths o f digestion times which would provide a library o f 
fragments between ~1.5 kb and -2 0 0  bp in size. Digests were stopped after various 
lengths o f time by heating to 80°C for 20 min. 2-3 pi o f each partial digest were then run 
on a 1% TAE agarose gel to assess the size o f the fragments in each. The protocol found 
to be successful w as as follows:
58
Extracted DNA was diluted in dH20  1:4 v/v. 1 pi o f each o f the four enzymes was 
added to 26 pi dH20 . The digest reaction was then performed as follows:
2 pi enzyme mixture (diluted 1 pi o f each enzyme in 26 pi dH20 )
15 pi DNA solution
2 pi restriction buffer 
1 pi dH20
(20 pi total volume)
The reaction was incubated at 37°C. 3 pi aliquots were removed at intervals o f 2, 5, 15 
and 35 min, heated to 80°C for 20 min to stop the reaction, and then run on a 1% TAE 
to check that the size range o f the DNA fragments was as required. To make the library, 
a larger number and volume o f DNA fragments was necessary, so the reaction was 
scaled up tenfold. From this reaction, the 25 min, 35 min and 60 min fractions were 
pooled and then cleaned using the Qiagen gel extraction kit.
Plasmid pG8H6 was supplied by Brian Henderson, Eastman Dental Institute. The 
plasmid was cut using Smal (NEB) to give blunt ends, and dephosphorylated with calf 
intestinal alkaline phosphatase (NEB) to prevent self-ligation o f  the vector in 
subsequent ligations. The M. tuberculosis DNA fragments were then ligated into the cut 
plasmid pG8H6 using the Ready-To-GoIM T4 DNA ligase system (Amersham 
Biosciences). The reaction used was:
13 pi digested DNA
3 pi cut plasmid DNA
4 pi dH20
The ligated DNA was cleaned with the Qiagen Minelute kit and resuspended in 10 pi 
dH20 .
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Electrocompetent E coli TGI cells were obtained from Stratagene. 2 pi o f the ligation 
product was added to 100 pi o f these cells and transformed by electroporation using a 
Bio-Rad electroporator. A 0.1 cm gap cuvette was used and a voltage o f 1700 V.
900 pi o f nutrient broth warmed to 37°C was added immediately and the cells incubated 
on a shaker-incubator at 37°C for 1 h. 10 ul and 20 pi aliquots were then plated onto 
nutrient agar containing 100 pg/ml ampicillin and incubated overnight at 37°C. 
Resultant clones were sub-cultured in nutrient broth containing 100 pg/ml ampicillin 
overnight. Plasmid DNA was extracted from each using the Qiagen Miniprep kit. The 
DNA was then digested with H indlll and Pstl to check for the presence and size o f 
inserts in the plasmid. Three electrotransformation reactions were performed and the 
transformants pooled.
2.6.2 Transfection and PEG precipitation o f  phage
The cells in the library were transfected with helper phage R408 (Promega). The cells 
were warmed to 37°C for a few minutes, then 200 pi o f  phage was added to 1 ml o f 
library (a 20-fold excess o f phage over cells). The mixture was left to stand at 37°C for 
15 min and then added to 100 ml nutrient broth containing 100 pg/ml o f  ampicillin. The 
broth was cultured overnight at 37°C on a shaker-incubator. The following morning the 
culture was spun down for 10 min at 5000. 14.3 ml o f 25% PEG 6000 in 2.5 M NaCl 
was added to the 100 ml o f supernatant, split between 4 Falcon tubes. The mixture was 
mixed gently and left at 4°C overnight. The precipitated phage was then spun down at 
5000 rpm for 15 min. A translucent gel-like precipitate was visible coating the sides o f 
the Falcon tubes. The supernatant was discarded carefully, and the precipitate 
resuspended in 5 ml TE buffer and stored at 4°C.
60
2.6.3 Titering o fphage stocks and fractions from  panning
10 ml o f nutrient broth was inoculated with 50 pi o f an overnight culture o f TGI cells
^ o
and grown until the O D 6oo was 0.5 (3 h). To titre phage stocks. 10 pi o f  10"' -  10’ 
dilutions o f the phage stock was added to 200 pi o f bacteria from this culture.
To titre fractions collected from panning, 100 pi o f appropriately diluted phage was 
added to 400 pi o f bacteria:
Unbound: 10° -  10‘8 dilutions
Last wash: neat -  10‘2 dilutions
Bound: neat -  10"4 dilutions
The mixture was incubated for 30 min at 37°C. 100 pi volumes were then plated out on 
nutrient agar plates containing 100 pl/ml ampicillin. Colony counts were performed the 
following day after overnight incubation at 37°C.
2.6.4 Panning fo r  RpfB receptor protein
Fresh recom binant RpfB was used. The protein was first dialysed in PBS using a 0.5-3.0
TM
ml Slide-A-Lyzer dialysis cassette (Pierce) to remove urea and imidazole. A
5 ml polystyrene tube was then coated with the protein overnight at 4°C. The following 
day RpfB was removed from the tube which was then blocked for 2 h with PBS 2% 
BSA. BSA was also added to the library prior to the panning to avoid selection for any 
phage with affinity for it. The polystyrene tube was washed with PBS and 1ml o f  the 
library was added to the tube. The tube was left rotating for 2 h at room temperature (or 
4 h in the first round o f panning only). The library w;as then removed from the tube and 
kept (unbound fraction) for colony counts. The tube w as then washed with 10 x 4 ml o f 
PBS 0.05% Tween, then 10 x 4 ml o f  PBS. The final wash was kept. The bound phage 
was removed from the tube by adding 1 ml 0.1 M glycine pH 2.1 for 10 min at room
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temperature. The glycine was then removed and added to 0.5 ml 1 M Tris pH8.0. The 
phage fractions were then titred according to the protocol in 2.6.3.
2.6.5 Sequencing and analysis o f  inserts from  clones selected by panning
To investigate the clones selected after three rounds o f panning, the inserts were 
sequenced. The primers used to amplify the inserts from pG8H6 had the following 
sequences: 5 '-TTG  CCT ACG GCA GCC GCT GAA-3' and 5'-TGC GGC CCC ATT 
CAG ATC CTC-3' (Jacobsson 1995. Heilmann 2002). Sequencing was performed on a 
thermal cycle sequencer.
2.6.6 Cloning and expression o f  Rv0328
Rv0328 was amplified by PCR from M. tuberculosis genomic DNA using the primers 
and protocol described in 2.1.4 ; cloning into the TO PO IM vector and DH5a host, and 
sub-cloning into pET-21a and Origami DE3 were also done as described previously in 
2 . 1 .
The protein was expressed as described in 2.2, with a 3 h induction with IPTG. 
Purification was with Novagen Quick 900 columns.
2.7 Immunocvtochemistry of M. tuberculosis-infected tissues with anti-Rpf 
antibodies
Purified polyclonal sheep anti-Rpf antibodies were provided by Mike Young 
(M ukamolova et al 2002b). Secondary rabbit anti-sheep antibodies, and tertiary 
antibodies (peroxidase-conjugated streptavidin) were obtained from Jackson 
ImmunoResearch. Tissue infected with M. tuberculosis, and all control tissue, was 
provided by the histopathology department at the Royal Free Hospital.
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2.7.1 Immunocytochemistry protocol
Sections were deparaffmised in xylene for 10 min, then rinsed twice in clean xylene for 
a few seconds each, followed by 3 rinses in industrial methylated spirits to remove the 
xylene. Endogenous peroxidase activity was blocked by immersing the sections in 
blocking agent (590 ml methanol: 10 ml water) for 10 min. The slides were then washed 
under running water for 5 min. It was found that pre-treatment o f  samples by enzyme 
digestion or heat was not required. The slides were transferred to a humidity chamber 
and the sections ringed with a hydrophobic pen. Non-specific protein binding was 
blocked by covering the sections with normal rabbit serum (NRS) (Stratech) at a 1:10 
dilution (equivalent to 6 mg/ml) for 20 min at room temperature. The NRS was shaken 
o ff and the sections covered with prim ary antibody at an appropriate dilution, and left to 
stand in the hum idity chamber for 1 h. A negative control was always used in which the 
NRS was left on the slide and the addition o f prim ary antibody was omitted.
The sections were then washed with TBS which was left on for 6 min, before shaking 
off and applying secondary antibody for 30 min. Then the sections were washed again 
with TBS as previously (left on for 6 min) and peroxidase-conjugated streptavidin 
(tertiary antibody) at a concentration o f 1 pg/ml was added for 30 min. After a further 
wash with TBS the sections were developed with freshly prepared diaminobenzidine 
(DAB) solution (Vector) for 8 min. They were then washed again with TBS and then 
running water for 5 min. Counter-staining was performed with M ayer's haematoxylin 
for 5 min, then sections were rinsed in w^ater again before being dehydrated by dipping 
in alcohol and then cleared by dipping in xylene. Slides were mounted in a synthetic 
mountant (DPX).
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The correct working dilution o f rabbit anti-sheep secondary antibodies was determined 
by binding various dilutions o f  the antibodies to sheep anti-factor 8 (Serotec) bound to 
sections o f  human placenta. The secondary antibody was tested at dilutions o f 1:1000 
and 1:5000, against dilutions o f the sheep anti-factor 8 antibody o f  1:100, 1:500, 1:1000 
and negative control (no primary antibody).
Next, to determine the optimum dilution o f anti-Rpf antibodies, a dilution o f 1:1000 
rabbit anti-sheep (secondary) antibody was used against the following dilutions o f  anti- 
R pf (primary) antibodies: 1:100, 1:500, 1:1000, 1:2000. Experiments using the anti-Rpf 
antibody were performed on human tissue samples known to contain M. tuberculosis 
(from gastro-intestinal lymph nodes).
2.7.2 Absorption o f  anti-Rpf antibodies using RpfB
These experiments were carried out in order to demonstrate that positive 
im munohistochemistry results were due to binding o f the anti-Rpf antibodies to Rpf. 
The addition o f  recombinant RpfB to the anti-Rpf antibodies at the start o f  the 
experiment should neutralise them and lead to a negative immunohistochemistry result. 
Fresh recom binant RpfB was added to the anti-Rpf antibodies and left at room 
temperature for 1 hour. Then the staining was carried out as described in 2.7.1.
2.7.3 Ziehl-Neelson staining o f  sections
In some immunohistochemistry experiments, sections were stained by the cold Ziehl- 
Neelson technique after to immuno-staining, to demonstrate the location o f acid-fast 
bacilli in the sections. Slides were left to stand in filtered carbolfuchsin (BDH fuchsin 
RAL 22 Cold) in a Coplin ja r for 10 min. After washing in tap water they were 
differentiated by dipping several times in 1% acid alcohol. This was repeated until the
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sections were a very pale pink colour, then they were washed in tap water for 2 min. 
Counterstaining was performed with C arazzi's haematoxylin for 3 min, then the slides 
were washed again in running tap water for 5 min. Slides were then dehydrated, cleared 
and mounted.
2.7.4 Staining o f  sections with anti-lipoarahinomannan antibodies 
Anti-lipoarabinomannan (LAM) antibodies were obtained from Vladimir K oulchin's 
laboratory at Chemogen, Portland USA. The antibodies were raised in rabbits and 
conjugated to horseradish peroxidase. They were used at a 1:50 dilution, with 
peroxidase-conjugated streptavidin as used in the anti-Rpf experiments. The method 
used was as described in 2.7.1.
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CH APTER III
RESULTS: CLONING AND EXPRESSION OF M .TUBERCULOSIS
Rpfs
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3.1 Introduction
3.1.1 Aims
The aim o f the work described in this chapter was to express the cloned genes for the 
five M. tuberculosis Rpfs and to purify the proteins for use in subsequent experiments. 
RpfD was cloned de novo from M. tuberculosis DNA into the pE T -2la (Novagen) 
vector and expressed in the E. coli host Origami B (DE3) pLysS (Novagen). This host 
and vector had not previously been used for the expression o f Rpfs. The other Rpfs 
were initially expressed in vector pET-19b (Novagen) and E. coli host HMS174(DE3) 
(as provided by Mike Young's group. University o f Wales. Aberystwyth) and then 
subcloned into expression host Origami B (DE3) pLysS, with the aim o f achieving 
better solubility o f  the expressed protein.
3.1.2 Host strain
Origami B (DE3) pLysS is a strain with mutations in both thioredoxin reductase (trxB) 
and glutathione reductase (gor), which permits the formation o f disulphide bonds in the 
cytoplasm and thus may enable optimal folding o f a protein that is normally secreted. 
Since the Rpfs contain cysteine residues it was thought that disulphide bond formation 
between these residues might play an important part in the activity o f the proteins. 
Studies have showm that expression in Origami (DE3) yielded 10-fold more active 
protein than in another host even though overall expression levels were similar (Prinz 
1997). In addition the pLysS plasmid provides T7 lysozyme to reduce basal expression 
o f target genes and therefore stabilise plasmids that express proteins toxic to E. coli. All 
Origami B strains contain a lacY  deletion mutation which allows control over the 
amount o f protein expression by controlling the concentration o f the IPTG inducer.
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3.1.3 Vectors
The pET system for the cloning and expression o f recombinant proteins in E. coli has 
been developed by Novagen. Target genes are cloned in pET plasmids under control o f 
strong bacteriophage T7 transcription and translation signals: expression is induced by 
providing a source o f T7 RNA polymerase in the host cell. T7 RNA polymerase is so 
selective and active that almost all the cell's resources are converted to target gene 
expression; the desired product can comprise more than 50% o f the total cell protein 
after a few hours o f induction. The system maintains target genes transcriptionally silent 
in the uninduced state. Target genes are initially cloned using hosts that do not contain 
the T7 RNA polymerase gene, so that they are switched ’o f f  and cannot cause plasmid 
instability due to the production o f  proteins potentially toxic to the host cell. Once 
established, plasm ids are transferred into expression hosts containing a chromosomal 
copy o f T7 polymerase. This is done by using a lysogen o f bacteriophage DEB, which 
carries a DNA fragment containing the la d  gene, the lacUVS promotor and the gene for 
T7 RNA polymerase. The lacUVS promotor is inducible by the addition o f isopropyl-p- 
D-thiogalactopyranoside (IPTG). Different pET vectors have different features which 
may be useful in different settings. For example, pET-19b has an N-terminal histidine 
tag and an enterokinase protease site, whilst pET-21a has a C-terminal histidine tag and 
no protease cleavage site.
pLysS is not a cloning vector, but is used to suppress basal expression from the T7 
promoter by producing T7 lysozyme, a natural inhibitor o f T7 RNA polymerase. The 
presence o f  the pLysS plasmid increases the tolerance o f the host cell for plasmids with 
toxic inserts: unstable plasmids become more stable.
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Maps o f plasmids pET-19b, pE T -2 la  and pLysS, and the cloning and expression 
regions o f pET-19b and pET-2 la  are shown in Appendix iv.
3.2 Materials and Methods
Detailed technical descriptions o f the materials and methods are to be found in Chapter 
2 sections 2.1 (cloning methods) and 2.2 (protein expression). Here the procedures used 
are summarised.
3.2.1 Cloning o f  rpfD into pET-2 la  vector and Origami B (DE3) pLysS host 
RpfD is one o f the smaller M. tuberculosis Rpfs (154 aa, predicted molecular weight 
15,664 Da) and was chosen for cloning as its size made it more suitable for structural 
analysis by NMR, at a later date.
DNA was extracted from M. tuberculosis H37Rv. PicoG reen1M analysis showed that the 
concentration o f  the extracted DNA was 50 pg/ml. Primers were designed to amplify 
the rpfD  gene without the N-terminal signal sequence and their sequences are shown in 
2.1.4. The prim ers had an NdeI site at the N-terminal end and an Xhol site at the C- 
terminal end. The sequence for amplification had a length o f  315 bp.
The PCR reaction was set up as described in 2.1.4. The amplified DNA, which was o f 
the required size o f 300 bp on agarose gel electrophoresis, w;as excised from the gel and 
extracted using the QIAquick gel extraction kit. The DNA was ligated into T O PO iM, 
transformed into DH5a cells, and plated out for blue-wTiite selection.
Approximately 50% o f the resulting colonies were white and ten o f these were picked 
off and inoculated into nutrient broth containing ampicillin 50 pg/ml for overnight
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culture. Plasmid DNA was extracted from the broth cultures and restriction digests, 
using Xhol and Ndel, were done to confirm the presence o f  a -315  bp fragment. All 10 
clones contained the required fragment.
Two clones were selected, designated ADI and AD2. The presumed rpfD  gene inserts 
from ADI and AD2 were excised from an agarose gel and purified. To check whether 
they contained any mutations they were sequenced using laser fluorescence detection 
(see 2.1.14) and the data was analysed using Chromas software. This revealed that ADI 
contained a point mutation near the 3* end but that the sequence o f AD2 was correct. 
Clone ADI was therefore discarded.
T \1Clone AD2 consisted o f the TOPO vector containing the rpf-D gene insert in DH5a. 
pET-2 la  (Novagen) was used as the expression vector. PET-2 la  was digested with Xhol 
and Nclel, and the linear plasmid was purified by agarose gel electrophoresis and gel 
isolation. The rpfD  gene insert from AD2 was ligated into the digested pET-2 la  vector.
The product o f  the ligation reaction was transformed into DH5a and plated onto 
ampicillin selective plates. Initial attempts at transformation were unsuccessful, with all 
resulting clones lacking the insert. Subsequently the ligation was repeated after first 
treating the digested pET-2 la  vector with calf-intestinal alkaline phosphatase. One 
colony was obtained. Digestion o f the plasmid present in this colony revealed the 
presence o f  a -  300 bp insert. This clone therefore consisted o f pET-2 la  vector with 
rpfD  insert in the DH5a host (ADS). The plasmid with the RpfD insert was purified and 
transformed into the commercial expression host, E. coli Origami B (DE3) pLysS 
(Novagen).
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The success o f the transformation was checked by extracting the plasmid DNA, 
digesting with Xhol and Ndel, and running on an agarose gel to visualise the insert. This 
clone was designated AD4.
3.2.2 Transformation o f  Origami B (DE3) pLysS host cells with rp f A, rpfB, rpfC and  
rpfE.
Mike Y oung's group at University o f Wales, Aberystwyth, provided cloned sequences 
for the other four M. tuberculosis rp f  genes. The DNA sequences were located in pET- 
19b vectors in host E. coli strain HMS174. However, the proteins were very poorly 
soluble, requiring a denaturant (urea) to solubilise them, a problem discussed further in 
Chapter 4. To try and improve the folding, and hence solubility and activity o f the 
expressed Rpfs, plasmid DNA was extracted from each o f  these strains, and 
transformed into competent E. coli Origami (DE3) pLysS, as has already been described 
for the rpfD  construct (section 3.2.1). These clones in Origami (DE3) pLysS were 
designated AD7 (containing rp f A), ADS (containing rpfB), AD6 (containing rpfC), and 
AD8 (containing rpfE). They were used later in the course o f the project when trying to 
improve protein solubility and the level o f expression (Chapter 4). A table showing the 
clones constructed during the course o f this project is shown in Appendix Hi.
3.2.3 Expression and purification o f  the fiv e  M. tuberculosis Rpfs
Initially expression was performed from the clones supplied by Mike Y oung's group at 
the University o f Wales, Aberystwyth. As described in the introduction to this chapter, 
these consisted o f the rp f  genes (without signal sequence) in pET-19b vectors and 
HMS174 E. coli hosts. The proteins were all extracted, expressed and purified as 
described in 2.2 and 2.3, using in-house Sepharose columns and buffers containing
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8 M urea. Later in the course o f  the project, for greater convenience, Quick-900 
columns (Novagen) were used with buffers containing 6 M urea. The methods used are 
summarised in the flow charts (Figures 3.1 and 3.2).
The concentration o f  R pf in the purified eluted fractions was calculated using the A 280nm 
o f the fractions and the molar extinction co-efficient o f the R pf in question (Appendix 
/ ) •
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Figure 3.1 Flowchart showing procedure for induction and expression of Rpfs
10 ml nutrient broth 
50 pg/ml ampicillin 
inoculated with desired clone from 
storage at -70°C
10ml
NB
Overnight on shaker-incubator i
1.5ml
spun
down
Spun down deposit
Add deposit to: 
150 ml NB 
50 pg/ml ampicillin
shaker-incubator at 37°C until ODboonm = 0.7 - 0.9 (c. 4 h). i
IPTG 1 mM added
shaker-incubator at 37°C for 3 h
Spin.
Wash deposit in 
20mM Tris-HCl 
pH8
Store pellet -20°C
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Figure 3.2 Flowchart showing procedure for extraction and purification of Rpfs
Frozen induced cell pellet 
resuspended in 5ml binding 
buffer containing 6 -  8M urea
Sonicated on ice: six 30 s 
periods of sonication with 30 s 
intervals
induced 
cell pellet
▼
Rested on ice 20 min -  1 h then 
sonicated on ice again: four 30 s 
periods of sonication with 30 s 
intervals
sonicated 
induced 
cell pellet
Aliquoted into 1.5 ml Eppendorfs
Spun 30-40 min in refrigerated 
centrifuge
Supernatants filtered and applied 
to Ni-NTA column
20 pi crude extract saved
Column washed with 20 ml 
binding buffer then 50 ml wash 
buffer
^  Unbound fraction collected
Wash fraction collected
5 ml elution buffer applied
1 ml elution fractions collected in 
numbered Eppendorf tubes
E4
E5
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3.3 Results
3.3.1 Expression and purification o f  RpfA
Purifying RpfA using the method described in Figure 3.2 resulted in 20 pM  (380pg/ml) 
RpfA being eluted from the nickel column. A band was visible on SDS-PAGE 
corresponding to a protein o f -6 6  kDa (Figure 3.3). However the predicted molecular 
weight o f RpfA is 39,963 Da. M obility corresponding to a greater size than expected 
has been observed with all the Rpfs (see discussion).
Figure 3.3
SDS-PAGE showing purified recombinant M. tuberculosis RpfA: a crude fraction, b 
unbound fraction, c wash fraction, d elution fraction, e strip fraction. A band 
corresponding to RpfA with molecular weight -6 6  kDa is visible in the elution fraction.
Purified RpfA
21.5
14.5
MW a
3.3.2 Expression and purification o f  RpfB
Using the method described 5 pM RpfB (180pg/ml) was eluted from the nickel column. 
After SDS-PAGE a protein band was visible corresponding to a molecular weight o f 
-45  kDa (Figure 3.4). The predicted molecular weight is 38,069 Da.
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Figure 3.4
SDS-PAGE showing purified recombinant M. tuberculosis RpfB: a crude fraction, b 
unbound fraction, c wash fraction, d elution fraction. A band corresponding to RpfB 
with molecular weight ~45 kDa is visible in the elution fraction.
d c b a MW
3.3.3 Expression and purification o fR p fC
Previous experience had shown that this protein only expressed in low amounts (Galya 
Mukamolova, personal communication). Therefore, two 150 ml cultures were set up for 
expression and the induction was continued for 6 h (instead o f the 3 h period used in 
previous experiments). SDS-PAGE revealed that the protein migrated to a position just 
above the level o f  the 14.5 kDa marker. Its predicted molecular weight is 18,003 Da 
(Figure 3.5).
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Figure 3.5
SDS-PAGE showing purified recombinant M. tuberculosis RpfC: a crude fraction, b 
unbound fraction, c wash fraction, d elution fraction, e strip fraction. A band 
corresponding to RpfC is visible in the elution fraction.
97.4
66
45
31
<4--------------------------- Purified RpfC
MW  a b c d e
3.3.4 Expression and purification o f  RpfD
This protein had also been found to have a very low level o f expression and so as for 
RpfC, two 150 ml cultures were prepared and incubation continued for 6 h after IPTG 
induction. A 3 pM concentration (300pg/ml) o f purified protein was obtained. The gel 
image is shown in Figure 3.6. The protein band migrated to a position just below the
21.5 kDa markers. The predicted molecular weight is 15,664 Da.
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Figure 3.6
SDS-PAGE Gel showing purified recombinant M. tuberculosis Rpf D: a crude fraction, 
b unbound fraction, c wash fraction, d elution fraction, e strip fraction. A band 
corresponding to RpfD is visible in the elution fraction.
e d c b a MW
•97.4 
66
45
31
21.5
14.5
Purified RpfD
3.3.5 Expression and purification o f  RpfE
Figure 3.7 shows the band representing RpfE in the elution fraction after column 
purification. The concentration o f protein in the elution fraction was calculated as 30 
jiM  (560 pg/ml). The predicted molecular weight o f RpfE is 17,422 Da. On the gel the 
band appears at just below the 31 kDa marker.
Figure 3.7
SDS-PAGE showing purified recombinant M. tuberculosis RpfE: a crude fraction, b 
unbound fraction, c wash fraction, d elution fraction, e strip fraction. A band 
corresponding to RpfE with molecular weight ~ 31 kDa is visible in the elution fraction.
a b c d e Mw
Purified RpfE
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Figure 3.8
All five recombinant M. tuberculosis Rpfs run on the same gel by SDS-PAGE.
97.4
21.5
14.5
RpfD Rpf C RpfB RpfA RpfE
3.4 Discussion
This chapter has described the cloning o f RpfD de novo from M. tuberculosis DNA, 
into a host and vector not previously used to express Rpfs (pET-2la and Origami B 
(DE3) pLysS). It has also described the subcloning o f the other four M. tuberculosis 
Rpfs into the Origami B (DE3) pLysS host. As outlined in the introduction, this host, 
with its trxB/gor mutations, permits the formation o f  disulphide bonds in the cytoplasm 
and thus may enable optimal folding o f a protein that is normally secreted. This host 
was chosen since it is thought that disulphide bond formation between the cysteine 
residues found in Rpfs may play an important part in the activity o f the proteins. The 
clones with the Origami B (DE3) pLysS host were used later in the course o f the project 
in an attempt to improve protein solubility and expression (see Chapter 4). There was no 
particular reason favouring the use o f pET-21a rather than pET-19b for cloning RpfD. 
The two vectors differ in various ways including the fusion cloning sites (different 
restriction enzymes therefore used for cloning), the cleavage o f pET-19b by 
enterokinase and the C-terminal histidine tag in pET-2 la. A trial o f different vectors 
may result in improved yields for reasons which may not be apparent but in this case the 
advantage o f either in terms o f protein stability and solubility was not demonstrated.
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This chapter then described the expression and purification o f all five M. tuberculosis 
Rpfs. Concentrations o f eluted proteins were low, ranging between 3 pM and 30 pM. 
reflecting the poor solubility o f these proteins, which will be considered in more detail 
in the next chapter. The band representing RpfA on SDS-PAGE had a characteristic 
crenated appearance (see Figure 3.3) which may be associated with the high proline and 
alanine content o f a substantial part o f this protein, giving it a snake-like structure. Also 
it was notable that all five Rpfs, apart from RpfC, when subjected to SDS-PAGE, 
migrated to a level corresponding to an apparent molecular weight substantially greater 
than predicted from the sequences -  in the case o f  RpfE the apparent molecular weight 
was almost twice that predicted. Work published since these experiments were done 
may shed some light on this (Hartmann 2004). H artm ann's studies o f one o f the two 
Rpfs (Rpf2) o f  Corynebacterium glutamicum  found that it too had reduced mobility 
during SDS-PAGE compared with predicted values. Western blot-based glycan 
detection provided evidence that the RpfZ was glycosylated. The different mobility seen 
with different gels might result from differences in the length o f the carbohydrate 
moieties or from the use o f different glycosylation sites.
In view o f  the small concentrations o f R pf eluted after expressing these clones, and the 
fact that even these were only achieved using 6-8 M urea as a denaturant, the next aim 
was to improve the solubility o f some o f the Rpfs, so that they could be produced in 
larger quantities without the use o f a denaturant. Chapter 4 will describe how this was 
done.
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CH APTER IV
RESULTS: IMPROVING SOLUBILITY AND EXPRESSION OF
Rpfs
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4.1 Introduction
4.1.1 Recombinant protein expression in E. coli
A wide array o f  successful protein expression systems based on E. coli have been 
developed, consequent upon our vast knowledge o f the genetics and physiology o f this 
organism. However, its use for protein expression does have some drawbacks. For 
example, it has a limited capacity to secrete proteins, and cannot perform many o f  the 
posttranslational modifications found in eukaryotic organisms, such as glycosylation 
and acetylation. The reducing environment o f the cytoplasm creates a problem in terms 
o f the formation o f  disulphide bonds. Overexpression o f heterologous proteins in E. coli 
frequently results in the formation o f  insoluble aggregated folding intermediates, known 
as inclusion bodies. Kiefhaber (1991) suggested that the formation o f inclusion bodies 
might be due to the protein translation rate exceeding the capacity o f the cell to fold the 
newly-synthesized polypeptide chain. There may be some advantages to expressing a 
protein in inclusion body form: large amounts o f highly enriched protein, protected 
from proteolytic degradation, with protection o f the host cell from toxic effects o f the 
protein (Clark 2001). However in order to recover protein from such inclusion bodies 
the covalent bonds that hold the insoluble aggregates together must be disrupted with a 
denaturant such as 6-8M urea, and this is how the M. tuberculosis Rpfs had been 
produced so far (Chapter 3). The denaturant must then be removed under conditions that 
are optimal for protein refolding and the final yield o f renatured protein may be 
relatively low. The resulting protein might also be less than optimally active, or not 
active at all. If Rpfs could be expressed in a soluble form a better yield might be 
obtained, with improved stability and activity.
Key parameters governing the formation o f soluble protein in E. coli include structural 
features o f  the protein sequence, the stability and translational efficiency o f mRNA, the
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ease o f protein folding, degradation o f  protein by host cell proteases, major differences 
in codon usage between the foreign gene and E. coli, and plasmid stability (which is 
reduced if  the recombinant protein is toxic to the host) (Old & Primrose 1994, M isawa 
1999, Swartz 2001). To help establish a more efficient expression system, two issues 
are o f particular concern -  the 'quantity ' and 'quality ' o f proteins produced. The latter 
includes consideration o f folding, solubility, activity and homogeneity o f the protein 
produced. Factors affecting 'quantity’ and 'quality ' o f protein are not mutually 
exclusive. Three strategies were employed to improve protein yield and solubility for 
the work in this chapter: change o f host strain, the use o f fusion proteins and lowering 
the induction temperature.
4.1.2 Host strain
E. coli possesses a large number o f proteases, located in its cytoplasm, periplasm, inner 
and outer membranes. Recombinant proteins produced in E. coli are particularly prone 
to proteolysis, as they may appear foreign and are not recognised by the host. E. coli can 
also affect recom binant protein production through rapid degradation o f mRNAs, using 
endonucleases and 3 ’ exonucleases Therefore, protease- and endonuclease-deficient 
host strains such as E. coli BL21 (from which Origami B is derived) are commonly used 
for expressing recombinant proteins. In Chapter 3, Origami B (DE3) pLysS was used to 
express the Rpfs, and this strain is deficient in both Ion and ompT  proteases. The 
product o f  Ion, protease La, is one o f the most important proteases involved with 
breakdown o f recombinant proteins in E. coli. The product o f om pT  is an outer 
membrane protein, T protease, which cleaves at dibasic amino acid sequences.
The E. coli Origami (DE3) hosts have mutations in both thioredoxin reductase (trxB ) 
and glutathione reductase (gor), permitting the formation o f disulphide bonds in the
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cytoplasm. In addition the strain used in Chapter 3 had a pLysS plasmid which provides 
T7 lysozyme to decrease basal expression o f target genes and thus stabilise plasmids 
expressing proteins toxic to E. coli.
4.1.3 Fusion proteins
By expressing a recombinant protein as a fusion with another protein, better solubility 
can be achieved. Certain highly soluble fusion protein partners improve the solubility o f 
passenger proteins that would otherwise accumulate as inclusion bodies. Examples o f 
fusion proteins include glutathione S-transferase (GST), thioredoxin (TRX), and NusA 
(Davis 1999). The fusion protein chosen for use in this work was NusA. This protein 
has been shown to have good solubilising characteristics and a very high expression 
level (Davis 1999, Harrison 2000). One o f the biological activities o f NusA thought to 
be responsible for its solubilising effect is that o f pause-enhancement during 
transcription (Davis 1999): the presence o f NusA causes RNA polymerase to pause for 
longer periods o f  time at certain pausing sites along the template DNA. Since 
transcription and translation are coupled in E. coli, NusA may improve solubility by 
slowing down translation at the transcriptional pauses and allowing critical folding 
events to occur. The NusA gene is available from Novagen as a fusion tag in the vector 
pET-43.1, under the control o f the T7 lac promoter. This vector has an N-terminal Nus- 
tag and an internal histidine tag, with thrombin and enterokinase cleavage sites. A 
circular map o f  the plasmid is shown in Figure 4.1.
4.1.4 Induction temperature
The formation o f soluble recombinant proteins in E. coli is found to be favoured at 
growth temperatures lower than 37°C (Schein 1988). This is one o f  the easiest ways to 
overcome insoluble protein production. One proposed explanation is that at high
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temperatures, heat-shock proteins are produced which include proteases, and this may 
affect the folding o f proteins (Schein 1991). According to Kiefhaber (1991) inclusion 
body formation is determined by the rate o f protein synthesis, folding and aggregation. 
At higher temperatures, the rate o f protein synthesis might be faster, favouring 
aggregation over folding.
Figure 4.1
Diagramatic representation o f vector pET-43.1b (Novagen).
T7 terminator
f1 o
bla (Ap res
pBR322
pET43.1 b
7274
Hi s. tag
X hol (531)
HSV.tag 
Hin dill (600)
M M  (609)
'stl(640) 
geoRI (655) 
Bam HI (661) 
S.tag 
His.Tag 
Bgl(943) 
N us.Tag
T7 Promotor
S p h I (2622)
Mw I (3147)
lad
4.1.5 Aims
The aim o f the work presented here was to improve the yield and solubility o f  Rpfs. As 
already mentioned, the strategies adopted involved changes o f expression host, the use 
o f a fusion protein, and lowering the induction temperature. Two different sets o f
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experiments were performed: first, improving the solubility and yield o f an R pf from 
Mycobacterium smegmatis by using a new expression host and a fusion protein (section 
4.2) and second, improving the yield and solubility o f RpfB and RpfE by changing the 
expression host and induction temperatures (section 4.3).
4.2 Improving the solubility and yield of R pf from Mycobacterium smegmatis by 
using a new expression host and a fusion protein.
4.2.1 M. smegmatis Rpf
Sequence analysis reveals that M. smegmatis has four R pf orthologues. One o f  these 
encodes a product that is the smallest o f the Rpf-like proteins so far identified: the 
secreted portion consists o f 87 amino acids. It is o f particular interest since, if  it could 
be shown to have activity, it could then be inferred that the Rpf-like domain shared by 
all proteins in this family is responsible for their observed biological activity. (A 
recombinant, truncated form o f M. luteus Rpf, o f a similar size, has already been shown 
to have activity (Mukamolova 2002) but it is not a naturally-occurring protein). The 
small Rpf-like protein from M. smegmatis (Rpfsrneg) had already been cloned into E. coli 
at the University o f  Wales, Aberystwyth. However, attempts to produce it for use in 
experiments had proved unsuccessful, due to its poor solubility. Although immuno- 
blotting confirm ed that a small amount o f protein was produced, the band was not 
visible on SDS-PAGE gels and the amounts produced were insufficient for testing its 
activity. To improve the solubility o f Rpfsmeg fusion with the carrier protein NusA was 
used. By expressing Rpfsmeg using a new vector (pET-43.1b - Novagen) and host 
(Origami (DE3) E. coli cells - Novagen) it was hoped that quantities sufficient to 
demonstrate activity would be obtained. It might also provide a way o f producing more 
stable Rpf, with more reliable expression, as it was hoped that the improved solubility 
would mean it could be extracted and purified without the use o f a denaturant. The host
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strain chosen to carry the vector for the work in this chapter was E. coli Origami (DEB), 
from Novagen. Important features o f  this expression host have already been discussed 
in 3.1.2 and 4.1.2.
4.2.2 Materials and Methods
Further technical details are to be found in Chapter 2 Materials and Methods 2.1, 2.2 
and 2.3 but the following is a summary o f the methods used.
4.2.2.1 Subcloning o fR p fsme% into NusA fusion  protein and Origami (DE3) host 
Clone E. coli CA1261 containing plasmid pSDY5 was provided by Danielle Young 
(University o f  Wales, Aberystwyth). This plasmid contained a 251 bp fragment 
encoding the secreted portion o f the Rpfsrneg protein. This fragment had been amplified 
from M. smegmatis DNA by PCR with primers ‘Srneg S '(S '-A C C  GCG AAT TCG 
GAC AGC GTG AAC TGG GA-3?) and ‘Smeg 6 ’(5?-CAG CTT CTC GAG GCC GCG 
CTT GCC GCA-B"). The ends o f the PCR product had been cut with EcoRI and Xhol 
(sites underlined) and cloned into pMTL21 (obtained from N.P.M inton -  see Chambers 
et al 1988), cut with the same enzymes. This had been transformed into E. coli strain 
XL2-Blue (Stratagene).
DNA from an overnight culture o f this strain was extracted and digested with £c’c>RI 
and Xhol. Agarose gel electrophoresis confirmed the presence o f  an insert o f 
approximately 250 bp (Figure 4.2.1).
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Figure 4.2.1
2% agarose gel electrophoresis o f plasmid pSDY5 digested with EcoRA and Xhol to 
check for the presence o f the 251 bp insert encoding rpfsrn£g. This is visible as a diffuse 
band at the expected position.
100 bp MW pSDY5
marker
lOOObp
Danielle Young also provided E. coli strain CA1272, which comprised E. coli strain 
XL2-Blue (Stratagene) containing the pET-43.1b vector (Novagen). Extracted plasmid 
DNA was cut w ithin the multiple cloning site with EcoRA and Xhol, ready for insertion 
o f the pSDY5-derived DNA fragment, encoding the rpf-like gene from M. smegmatis.
Both the digested vector and the digested plasmid pSDY5 were subjected to 
electrophoresis. The required insert from pSDY5 was again visible with a size o f  about 
250 bp (Figure 4.2.2). The digested pET-43.1b DNA and the insert from pSDY5 were 
excised and extracted from the gel. The pET-43.1b vector and the pSDY5 insert were 
then ligated.
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Figure 4.2.2
Products o f digestion o f pSDY5 and pET-43.1b with EcoRA and Xhol, after extraction 
from an agarose gel. The 251 bp insert from pSDY5 is visible, lkb MW marker. 
pSDY5 lk b  MW pET43.1b
Digested pET43.1b vector
8000 bp 
"3000 
2000
—  1500
—  250
250bp insert
Competent cells o f  E. coli XL2-Blue (Stratagene) were transformed using the ligated 
DNA (see 2.1.12). Blue-white selection was carried out as described in 2.1.13. The 
plates yielded w hite and blue colonies in approximately a 3:1 ratio. White colonies were 
picked off and subcultured. Plasmid DNA was extracted from four o f the transformed E. 
coli clones and digested with ZscoRI and Xhol. The digestion products were separated 
on an agarose gel. The insert o f approximately 250 bp was clearly visible in the clones 
numbered 3 and 6 in Figure 4.2.3.
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Figure 4.2.3
Digestion products o f putative clones, containing rpfsme g: insert visible in clones 3 and 6 
Digests Undigested
1 3 6 8 1 3 8 lkb marker
1500bp
1000
750
500
250
251 bp inserts
DNA extracted from clones 3 and 6 was used to transform competent Origami (DE3) E. 
coli cells (see 2.1.11, 2.1.12). To check that the transformation had been successful, 
DNA was extracted from four subcultured Origami (DE3) transformants, and digested 
with Xhol and £coRI. Gel electrophoresis revealed bands at 250 bp (Figure 4.2.4) and at 
7275 bp, corresponding to the pET-43.1b plasmid (Figure 4.2.5). The new E. coli 
Origami (DE3) strain, harbouring a pET-43.1b derivative containing the rpfsmeg gene, 
was designated C A B  18.
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Figure 4.2.4
DNA extracted from one o f the subcultured Origami (DE3) transformants, digested with 
Xhol and iscoRI, revealing a band at 250 bp. This is the insert encoding Rpfsmeg in strain 
CA1318. 2% agarose gel.
100 bp CA1318 
marker DNA
lOOObp
500
400
300
200
100
Figure 4.2.5
DNA extracted from the same Origami (DE3) transformant as in Figure 4.2.4, also 
digested with X hol and £coRI, but run on a 0.8% agarose gel to demonstrate the 7275 
bp pET43.1b plasmid.
lk b  CA1318 
ladder DNA
10kb
8kb
6kb
5kb
4kb
3kb —
2.5kb
2kb
-PET43.1b v ector
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4.2.2.2 Expression o f  R p fmeg, with M. luteus R p f for comparison
150 ml cultures o f CA1318 (containing the plasmid-encoded M. smegmatis r p f  gene), 
were induced with IPTG, then harvested and frozen (2.2.1, 2.2.2). For later SDS-PAGE 
comparison with an R pf o f known yield and band mobility, the same procedure was 
followed to obtain recombinant M. luteus Rpf, provided by Galya M ukalamova in a 
pET-19-derived plasmid in the E.coli host HMS174 (DE3).
4 .2 .23  Immunoblotting fo r  Rpfsmeg and M. luteus R p f
This was done using 20 pi aliquots o f frozen induced cells from 4.2.2.2 above. Two 
blots were done simultaneously. In one, a commercially available anti-His-tag antibody 
(mouse monoclonal antipolyhistidine -  Sigma) was employed as the primary antibody, 
and anti-mouse alkaline phosphatase (also from Sigma) as the secondary antibody. In 
the other, a prim ary specific anti-Rpf antibody was employed (obtained from Mike 
Y oung's collaborators in Moscow). This mouse antibody detects the conserved Rpf-like 
region o f the protein. The secondary antibody used was the same.
4.2.2.4 Extraction and purification o fR p fsmeg
The next step was to extract and column-purify the Rpfsmeg from the frozen induced 
pellet o f CA1318, as described in 2.3.1 and 2.3.2.1. The aim was to obtain enough 
protein for assay without the need to use urea to solubilise the protein. Therefore, to 
avoid the actions o f proteases, extraction and purification were performed keeping 
temperatures at 4°C throughout. The steps up to purification were done on ice and using 
a refrigerated centrifuge, and the purification procedure was carried out entirely in a 
4°C cold room. The procedures were repeated several times in order to optimise each 
step as far as possible.
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4.2.3 Results
4.2.3.1 Expression o fR p fsmeg
To check that CA1318 was producing Rpfsmeg, a small sample o f the frozen induced 
cells from 4.2.2.2 was taken and diluted in sample buffer. It was boiled, centrifuged at 
13,000 rpm for 10 min and then the supernatant was loaded on a SDS-PAGE gel at 
various dilutions (undiluted, 1:2, 1:5 and 1:10). This was repeated with the clone 
containing M. luteus Rpf. After SDS-PAGE, clear bands were visible, corresponding in 
size those expected for the histidine-tagged recombinant versions o f M. luteus R pf (~31 
kDa) and Rpfsmeg (~70 kDa) (Figure 4.2.6).
Figure 4.2.6
SDS-PAGE gel showing crude extracts of: A-Recombinant M. luteus R pf (pET-19 
vector, HMS174 (DE3) host); B-Recombinant Rpfsmeg CA1318 (pET-43.lb vector, 
Origami (DE3) host); C-Recombinant M. luteus R pf (pET-19 vector, Origami (DE3) 
host). All are shown in dilutions of, from left to right, neat, 1:2, 1:5, 1:10.
protein A B C
marker(kDa)
97.<
66
45
31
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14.„
M. luteus Rpf M. smegmatis M. luteus Rpf 
Rpf
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To confirm that this was the desired R pf protein, immunoblotting was carried out. The 
results are shown in Figure 4.2.7. Using both the anti-His-tag and the anti-Rpf 
antibodies, bands representing Rpfsmeg and M. luteus R pf were clearly visible. Using the 
anti-His-tag antibody, but not the anti-Rpf antibody, multiple bands were seen with the 
Rpfsmeg- These additional bands might represent C-terminal degradation products, which 
would contain a His-tag but not R pf (hence they were not visible using the anti-Rpf 
antibody). With the Rpf-specific blot, numerous bands were visible with the M. luteus 
Rpf. As the anti-Rpf serum has not been affinity purified, it may be less pure and 
specific than the anti-His-tag antibody.
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Figure 4.2.7
Immuno-blot o f the SDS-PAGE gel in Figure 4.2.6 
A stained with anti-Rpf antibody 
c b marker
— 97.4kD<
k*r
< — — 45
■ — ^ 31
< ------- 21.5
M. luteusRpf M. smegmatis R pf M. luteusRpf
B  stained with anti-His-tag antibody 
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< ------- 14.5
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-97.4kD<
66
< -------45
^ ____ 31
< ------- 21.5
< ------- 14.5
M. luteusR pi M. smegmatis R pf M. luteusRpf
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4.2.3.2 Extraction and purification o fR p fsmeg
This was performed seven times in order to establish the optimum conditions for the 
greatest yield and solubility. Each time, after sonication on ice, microscopy o f the cells 
was performed to see whether most o f them had been destroyed, and whether inclusion 
bodies were visible. The length o f  the bursts o f  sonication was reduced from 30 s to 15 s 
in order to avoid overheating, as there was no urea present to inactivate proteases. It was 
found that some cells remained intact, and the characteristic translucency o f  an 
adequately sonicated suspension was not apparent, until the bursts o f sonication had 
been increased from the 6 x 30 s bursts used in Chapter 3, to 20 x 15 s bursts with 30 s 
intervals. At this point microscopy showed very few intact cells, and the suspension was 
translucent.
Initial attempts at expression and purification resulted in a large amount o f protein in 
the crude extract, as seen on SDS-PAGE in Figure 4.2.8. Although -100  pg/ml pure R pf 
was being obtained in the elution fraction, much had been lost in the crude, unbound 
and wash fractions. This was confirmed by immuno-blotting with anti-His tag 
antibodies (Figure 4.2.9). Possible explanations for this which were considered included 
the overloading o f  the column due to the original fraction containing so much protein. If 
there was so much protein in the crude fraction that it was aggregating this would 
prevent binding to the column. Alternatively, the N-terminal His-tag may have folded 
itself within the tertiary structure o f the protein (which is large in its fusion protein 
form), thus disabling its interaction with the Ni2^  ions and allowing the protein to pass 
straight through the column; or, the desired protein forms inclusion bodies within the 
cell, in which case not all the protein may have been solubilised -  this explanation was 
not borne out by microscopy o f  the sonicated cells, which did not appear to contain 
inclusion bodies.
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Figure 4.2.8
SDS-PAGE gel o f CA1318 protein extract showing recombinant Rpfsmeg before 
optimisation o f expression: aggregation o f protein in the crude fraction may have 
prevented binding to the column, a-strip fraction; b-elution fraction; c-wash fraction; d- 
unbound fraction; e-crude fraction.
a b c d e protein marker (kDa)
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Figure 4.2.9
Immunoblot o f  gel in Figure 4.2.8 above, showing most Rpfsmeg is lost in the crude 
fraction and a smaller amount remains in the elution fraction, a-strip fraction; b-elution 
fraction; c-wash fraction; d-unbound fraction; e-crude fraction.
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Considering the first possibility - that there might be so much protein in the crude 
fraction that it was aggregating and not binding to the column -  further expression
experiments were performed with a five hour culture time but without the addition o f 
IPTG (which induces high-level expression). On one occasion a protein concentration 
o f 235 jig/ml was obtained in the elution fraction and a large band was visible in this 
fraction (Figure 4.2.10). However, a relatively large amount o f the protein was still lost 
in the unbound and wash fractions, and on three other occasions expression without 
IPTG resulted in disappointing yields o f R pf o f 75 pg/ml or less, and on two occasions, 
none.
Figure 4.2.10
SDS-PAGE gel showing purified Rpfsmeg after a 5 h induction without using IPTG, to 
overcome the problem of aggregation preventing binding o f  protein to column, a-crude 
fraction; b-unbound fraction; c-wash fraction; d-elution fraction; e-strip fraction.
protein marker
Purified M. smegmatis Rpf
In the final experiments, IPTG was again employed to induce protein expression, but 
only for 2 h, rather than 3 h. On these occasions concentration o f ~925 pg/ml were 
obtained, with a strong band visible on SDS-PAGE. Thus the optimum procedure for 
obtaining a good yield o f protein in the elution fraction, in the absence o f a denaturant,
was found to involve the addition o f  IPTG for protein expression, with incubation for 2 
h afterwards, with sonication for 8 or more bursts o f 15 s, as necessary, with 30 s 
intervals to prevent heating. The suspension should be translucent, and microscopy 
should demonstrate that cells have been completely disrupted.
This was the first time R pf from Mycobacterium smegmatis was expressed in quantities 
adequate for use in assays, achieved by using a suitable expression host and a vector 
which created a soluble fusion protein.
4.3 Improving the yield and solubility of RpfB and RpfE by changing
the expression host and induction temperatures, and scaling up of production to 
achieve greater yields.
As already discussed, lowering the temperature o f growth increases the yield o f 
correctly folded, soluble protein; a slower induction o f protein expression has a similar 
effect and can be achieved by the addition o f lower concentrations o f IPTG (eg 0.1 mM 
rather than 1 mM) in certain E. coli host strains. Strains such as Origami B (DE3) 
pLysS contain a lacY  deletion mutation which allows precise control over target protein 
expression based on inducer (IPTG) concentration. The solubility o f M. tuberculosis 
RpfB and RpfE was improved by altering the expression host and temperature o f culture 
after induction; attempts were then made to scale-up production in an attempt to obtain 
quantities o f  protein adequate for NMR spectroscopic analysis, which requires 
milligram quantities o f protein - far in excess o f those achieved in Chapter 3.
RpfB was chosen for these experiments as it was easier to produce in more substantial 
amounts, at least in the presence o f a denaturant; RpfE was chosen because o f  its
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smaller size (molecular weight 17.4 kDa) which made it a more suitable potential 
subject for NMR.
4.3.1 Materials and Methods
Further technical details are to be found in Chapter 2 Materials and Methods 2.1, 2.2 
and 2.3 but the following is a summary o f the methods used.
4.3.1.1 Generating clones o f  rpfB and rpfE in a new host and vector to improve 
solubility
rpfB  and rpfE cloned into plasmid vector pET-19b were used in a new host, Origami B 
(DE3) pLysS (Novagen) (see 3.2.2). The features o f this expression host are outlined in 
3.1.2. A further clone was constructed by subcloning rpfE from pET-19b into pET- 
15b.tev using restriction enzymes BamEW and Ndel. The pET-15b.tev vector allows 
removal o f  the N-terminal His-tag using TEV protease. Again Origami B (DE3) pLysS 
was used as the host.
rpfB in pET-19b vector and Origami B (DE3) pLysS host was designated clone ADS; 
rpfE in pET-19b vector and Origami B (DE3) pLysS host was designated clone AD8; 
rpfE in pET-15b.tev vector and Origami B (DE3) pLysS host was designated clone 
ADI 1. A table o f clones used in this project is shown in Appendix Hi.
4.3.1.1 Expression o f  RpfB and RpfE from  clones ADS, AD 8 and AD 11
150ml cultures o f the clones were induced with 0.1 mM IPTG (as opposed to 1 mM 
used in Chapter 3) and expressed at temperatures from 18°C - 22°C, for 16 h (unless 
stated otherwise). During extraction, none o f  the buffers contained urea, and sonication 
consisted o f 15 s bursts with 30 s intervals, rather than the 30 s bursts used when urea
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was present in the buffers, to minimise overheating. To minimise degradation by 
proteases, all buffers were ice-cold, centrifugation was done in a refrigerated centrifuge 
at 4°C, and the protein samples were kept on ice at all stages. The protein was extracted 
in this way on several occasions. In some experiments a protease inhibitor cocktail 
(Roche) was used.
4.3.1.2 Large scale expression o f  RpfE from  clone A D I 1
It was decided to scale up the expression from clone ADI 1 (rpfE in pET-15b.tev vector 
and Origami B (DEB) pLysS host). This part o f  the work was carried out at Birkbeck 
College with the co-operation o f Andrei Okorokov. The procedure is described in full in 
Chapter 2 M aterials and Methods section 2.3, specifically 2.3.4 and 2.3.5. Eight litres o f 
culture o f the E. coli host were set up for induction and IPTG 0.1 mM was used. The 
flasks were then incubated at 25°C for a further 4 Vi hours. Protease Inhibitor Cocktail 
(Roche) was added. The cell extract was loaded onto an A K TA rM FPLC™ 
chromatography system (Amersham Biosciences) and run down two 5 ml HiTrap 
nickel-chelating HP columns™ (Amersham Biosciences). Desalting was performed on 
the same equipment using HiPrep 26/10 50ml desalting columns ™ (Amersham 
Biosciences) and binding buffer. The use o f pET-15b.tev meant that eluted protein 
could be treated with TEV protease to remove the His-tag from the RpfE (2.3.5).
4.3.2 Results
4.3.2.1 Expression o f  RpfB from  clone AD5 (rpfB in pET-19b vector and Origami B 
(DE3) pL ysS  host)
150 ml cultures o f clone AD5 induced with 0.1 mM IPTG were expressed at room 
temperature (22°C) for 16 hours, and extracted at low temperatures as described in 
section 4.3.1.2. RpfB was extracted in this way on several occasions. The amounts o f 
protein in the eluted fractions ranged from 60 - 125 pg/ml. This compared with yields o f
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400 - 500 pg/ml when extracted with urea. SDS-PAGE confirmed a protein band at ~45 
kDa, corresponding to RpfB. The use o f the protease inhibitor cocktail (Roche) had no 
effect on the final protein yield (data not shown).
4.3.2.2 Expression o f  RpfE from  clone AD8 (rpfE in pET-19b vector and Origami B 
(DE3) pLysS  host)
150 ml cultures o f clone AD8 were induced with 0.1 mM IPTG and expressed at room 
temperature (22°C) for 16 hours. Extraction was performed as described for clone AD5. 
This was done twice and the amount o f protein obtained in the elute fractions was 50 
pg/ml and 60 pg/ml. SDS-PAGE confirmed a protein band at ~31 kDa, corresponding 
to RpfE.
4.3.2.3 Expression o f  RpfE from  cloneADl 1 {rpfE in pET-15b.tev vector and Origami B 
(DE3) pLysS host)
A 150 ml culture o f  AD 11 was induced with 0.1 mM IPTG at room temperature for 16 
hours and extracted as described above. 50 pg/ml o f recombinant protein was obtained 
in the eluted fraction and SDS-PAGE confirmed a faint band at ~31 kDa, again 
corresponding to RpfE. Therefore there appeared to be no difference in yield between 
clones AD8 and AD11, with the two different vectors pET-15b.tev and pET-19b. This 
experiment was repeated using a 500ml culture o f clone AD11. Again 0.1 mM IPTG 
was used, but this time induction was for 5h at 24°C. Protease inhibitors were added to 
all the buffers, and prior to sonication lysozyme was added at a concentration o f 200 
pg/ml, to improve the extraction. In this experiment the eluted fraction contained a 
recombinant protein concentration o f 100 pg/ml, which wras disappointing and 
represented an even poorer yield even than from the 150ml culture.
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These results demonstrated that soluble protein could be obtained from these clones - 
through the use o f the Origami B (DE3) pLysS host, lower induction temperatures and 
lower concentrations o f inducers - albeit in amounts approximately ten times less than 
was achieved using urea. Clones AD8 and AD 11 yielded a similar amount o f 
recombinant RpfE (-50  pg/ml in the eluted fractions, or approximately 150 pg from a 
150 ml culture) despite making use o f different vectors. Clone AD5 gave a slightly 
better yield o f  RpfB -  60-125 pg/ml -  but still much less than the 400-500 pg/ml 
amounts extracted using urea.
4.3.2.4 Scaling-up ofproduction o f  RpfE
In order to obtain a larger quantity o f protein, eight litres o f culture o f AD 11 were 
induced. Extraction was done on the deposit from 2 1 culture volumes - otherwise the 
volume o f frozen deposit would have been too great for effective cell lysis and protein 
extraction. After running the extracted material down the nickel columns, aliquots o f the 
eluate which corresponded to protein peaks on the chromatogram were saved and kept 
at 4°C. Aliquots containing protein peaks were aliquots numbers 40-45 and 51 -5 6  out 
o f 66 aliquots.
15 pi o f each o f these aliquots was run on a 15% SDS-PAGE gel. This showed -  28 
kDa bands and -1 9  kDa bands in the aliquots numbered 40-45 and 51-56 (Figure 4.3.1a 
and b). RpfE on SDS-PAGE gels runs at just below the 31 kDa marker and could 
correspond to the -28  kDa band seen. M ost o f  the -2 8  kDa protein was seen in fractions 
52 and 53; the protein in fractions 40-45 was mainly -1 9  kDa -  too small to represent 
RpfE. Therefore it appeared that most o f the RpfE was in fractions 51-56. Nonetheless, 
fractions 40-45 were pooled (pooled volume 40 ml) and fractions 51-56 were pooled 
(pooled volume 40 ml). Both pools were then desalted. The resulting chromatograms
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are shown in Figures 4.3.2 and 4.3.3. The protein flows through the desalting column 
before the imidazole in the sample, so that they become separated, a process reflected in 
the A280 o f the eluted material which shows two peaks, the first corresponding to the 
protein and the second to the imidazole. After desalting, the A280 was measured for each 
protein pool, 1 unit being equivalent to 1 mg/ml protein. The protein content o f pooled 
fractions 40-45 was 3.4 mg, and o f fractions 51-56, 2.24 mg.
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Figure 4.3.1a
SDS-PAGE o f aliquots o f eluted protein obtained from clone ADI 1 after passing 
through the FPLC equipment. -2 8  kDa and -1 9  kDa bands are present in fractions 40- 
45.
a molecular weight marker g fraction 39
b sonicated cell deposit (clone ADI 1) h fraction 40
c crude extract from ADI 1 i fraction 41
d flow-through (unbound) j fraction 42
e fraction 21 k fraction 43
f fraction 22 1 fraction 44
m fraction 45
a b  c d e  f  g h i j k 1 m
Figure 4.3.1b
SDS-PAGE o f  aliquots o f eluted protein obtained from clone ADI 1 after passing 
through the FPLC equipment. -28  kDa and -1 9  kDa bands are present in fractions 51 
56.
molecular weight marker 
fraction 46 
fraction 53
n o p q r s t
fraction 54 
fraction 55 
fraction 56 
fraction 52
97.2
66.4
55.6
42.7
36.5 
26.9 
20.0
14.3
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Figure 4.3.2
Chromatogram o f desalting o f pooled protein fractions 40-45 on Amersham AKTA 
FPLC equipment. The dark blue line represents UV absorbance and two peaks are seen 
corresponding to eluted protein and imidazole.
Protein peak
o
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Figure 4.3.3
Chromatogram o f desalting o f pooled protein fractions 51-56 on Amersham AKTA 
FPLC equipment. The dark blue line represents UV absorbance and two peaks are seen 
corresponding to eluted protein and imidazole.
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Protein peak
Imidazole
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Each o f the two protein pools were then treated with TEV protease to remove the His- 
tag from the RpfE (2.3.5). Samples were removed from the reaction hourly for the first 
3 hours and then after overnight incubation. SDS-PAGE o f these samples showed that 
the removal o f the His-tag was not evident at 3 h after the start o f the reaction, but had 
taken place by 24 h. A Western blot o f the reaction, using anti-His antibodies, is shown 
in Figure 4.3.4: this confirmed the removal o f the Elis-tag and showed RpfE and its 
dimers, trimers and aggregates prior to treatment with TEV protease. After cleavage, 
these bands disappeared as the His-tag had been removed and only the His-tagged TEV 
protease was seen, at approximately the same molecular weight (TEV protease runs to 
-26-29 kDa on SDS-PAGE and thus appears as a band the same size as the uncleaved 
RpfE). The 2-3 kDa His-tag is too small to be seen on the gel. The Western blot 
confirmed that although RpfE was present in both the pools o f  fractions (40-45 and 51- 
56), a higher concentration was present in fractions 51-56.
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Figure 4.3.4
Immunoblot o f fractions 40-45 and 51-56 with and without overnight digest with TEV 
protease, using anti-His-tag antibodies. Without cleavage, RpfE at -2 8  kDa is seen, 
together with dimers, trimers and aggregates o f  RpfE. With cleavage, the His-tagged 
TEV protease is visible with the same molecular weight; the cleaved RpfE is no longer 
visible as the His-tag has been removed. 2-3 kDa His-tags are too small to be visible on 
this gel.
a b c d e f  g
66.4 kDa
55.6
42.7'
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His-tagged RpfETEV protease
Lanes:
a 
b 
c 
d 
e 
f  
g
molecular weight marker
pooled desalted fractions 51-56 after overnight TEV protease cleavage
pooled desalted fractions 51-56 without TEV protease
pooled desalted fractions 40-45 after overnight TEV protease cleavage
pooled desalted fractions 40-4 without TEV protease
crude cell extract
crude cell deposit
The two pooled protein fractions were then run down the FPLC column again to 
separate the TEV protease from RpfE: as TEV protease is His-tagged it binds the 
column while RpfE passes through (Figure 4.3.5). Since R pf has some non-specific 
binding, peaks were collected after running through elution buffer containing increasing 
concentrations o f imidazole (the His-tagged TEV protease would not be expected to 
detach until 100 mM imidazole concentration was reached). The aliquots o f  eluate 
corresponding to the peaks occurring below 100 mM imidazole thus contained purified 
RpfE, extracted without a denaturant, from which the His-tag had been removed.
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The overall yield o f RpfE obtained from a 2 1 culture volume was -2 .25 mg -  about 1 
mg/1.
Figure 4.3.5
Chromatogram showing separation o f  RpfE from TEV protease using nickel columns 
on Amersham AKTA FPLC equipment, eluting with imidazole (IMZ). The His-tagged 
TEV protease does not start to elute from the column until the concentration o f  
imidazole reaches 100 mM; RpfE exhibits some non-specific binding and so step-wise 
increases in imidazole concentration were used to elute it.
100 mM 
IMZ
250 mM 
IMZ
50 mM 
IMZ
0 mM 
IMZ
Fractions 
containing 
eluted RpfE
O
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4.4 Discussion
In this chapter attempts were made to improve the solubility and yield o f three different 
Rpfs, and to extract them without using a denaturant. By expressing Rpfsmeg as a fusion 
protein with NusA, a much greater quantity o f soluble protein could be extracted, 
without the use o f urea. Previous attempts to express this protein had resulted in 
quantities too small to visualise on a Coomassie-Blue stained gel or on immunoblotting. 
Quantities sufficient for testing o f biological activity were now produced: and if  found 
to be active, this would support the belief that the core 'R p f domain’ common to all 
Rpfs is the active component, as the tiny Rpfsmeg consists o f little else but this domain. 
Studies o f the activity o f Rpfsmeg are described in Chapter 5.
In this chapter it was also demonstrated that soluble RpfB and RpfE can be obtained by 
using the Origami B (DE3) pLysS host, lower induction temperatures and lower 
concentrations o f  inducer - albeit in amounts approximately ten times less than was 
achieved using urea as a denaturant. Applying these modifications to a large-scale 
culture, extraction and purification, the yield o f purified RpfE was approximately 2.24 
mg from 2 1 -  approximately 1 mg per litre o f  culture. These concentrations were 
unfortunately still barely sufficient for successful NM R spectroscopy. In the meantime, 
structural biologists working at Birkbeck college were achieving better protein yields 
and solubility using a new construct consisting o f the core R pf domain alone, and were 
optimistic o f  obtaining high enough concentrations for crystallisation. Therefore this 
aspect o f  the work was not taken further. See Cohen-Gonsaud et al (2005) for the 
eventual results o f this structural work.
In order to further improve the solubility and yield o f RpfE, a possible next step would 
have been to clone the gene into the pET-43.1 vector to create a fusion protein with
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NusA, as was done with Rpfsmeg.. This, combined with a slow induction at low 
temperature, might have resulted in better solubility.
Although large quantities o f protein were not obtained, nonetheless an improvement in 
solubility had been achieved, particularly in the case o f Rpfsmeg. The next step was to 
test the biological activity o f the Rpfs, so that they could be shown to be suitable for use 
in further experiments. In order to do this, suitable bacterial cultures containing cells in 
a dormant state were required. Chapter 5 will describe how these cell cultures were set 
up and investigated; and the various activity testing methods which were tried and 
developed.
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CH APTER V
RESULTS: ACTIVITY TESTING  OF R pf USING CULTURES OF  
M YCOBACTERIUM  BO VIS BCG AND M ICROCO CCUS LU T E  US
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5.1 Introduction
Activity testing o f Rpfs has proved to be a problematic area. The activity testing 
methods in use when this project was started were laborious to set up, lengthy (5-29+ 
days depending on the organism used) and not always reliable. Testing was, however, 
always necessary, since even in experienced hands, batches o f R pf are found to vary in 
their activity, from highly active to no activity at all, and furthermore loss o f  activity 
occurs rapidly, within a few days or less, even when the proteins are stored at -20°C  in 
50% glycerol. All the activity tests employed required cells from dormant cultures o f 
responsive organisms to demonstrate R pf activity. As the activity o f M. tuberculosis 
Rpfs was to be studied, the ideal test organism would have been M. tuberculosis itself. 
However, at the laboratory in the University o f  Wales, Aberystwyth, where this part o f 
the project was done, only Containment Level 2 facilities were available, so M. bovis 
BCG was used as a test organism instead. This has been shown to be an excellent model 
for dormancy in M. tuberculosis. (Lim 1999, Shleeva 2002).
In order to be able to perform activity assays using M. bovis BCG, it was first necessary 
to establish and characterise dormant cultures o f  this organism. An important objective 
was to establish cultures under standard conditions that would produce reproducible 
results as an experimental system. This would permit the observation o f the growth 
characteristics o f the model, and the response to Rpfs, over a six month period. Section
5.4 o f  this chapter describes these experiments; section 5.5 describes the ensuing use o f 
these cultures for testing activity o f Rpfs.
Subsequently, Micrococcus luteus was used for activity testing, because o f its more 
rapid growth. In sections 5.6 and 5.7 activity testing assays using M. luteus cultures will
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be described; in particular, assays developed using measurement o f ATP 
bioluminescence o f cultures as an indicator o f R pf activity.
5.2 In vitro models of dormancy in M. tuberculosis
The best known in vitro model o f dormancy in M. tuberculosis is the Wayne model, 
which relies on oxygen depletion to induce the dormant state. In the original W ayne 
model (W ayne 1976) cultures o f M. tuberculosis were sealed in tubes and left to stand 
without agitation. The cultures became gradually more anaerobic and those organisms 
which sank to the bottom of the tubes first experienced more anaerobic conditions than 
those near the surface where there was a headspace o f  air. Wayne realised that this 
resulted in a heterogenous bacterial population and modified his model to involve 
agitation o f  the sealed vessels with a magnetic stirrer, so that all the organisms 
experienced anaerobiasis at the same time (Wayne 1996). Various headspace: broth 
ratios from 1:1 to 1:4 were used: the less the headspace the less the optical density the 
culture reached.
Wayne described dormancy as a state o f ‘non-replicating persistence’ (W ayne 1996) 
and distinguished between two persistent states which ensued with his model: non­
replicating persistence 1 (NRP1) and NRP2. NRP1 is a microaerophilic state, in which 
the organisms increase in size but do not replicate. When oxygen saturation reaches 
<0.06% NRP2 follows, which is an anaerobic state in which growth ceases altogether 
and alterations in drug susceptibility are observed. For example, in anaerobic conditions 
the bacilli lose their susceptibility to ciprofloxacin and isoniazid and have reduced 
susceptibility to rifampicin. They become susceptible to metronidazole, which has no 
activity on aerobic cultures o f M. tuberculosis. W ayne’s published experiments did not 
continue much beyond 16 days, by which time cultures were declared ‘dorm ant’ as 
evidenced by loss o f turbidity and cfu/ml.
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Reintroduction o f  oxygen led to resumption o f growth, which proceeded in an 
apparently regulated, synchronous fashion, with RNA synthesis preceding DNA 
synthesis. This model has been claimed to have clinical correlation with human lung 
cavities in which anaerobic conditions might prevail, and in which acid-fast bacilli may 
be microscopically visible but not culturable.
D ick’s group in Singapore used the Wayne model with M. bovis BCG (Lim 1999). The 
organisms became 'dorm ant’ after 20 days (ie no further increase in turbidity or cfu/ml) 
and they concluded that the 'dormancy response o f BCG is almost identical to that o f 
M. tuberculosis The same model was also used to study M. smegmatis (Dick 1998).
Other approaches have used models based on low pH (Loebel 1933, Heifets 1992), 
complete anaerobiasis (Loebel 1933, Cunningham 1998), and nutrient starvation 
(Loebel 1933, Smeulders 1999, Betts 2002).
For the purposes o f  this work, as discussed in section 1.2, dormancy was defined as 
being in 'a  state o f low metabolic activity and unable to divide or form a colony on an 
agar plate w ithout a preceding resuscitation phase'. In other words, dormancy is a state 
in which cells are present which cannot grow upon subculture on solid or liquid medium 
unless resuscitated, for example in this case by incubation in a suitable liquid medium 
containing Rpf. Although the models investigated were, like W ayne’s, based on oxygen 
deprivation, a much greater headspace was used in the vessels (headspace: broth ratio 
5:1), so that oxygen depletion would be more gradual, giving the organisms sufficient 
oxygen to grow to a higher density, at which nutrient depletion would normally also 
occur. It was postulated that gradual adjustment to the lowering oxygen tensions at a 
higher cell density might result in a more reproducible induction o f dormancy. The 
cultures were studied over the course o f 6 months, a much longer time span than that
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described by Wayne, and in a minimal medium, rather than W ayne’s Dubos Tween- 
albumin. The presence o f cells requiring R pf to resuscitate them before they could 
divide was demonstrated by estimating the Most Probable Number (MPN) o f viable 
cells in a liquid medium in the presence and absence o f Rpf.
5.3 Most Probable Number tests
Most probable number testing is a method o f obtaining viable counts depending on 
dilution to extinction. A sequence o f dilutions o f a culture is made. At the levels where 
the concentration o f cells ranges from 10-0.1/ml there is a statistical probability that 
progressively fewer of the subcultures will grow. From the distribution o f  tubes 
showing growth at three such levels o f dilution, the most probable number o f bacteria in 
the preceding dilution can be obtained from tables (see Appendix v). Though the 
method is convenient it is relatively inaccurate as it is based on statistical probabilities: 
however where the viable count needs to be known within a factor o f about two it is 
adequate.
5.4 Establishing a dormancy model in M. bovis BCG
5.4.1 Method: setting up o f  cultures
Two types o f  culture vessel were used -  airtight glass test tubes with a rubber seal, and 
500 ml glass flasks, also with an airtight rubber seal. The headspace:broth ratio was 5:1 
in both flasks and tubes. The test tubes were kept in a 37°C incubator and remained 
stationary, whilst the flasks were incubated and constantly agitated in a waterbath, also 
at 37°C. Both contained Sauton’s medium inoculated with dilutions o f  a 6 day old 
culture o f M. bovis BCG. The flasks contained 200 ml cultures, and the tubes 2 ml 
cultures. The dilutions were calculated to give a starting cell count o f 2 cfu/ml in the
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tubes, and 20 cfu/ml in the flasks. For a full description o f the methodology used see 
Methods section 2.4.
5.4.2 Results
5.4.2.1 Tubes -  viable counts
The tubes were sampled at intervals and plated out onto Middlebrook agar to determine 
the viable count. The results are shown in Figure 5.1. These demonstrate that in the first 
20 days o f  the tube model there was rapid growth o f the cultures. Thereafter the 
bacterial population began to decline, reaching a nadir o f 106 cfu/ml on solid agar at 76 
days (two and a half months). There then appeared to be slight recovery but by 144 days 
(about 5 months) there was no growth at all on solid agar.
Figure 5.1 Viable count of M. bovis BCG cultured in Sauton’s medium in stationary
tubes, subbed onto solid agar plates over time.
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5.4.2.2 Flasks -  viable counts
The flasks were sampled at intervals and plated out onto Middlebrook agar to determine 
the viable count. Most Probable Numbers in liquid medium (Sauton’s) with and without 
R pf was also measured later in the course o f the experiments. The results are shown in 
Figure 5.2. These show that bacteria in the flask model grew initially up to ~107 cfu/ml 
on solid agar by 60 days (2 months). There followed a decline to 106 cfu/ml by 3 
months, after which there was a rapid drop to zero viability on solid agar at 4.5 months. 
However the organisms then started to recover again, for reasons which are uncertain 
(see Discussion section 5.4.4). Viable counts in liquid media (by MPN) were 
consistently higher by at least an order o f magnitude, whenever they were measured. 
Addition o f R pf to the liquid cultures at 111 days resulted in a four-fold increase in 
viable counts as measured by MPN, but this may possibly be attributable to 
experimental error since the reverse was found at 151 days. At 168 days (5/4 months) 
addition o f R pf to the liquid cultures resulted in a more convincing eight-fold increase 
in the viable counts. Appendix vi shows the results o f the MPN tests in liquid medium 
with and w ithout Rpf, in addition to the growth on solid agar.
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Figure 5.2
Viable count o f M. bovis BCG cultured in Sauton’s medium in constantly agitated 
flasks, subbed onto solid agar plates over time.
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5.4.4 Discussion -  dormancy model in M. bovis BCG
The model o f  dormancy used here is based on gradual oxygen depletion. The large 
headspace means that initially cells are well aerated. Later on, microaerophilic 
conditions ensue and only when all the oxygen in the headspace has been used do the 
organisms becom e anaerobic. The main difference between this and the W ayne model is 
that the headspace in the Wayne model is much smaller, resulting in more rapid oxygen 
depletion: other differences are the use o f a minimal medium (Sauton’s) instead o f  
Dubos Tween-albumin broth in the Wayne model, and a slightly lower pH in the Wayne 
model (~6.6, as opposed to 7.0 in this model). The Wayne model may be open to 
criticism because when inoculated into fresh medium the cells began to grow 
immediately, and apparently normally. This raises the possibility that they were not 
'dorm ant’, but simply that some o f the population had died resulting in the observed
1 2 0
decrease in cfu/ml. This criticism cannot be levelled at the model used here, in which 
dormancy had to be demonstrated by the presence o f organisms which could only grow 
after resuscitation by Rpf.
The tube model used did not include shaking or stirring o f  the cultures. This may be a 
disadvantage. W ayne’s original work (Wayne 1976) also looked at non-shaken cultures 
and he concluded that, as there is a spatial oxygen gradient from the surface to the 
bottom o f the culture, this might result in heterogeneous populations. Cells at the 
bottom may die quickly, whilst those at the surface may be 'a live’ rather than dormant. 
Continuous shaking o f the cultures, as with the flask model used here, avoids this 
problem.
In the first 20 days o f the tube model the cultures grew rapidly, but then the bacterial 
population began to decline. A slight recovery in the counts was observed at about 3 
months but by 5 months there was no growth at all on solid agar.
Bacteria in the flask model also grew initially, up to ~107 cfu/ml on solid agar by 60 
days (2 months). The peak o f the curve was reached about a month later than with the 
tube cultures. There followed a decline to 106 cfu/ml by 3 months, after which there was 
a rapid drop to zero viability at 4.5 months. However the organisms then started to 
recover again, a finding replicated in experiments by others in work published 
subsequently (Shleeva et al 2002). A similar phenomenon was also noted in cultures o f  
certain mutants o fM  smegmatis (Keer, Smeulders & Williams 2001), which recovered 
culturability after 8-15 days o f oxygen starvation. This group’s interpretation was that 
either the population had begun to die but then regrown using an unknown fermentation
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pathway, or, that the population had become transiently dormant or unculturable and 
then undergone resuscitation as conditions changed in stationary phase.
Most Probable Number determinations (in liquid broth), performed on the culture from 
the flask at 111, 132 and 151 days, consistently showed greater viability than the viable 
count on solid agar. Furthermore it was possible to demonstrate an increase in cfu/ml by 
the addition o f  R pf (these results are described in more detail in section 5.5). This 
means that possibly by 4 months, and more certainly by 5/4 months, 'dorm ant’ cells, 
defined as those rescusitatable by Rpf, were present.
Further experiments would be required to determine whether dormant cells, as 
evidenced by action o f Rpf on MPN counts, are present earlier than 4-5 /4 months. At 3 
months, a drop in cfu was already apparent. It would be helpful to be able to produce 
dormant cells in the minimum time possible. Experiments to compare the Wayne model 
with this one w ould also be helpful. Perhaps the smaller headspace o f the Wayne model 
has the effect o f  causing oxygen depletion to occur too quickly: cells may die because 
they cannot adapt to oxygen depletion under conditions when nutrients are in excess. 
Alternatively, the Wayne model might simply have the effect o f bringing about a state 
o f dormancy more rapidly.
5.5 Activity testing of mycobacterial Rpfs by MPN and concentration-activity 
tests on M. bovis BCG
Two types o f  experiment were used to test the effect o f Rpfs on dormant cultures o f  M. 
bovis BCG. They took the form o f conventional MPN tests, or, a 'concentration- 
activity test’. These two tests are described fully in Methods 2.4.2, but are briefly
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reviewed below. Both used cultures o f M. bovis BCG, produced as described in 5.4, 
which had been cultured in Sauton’s medium for between 3 and 6 months.
5.5.1 Methods
5.5.1.1 M PN  test
R pf at a picom olar concentration was used. Dormant M. bovis BCG cultures were used 
at a range o f  dilutions from 1CT2 -  10“7. A grid o f tubes was set up to test the R pf 
against each dilution of M. bovis BCG, using five replicates o f each tube. A tube 
became 'positive’ when growth was visible at the bottom o f the tube using the naked 
eye (growth appeared as a white 'button ' at the bottom o f the tube). The highest dilution 
of M. bovis BCG culture which was able to grow with and without addition o f R pf was 
recorded.
5.5.1.2 'Concentration-activity ’ test
This test differed from the MPN test in that it was the concentration o f R pf which was 
varied, in tubes with a constant dilution o f  dormant M. bovis BCG culture (rather than 
varying the dilution o f M. bovis BCG with a constant concentration o f Rpf). This 
allowed testing for the most active concentration o f a particular batch o f  Rpf. Testing 
was set up using a 10'3 dilution o f dormant M. bovis BCG cultures, with R pf added at a 
range o f concentrations between nanomolar and femtomolar. Five replicate tubes were 
set up for each concentration o f Rpf.
5.5.2 Results
5.5.2.1 ResultsRpfA: concentration-activity test
The activity o f a sample o f RpfA prepared 24 h earlier and stored in glycerol (50:50 v/v)
at -20°C was tested. The stock solution o f RpfA was diluted and tested for activity at
concentrations between 100 pM and 1 aM. The different concentrations o f R pf were
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added tubes containing 1:1000 dilutions o f  a 5-month old dormant culture o f  BCG 
incubated for 5 months. Tubes were read daily to look for growth, appearing as a 
‘button’ at the bottom of the tube, detectable by the naked eye. It was necessary to 
check tubes daily since once all the tubes displayed growth the result would be 
meaningless. The test relied on the rapidity o f  growth in each tube relative to the others. 
For clarity, results are shown in tabulated form (table 5.1). A *+' sign represents visible 
growth in that tube.
Table 5.1
Result o f RpfA concentration-activity test at 9 days:
Concentration o f R pf 1 2 3 4 5
100 pM + + + + +
1 fM - - - - -
10 fM - - - - -
100 fM + - - - -
1 aM
At 14 days all the tubes displayed visible growth.
This result shows that in tubes containing RpfA at a concentration o f 100 pM, growth 
was seen when there was no growth in tubes containing lower concentrations o f  RpfA. 
Growth occurred with RpfA at lOOpM 5 days before it occurred in most o f the other 
tubes, indicating that RpfA has activity at this concentration. (No control w ithout RpfA 
was set up on this occasion. This should have been done to exclude the presence o f  any 
inhibitory substances in the RpfA stock. However such inhibitors would have been
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present in ever decreasing concentrations in each dilution. Since the tubes with the most 
concentrated RpfA grew fastest, an inhibitory effect in the other tubes is very unlikely).
5.5.2.2 Results RpfB: M PN test
To test the activity o f RpfB the MPN method was used rather than a concentration 
activity test. An RpfB concentration o f  ~25 pM was used. Dormant BCG cultures (5.5 
months old) were used at dilutions o f  KT2-1(T7. The protein was used 3 days after 
production. The data are summarised in the growth curves seen in Figure 5.3. The final 
MPN without R pf was 1.75 x 106. The MPN in the presence o f R pf was 8 x 106, i.e. 
increased by about a factor o f four. The results show both a reduced lag phase and a 
higher MPN (growth at greater dilutions) with 25 pM RpfB than without.
Figure 5.3 Growth curve o f M. bovis BCG (5.5 m onth-old culture) with and without 
RpfB. The effect o f  adding 25pM RpfB to the culture is shown in pink. The negative 
control (without Rpf) is in blue.
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5.5.2.3 Results RpfC: M PN  test
An MPN assay was set up using 10 pM concentration o f fresh RpfC. The data are 
summarised in the growth curves in figure 5.4. The MPN without R pf was 1.1 x 106 
cfu/ml; the MPN with R pf was 8 x 106 cfu/ml, a difference o f  a factor o f ~8. RpfC has 
biological activity at the in  pM concentration used. In contrast to the result with RpfB 
however a reduced lag phase was not evident, indicating that these two Rpfs have 
different effects.
F igure 5.4 Growth curve o f M. bovis BCG (5.5 month old culture) in Santon’s
medium with and without RpfC. The effect o f  adding lOpM RpfC to the culture is 
shown in pink. The negative control (without Rpf) is in blue.
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5.5.2.4 Results RpfD: concentration-activity test
RpfD in concentrations ranging from 15 fM to 150 pM (see Table 5.2) were used, with 
a 10"4 dilution o f cells from a dormant BCG culture. Negative control tubes contained 
no Rpf. The protein was 24 h old when used. At 10 days, all five tubes containing RpfD 
at a concentration o f 1.5 pM were displaying growth, compared with two or three tubes 
only for the other concentrations (Table 5.2). By 13 days all the tubes showed visible 
growth. This result may indicated some activity o f  RpfD at a concentration o f 1.5 pM, 
compared to the negative control tubes, but the possibility that the effect is due to 
random variation cannot be dismissed. Further experiments, using a larger number o f 
tubes with containing 1.5pM RpfD, and more negative controls, would be required to 
conclusively demonstrate a significant difference.
Table 5.2
Result o f RpfD concentration-activity test at 10 days:
Concentration of 
R pf
1 2 3 4 5
Controls (no Rpf) + + - - +
150 pM + - - + -
15 pM + - - - +
1.5 pM + + + + +
150 fM - + + + -
15 fM + + + - -
5.5.2.5 Results RpfE: concentration-activity test
The activity test was set up using RpfE in pM concentrations. 10'4 concentrations o f 
BCG from a 5 month old dormant culture were used. The RpfE was 24 h old. Tubes
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were read daily, however the experiment did not appear to show any activity o f RpfE, at 
any concentration. As RpfE is expressed at high concentrations, with a heavy band 
visible on SDS-PAGE, aggregation may have been occurring, with consequent loss o f 
activity. In Chapter 4 RpfE was induced using lower concentration o f  IPTG, at lower 
temperatures and longer induction periods, in an attempt to improve its solubility.
5.5.2.6 Results Rpfsmeg: concentration-activity tests and M PN tests 
The activity profile o f Rpfsmeg had not been tested before: its expression had been too 
poor to produce sufficient quantities for testing. However, once a soluble form had been 
produced, as described in Chapter 4, using the NusA fusion protein and Origami (DE3) 
host, much greater quantities were obtained, so that the activity could be tested.
Four batches o f  Rpfsmeg were tested for activity and the results are described below. The 
results o f the Rpfsmeg activity testing are summarised in Table 5.6.
5.5.2.6.1 Experiment 1: concentration-activity test
Rpfsmeg was used two days after it had been purified and stored at -20°C. A 10~3 dilution 
o f a dormant BCG culture (age 3 months) was used to find the most active 
concentration o f  Rpfsmeg. Rpfsmeg activity was tested at concentrations between 
picomolar and femtomolar. Table 5.3 shows the results at 15 days.
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Table 5.3
Growth o f  dormant cultures o f  M. bovis BCG in the presence o f  Rpfsmeg in 
concentrations between pM and fM, after 15 days. indicates visible growth o f BCG 
in the tube:
Rpf dilution 1 2 3 4 5
No R pf -control - - - - +
18 pM - - + - +
1.8 pM
180 fM
18 fM + + + + -
1.8 fM + + + + +
After 19 days growth was visible in all the tubes. These results suggested that, 
compared with tubes containing no Rpf, BCG in tubes with 18 fM and 1.8 fM o f Rpfsmeg 
grew more quickly, i.e. the protein had biological activity at 1.8 fM.
The experiment was repeated, using the same R pf after storage for 2 weeks at -20°C . 
Rpfsmeg no longer appeared to have significant activity.
5.5.2.6.2 Experiment 2: M PN test
For MPN testing dormant BCG cells (culture age 4 months) were used at dilutions o f 
KX’-IO'6. One-day old Rpfsmeg was used at a concentration o f ~50 fM. The tubes were 
read daily until there was no further growth in any tube for at least 10 days. New growth 
in tubes ceased after 34 days. Throughout the experiement, the number o f positive tubes 
with Rpfsmeg exceeded the number without Rpfsmeg, usually by a difference o f  one row; 
ie there was visible growth in tubes containing ten-fold less inoculum when Rpfsmeg was
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present. Towards the end o f the experiment, the tubes without Rpf started to catch up as 
growth had stopped in those with Rpf: but even so the final result showed a greater 
MPN when estimated in the presence o f Rpf. Using MPN tables (Appendix 3) it was 
estimated that without Rpf, the undiluted culture o f dormant BCG appeared to contain
1.2 x 105 viable organisms. With Rpf, the number o f viable organisms detected was 
approximately four times this amount, at 4.6 x 105. Growth curves for these BCG 
cultures with and without Rpfsmeg are shown in Figure 5.5.
Figure 5.5 Growth curve o f M. bovis BCG (4 month old culture) in Sauton’s 
medium with and without M. smegmatis Rpf. The effect o f adding 50 fM M. smegmatis 
R pf is shown in pink. The negative control (without Rpf) is in blue.
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5.5.2.6.3 Experiment 3: M PN  and concentration-activity tests
A third batch of Rpfsmeg was produced, and was 3 days old when it was used for this 
experiment. MPN determination was carried out using this protein at a concentration o f
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about 70 fM, and a 5-month old dormant BCG culture. A concentration activity test was 
also set up. Neither o f these tests revealed any difference between the cultures 
containing Rpfsmeg and the controls.
5.5.2.6.4 Experiment 4: M PN and concentration-activity tests 
A  fourth batch o f Rpfsrneg was produced. Both concentration activity testing and MPN 
determination was carried out, when the protein was one day old. The concentration 
activity test used a 10'3 dilution o f a 6-month old dormant BCG culture, and 
concentrations o f  Rpfsmeg in the pM -  fM range. Results are shown in table 5.4.
Table 5.4
Concentration-activity testing o f Rpfsrneg in pM - fM concentrations, in tubes o f  a 6- 
month old dormant BCG culture. There were five replicates o f each tube. Result shown 
was obtained after 7 days. A '+ ’ signifies visible growth in the tube.
R pf dilution 1 2 3 4 5
No Rpf- control
70pM + - - - -
7pM + + + - -
0.7pM - - + - -
70fM - + - - -
7fM
0.7fM - - - - -
70aM
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After 9 days most tubes contained visible growth. This result may be indicative that the 
R pf was active at 7pM but without further replicates it would not be possible to rule out 
that it is a random effect. A follow up experiment would be required using more 
replicates at 7pM rather than systematic ones as performed.
Table 5.5
Summary o f  results o f Rpfsmeg activity testing:
Batch of
Rpfsmeg
Stock
concentration
Age of 
stock
Type of test Rpfmeg final 
concentration 
(MPN)
Increase in 
viable count 
with Rpf 
(MPN)
Most active 
concentration 
(concentration 
-activity test)
1 1.8uM 48h Concentration
-activity
1.8fM
1 1.8uM 2 weeks Concentration
-activity
No activity
2 500nM 24h MPN 50fM 4-fold increase -
2 500nM 24h MPN 50aM No activity -
3 7uM 72h MPN 70fM No activity -
4 7uM 24h Concentration
-activity
7pM
5.5.3 Summary, o f  results o f  activity testing o f  mycobacterial Rpfs on dormant cultures 
o f  M. bovis BCG
Four o f  the five Rpf-like proteins o f M. tuberculosis (recombinant versions) showed 
biological activity in these tests: this was least marked for RpfD (Rv2389c). RpfE 
(Rv2450c) did not show any biological activity on this occasion, possibly because o f 
aggregation.
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O f four batches o f Rpfsmeg produced without the use o f urea, three displayed biological 
activity, using either MPN or concentration-activity testing (see Table 5.5). No activity 
was seen after the protein had been stored for 2 weeks. Concentration-activity testing 
indicates a range o f activity at between pM and fM concentrations. This protein consists 
only o f an Rpf-like domain (shared by all known members o f the R pf protein family) 
together with a secretory signal sequence. These experiments therefore confirm that the 
biological activity o f these proteins resides in their Rpf-like domain. It was hoped that 
the Rpfsmeg, which unlike the other Rpfs was produced without the use o f urea, might be 
more reliably active and stable. This may be the case, but was not conclusively 
demonstrated: more experiments would be needed to prove this.
5.6 Activity testing by measuring OD600 of M. luteus cultures in microtitre 
plates
The length o f  time to a result, and the laboriousness o f the methods, limited the 
usefulness o f  tests on cultures o f M. bovis BCG for testing activity o f Rpfs. A more 
rapid and reliable activity test was considered a priority for this project, so that later 
experiments could rely on known active protein being available. Since it is known that 
M. tuberculosis Rpfs are active on M. luteus cells, which are relatively rapidly growing, 
tests based on this organism were investigated.
Attempts were made to measure the activity o f R pf on M. luteus by measuring change 
in OD600 in cultures in microtitre plates (as described by Mukamolova 2002a and 
2002b). These experiments were carried out using both M. luteus R pf and Rpfsmeg- See 
M ethods 2.5.1 for a full description o f the assay. The test employed a low inoculum 
(103 cfu/ml) o f stationary phase culture o f M. luteus in lactate minimal medium (LMM),
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as these are the experimental conditions in which the best activity o f R pf has been 
demonstrated. The inoculum was passed through a needle ten times but despite this 
clumping o f  cells remained and this tended to result in uneven growth o f M. luteus in 
random wells. To overcome the problem o f clumping, the M. luteus cells were filtered 
through a 5 pm filter to try to remove clumps, and to balance the effect o f filtering 
resulting in loss o f cells, a tenfold higher concentration o f M. luteus cells was used: 
however after filtering no growth was obtained in any o f the wells. On other occasions, 
even with unfiltered cells, no growth occurred in any well at 10 days, either with or 
without Rpf. To check that the LMM could support bacterial growth properly, the M. 
luteus suspension was simultaneously inoculated into a flask containing the LMM, to 
give the same final cell density: this grew well overnight. Quantitative counts o f  the 
inoculum o f  M. luteus were also made on LB plates: this showed that -500  cfu had been 
inoculated into each well, considered a sufficient amount. Furthermore the cultures in 
the microtitre plates required so much manipulation during the complex setting-up 
process that there was a high risk o f contamination, even though the plates were set up 
in a Class 2 cabinet to prevent this.
None o f the experiments using this assay were successful - the results are summarised 
in Table 5.6.
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Table 5.6
Summary o f results o f activity testing using M. luteus in microtitre wells
Experiment
number
R pf used Age o f  R pf Filtered/
unfiltered
Starting
inoculum
(cfu/ml)
Result
1 R pf fresh unfiltered 10J Clumping in random wells
2 R pf 1 week filtered 104 Contaminated
Rp fsmeg fresh filtered 104 Contaminated
4 R pf 1 week filtered 104 No growth any well at 2 
weeks
5 R pf 1 week filtered 104 No growth any well at 2 
weeks
6 Rpfsmeg 1 week unfiltered 10J No growth any well at 1 Od
7 R pf 1 week unfiltered i<y No growth any well at lOd
These results were disappointing, though not entirely unexpected, since experienced 
workers reported difficulty in obtaining reproducible data from one experiment to the 
next, with this model (see Discussion). The tendency o f the cells to clump in culture, 
and the very low innocula required to demonstrate the effect o f Rpf, both contributed to 
the problems o f  poor reproducibility. No further experiments were done using this 
method.
5.7 Activity testing using ATP bioluminescence of M. luteus cultures
ATP-bioluminescence is a well-established technique which has been used as a measure 
o f bacterial counts, particularly in food and environmental microbiology. Luciferase 
from the American firefly catalyses the following reaction:
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ATP  + D-luciferin + O2 —* oxyluciferin + PP, + AMP + CO2 + light
The amount o f ATP present can be calculated from the amount o f light emitted and is 
proportional to the bacterial count/ number o f cells present. Even extremely low 
concentrations o f ATP can be measured. Thus by measuring the ATP content o f a 
culture, the problem of cells clumping could be overcome. An assay was therefore 
developed which could measure the difference in concentration o f ATP between 
cultures o f  M. luteus grown with and without R pf in LMM. The ATP content was 
measured by bioluminescence in a luminometer. Two assays were developed: an 
overnight test, which had greater discrimination between batches, and a rapid four hour 
test, which could more quickly demonstrate the presence or absence o f active protein, 
but which was less discriminating between batches.
5 .7.1 Overnight A TP bioluminescence activity test
5.7.1.1 Method: overnight ATP bioluminescence activity test
The method is described in detail in section 2.5.3.1 but to summarise, stationary phase 
cultures o f  M. luteus were diluted a thousand-fold in LMM and incubated with R pf for 
16-18 hours. The inoculum was equivalent to 106 cfu/ml, higher than that in 5.6. 
Growth was slight under these conditions with turbidity normally not visible to the 
naked eye, though sometimes small clumps o f cells were seen.
All the experiments were done using RpfB. RpfB was expressed from both clone 
CA1002 (pET19b vector and HMS174 host) and clone AD5 (pET19b vector and 
Origami B (DE3) pLysS host) to see which expression system produced the most active 
recombinant protein. RpfB was chosen because in contrast to the other M. tuberculosis 
Rpfs, its activity profile had not previously been measured against M. luteus
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(Mukamolova 2002b) - although it was known to have activity in cultures o f M. bovis 
BCG - and because it is relatively easy to prepare reasonable concentrations o f the 
recombinant protein. The positive control was M. luteus culture supernatant, obtained as 
described in 2.5.3.1’, the negative control was a dilution o f elution buffer in LMM, 
equivalent to the dilution o f R pf used.
After spinning down the cultures and extracting ATP, the ATP bioluminescence o f  the 
cultures and o f  ATP standards was measured in a luminometer. A standard curve was 
drawn using the results for the ATP standards, on a log-log graph, to correlate 
bioluminescence with ATP concentration. The ATP concentrations in the cultures could 
then be read o ff the graph.
5.7.1.2 Results: overnight ATP bioluminescence activity test 
These results are summarised in Table 5.7 and are described below.
5.7.1.2.1 Results: positive control
A range o f  activity o f the positive control was found, with from 2.4 -  >35 x greater 
concentrations o f ATP than the negative control. The >35 x greater concentration o f 
ATP was found after culture supernatant was used immediately; the other results (2.4 x,
4.5 x and 5 x greater concentration o f ATP) were obtained after the supernatant had 
been kept on ice for 30-60 min. Examples o f these results are shown as graphs in figures
5.6 and 5.7.
137
Figure 5.6
ATP bioluminescence o f positive control (M  luteus supernatant) for overnight activity 
test after 16 h incubation. ATP concentration in the control = 4 x 10"6 M. ATP 
concentration in the supernatant =1.8 x 10° M. Hence there is a 4.5-fold increase in 
ATP concentration in the positive control compared to the negative control.
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Figure 5.7
ATP bioluminescence overnight activity test result using 12 nM fresh RpfB from clone 
CA1002. ATP concentration in negative control <10"8 M; ATP concentration in positive 
control = 3.5 x 10'7M; ATP concentration with 12 nM RpfB = 6.3 x 10'8M.
Hence ATP concentration with 12 nM RpfB is >6 x negative control and ATP 
concentration with positive control is >35 x negative control.
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5.7.1.2.2 Results: overnight ATP bioluminescence activity testing o f  RpfB from
clone AD5 (pET19b vector and Origami B (DE3) pLysS host).
Activity o f RpfB from clone AD5 was measured three times. The protein was used 
immediately after production on each occasion. No protease inhibitors were used. In the 
first two experiments activity was greatest at RpfB concentrations o f 60 - 100 nM, with 
a 5 and 12 x greater ATP concentration respectively in the RpfB culture compared with 
the negative control (see figures 5.8 and 5.9). In both cases, at concentrations o f  6 - 10 
nM there was a small increase in activity; at lower concentrations no effect was 
detected. Figure 5.10 demonstrates the measured activity o f RpfB at different 
concentrations in one o f these experiments. A bell-shaped curve is seen, in which the 
optimal activity is seen at an RpfB concentration o f 60 nM, with less activity at 
concentrations o f 600 nM and 6 nM and below. A similar pattern was seen in 
experiments w ith M. luteus Rpf on M. luteus cells (Mukamolova 1998) - except that the 
optimal activity was in the picomolar range - and with RpfA, C, and D on M. luteus and 
M. smegmatis (Mukamolova 2002b) -  with optimal activity varying from subpicomolar 
-  picomolar. Only RpfE has shown no evidence o f reduced activity at elevated 
(micromolar) concentrations, when tested using M. luteus.
In a third experiment, ATP bioluminescence was measured at 4, 8, 12 and 16 hours 
with RpfB at a concentration o f 80 nM. No activity o f  R pf was measurable until the 12 
hour reading, when there was a 3 x greater concentration o f ATP with RpfB than in the 
negative control; at 16 hours this had risen to a 7 x greater concentration (figures 5.11 
and 5.12).
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Figure 5.8
Result o f overnight ATP bioluminescence activity test using 100 nM fresh RpfB from 
clone AD5. ATP concentration o f  negative control = 1.5 x 10'8 M; ATP concentration 
with RpfB at concentration o f 100 nM = 1.8 x 10‘7 M. Hence there is a 12 x greater ATP 
concentration with 100 nM RpfB.
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Figure 5.9
Result o f ATP bioluminescence overnight activity test using 60 nM fresh RpfB from 
clone AD5. ATP concentration o f negative control = 7.5 x 10’7 M; ATP concentration 
with 60 nM RpfB = 3.8 x 10'6 M. Hence sample containing 60 nM RpfB has 5 x greater 
ATP concentration.
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Figure 5.10
Activity o f RpfB at different dilutions o f 6.3 pM stock solution, measured by ATP 
bioluminescence of M. luteus cultures. The greatest activity is seen at a concentration o f 
60 nM. Concentrations o f 600 nM, 6 nM and less display less activity.
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Figure 5.11
Results o f ATP bioluminescence overnight activity test measured at 12 hours, using 80 
nM RpfB from clone AD5. ATP concentration in negative control = 2.2 xlO '8 M;
ATP concentration with 80 nM RpfB = 7.1.X.10"8 M. Hence 3 x greater ATP 
concentration with RpfB detected at 12 h.
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Figure 5.12
Results o f ATP bioluminescence overnight activity test measured at 16 hours, using 80 
nM RpfB from clone AD5. ATP concentration in negative control = 3.98 x 10’9M;
ATP concentration with 80 nM RpfB = 2.8.x. 1 O'8 M. Hence 7 x greater ATP 
concentration with RpfB detected at 16 h (cf 3 x greater at 12 h, see figure 5.11).
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5.7.1.2.3 Results: overnight ATP bioluminescence activity testing o f  RpfB
from  CA1002 (pET19b vector and HMS174 host)
This was also measured on three occasions. Both with and without protease inhibitors, 
the most active concentration was found to be in the range 1-12 nM, which resulted in a 
22-63 x greater ATP concentration in the cultures with RpfB compared to the negative 
controls. There was evidence o f some activity in concentrations as low as 1 pM, but less 
so. One o f  these batches o f protein was re-tested for activity after 6 days kept neat in the 
fridge. No activity could be then demonstrated. The results are shown in Figures 5.7 and 
5.13.
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Figure 5.13
Results o f ATP bioluminescence overnight activity test using 1 nM concentration o f 
1 day-old RpfB from clone CA1002. ATP concentration o f negative control = 5.1 x 10'7 
M; ATP concentration o f positive control = 2.5 x 10'6M; ATP concentration with 1 nM 
RpfB = 1.1 x 10°M . Hence sample containing 1 nM RpfB has 22 x greater ATP 
concentration than negative control.
o.o
-0.5 -
1 nM RpfB
0oc0o
C/3
0c
EJD
O
0)o
positive control
negative control
-3.0
-7.0-7.5 -6.5 - 6.0 -5.5 -5.0 -4.5 -4.0 -3.5
log [ATP]
See Table 5.7 for a summary o f the results o f the overnight activity testing using ATP 
bioluminescence.
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Table 5.7
Sum m ary o f  results o f  overnight A TP b io lum inescence activ ity  tests w ith RpfB.
Clone used Protease 
inhibitor used?
Age o f  
protein
Stock
concentration
Most active 
concentration
Increase in ATP cf  
negative control
ADS no fresh 6.3 uM 60 nM x 5
ADS no fresh 11.25 pM 100 nM x 12
ADS yes 9 hrs 7.8 pM 8 0  nM x 7
CA1002 yes 24 hrs 10 pM 1 n.M x 22
CA1002 yes 6 days 10 pM none none
CA1002 no fresh 12.6 pM 12 nM >x 6
5. 7.1.3 Conclusions -  overnight A TP bioluminescence activity test
The overnight ATP bioluminescence activity test gave results within 24 hours which 
were discrim inatory between batches, and was less laborious to set up than the methods 
described previously. The increase in ATP varied from x 5 - 22; the most active 
concentrations o f  RpfB were 1 -1 0 0  n \ l  (10 uNl - fM were tested). As previously found 
for Rpf, there is an optimal concentration for activity above and below which activity 
declines (figure 5.10). Difference in ATP was not detectable until 12 hours incubation at 
earliest and, o f  the times tested, was maximal at around 16 hours.
Recom binant RpfB from both the clones tested showed activity. If anything, RpfB from 
clone CA1002 (pET 10b vector, H.V1S174 host) showed a higher level o f  activity -  the 
reverse was expected as clone ADS was expressed using Origami B (DE3) pLysS host, 
which should, by facilitating disulphide bond formation in the cytoplasm, result in 
better-folded protein with potentially better biological activity. Use o f  protease 
inhibitors appeared to make little difference to the activity. Protein which was active
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when first tested at 24 hours, was inactive when retested after 6 days storage in the 
refrigerator, though 24-hour old R pf still had good activity.
5. 7.2 Rapid A TP biohtminescence activity test
5.7.2.1 M ethod
Having developed a successful assay for measuring R pf activity using ATP 
biolum inescence, the next step was to develop a version o f  the assay which could give a 
result within one working day, so that active R pf could then be used in further 
experim ents as soon as possible. A similar overnight culture o f M  luteus in nutrient 
broth was used as the starting inoculum, but only diluted about 20-fold in LMM rather 
than 1000-fold, to give an OD6qu in LMM o f  0.1. The rest o f the assay was performed in 
the same way as the overnight assay method (for details see M ethods sections 2.5.3.1 
and 2.5.3.2). To characterise the model, ATP in separate aliquots o f culture was 
measured at different times up to 76 h. Early on in the experiment measurements were 
taken two-hourly; later they were taken at longer intervals. The aim was to use this 
model as a test to be read after a few hours rather than requiring an overnight 
incubation.
5. 7.2.2 Results: rapid A TP bioluminescence activity test 
5. 7.2 .2 .1 A TP levels over 76 hours
Figure 5.14 show s an example o f  the results obtained using this model, and measuring 
ATP at different times up to 76 hours. ATP peaked more rapidly in the presence o f 
RpfB - at 4 hours w ith RpfB and 10 hours w ithout RpfB, reflecting a shorter lag phase 
with RpfB - then decreased. Also, ATP achieved a peak four times greater in the 
presence o f  RpfB. Further m easurements o f  ATP concentration taken at time points up
145
to 76 hours showed that the concentration o f  ATP then levelled o ff in both test and 
control samples, eventually reaching a similar level after 40 hours or so.
Figure 5.14
ATP concentration in M  luteus cultures in LMM with and without RpfB, over 76 h.
ATP peaked more rapidly in the presence o f  RpfB - at 4 h, compared with 10 h without 
RpfB, reflecting a shorter lag phase with RpfB. ATP achieved a peak 4 times greater in 
the presence o f  RpfB.
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5.7.2.2.2 Results: rapid ATP bioluminescence activity test -  O D m  and protein
levels over 76 h
The OD600 and the protein content o f  the samples were measured to see how they
correlated with the ATP concentration at intervals over periods o f up to 76 hours. As
might be expected, rises in OD600 and protein content lagged behind rises in ATP
concentration: peaks in protein and OD600 were seen at ~12 - 24 hours o f incubation,
when organisms reached stationary phase. Higher peaks o f  both parameters were
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obtained in the presence o f Rpf, although the difference in both O D 6oo and protein 
content reached only 1.5 - 2-fold, com pared with the 4 - 5-fold difference seen in the 
ATP concentration. Figures and 5.15a and b (protein) and 5.16 ( O D 6oo) show examples 
o f the results obtained.
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Figure 5.15a
Protein content o f  M  luteus culture in LMM with and without RpfB, measured at 
intervals over 76 h. The rise in protein content lagged behind the rise in ATP 
concentration (figure 5.14), peaking at ~20 h, and was 1.5-fold higher in the presence o f  
RpfB.
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Figure 5.15 b
Protein content o f  M. luteus culture in LMM with and without RpfB, measured at 
intervals over 24 h. Protein content peaked at ~12 h and was approaching 2-fold higher 
in the presence o f  RpfB.
Figure 5.16
OD600 o f  M. luteus cultures in LMM with and without RpfB, measured at intervals over 
76 h. The rise in OD600 approximately mirrored that o f  the protein content. Peak O D 6oo 
was seen at ~12 - 24 hours o f  incubation, with a peak 1 . 5 - 2  -fo ld  higher in the 
presence o f  RpfB.
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5.7.2.2.3 Results: rapid ATP bioluminescence activity test -  limiting fac tors fo r
growth
To investigate the limiting factors for growth in the model, fresh nutrient broth was 
added to the cultures after ATP, protein content and OD600 bad plateaued, 21 hours into 
the experiment. Controls and test samples were all set up in duplicate. In the samples 
containing RpfB, addition o f nutrient broth was followed by a further sharp increase in 
OD 600. No such increase in OD^o was seen in the samples lacking RpfB. An almost 
identical result was seen when a glucose solution was added instead o f nutrient broth, 
indicating that it was availability o f  a carbon source that was responsible for the 
increase in OD600 when RpfB was present. W ithout RpfB, addition o f  glucose did not
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result in any increase in O D 60o. These results are shown in figure 5.17, and indicate that 
the growth o f  cells in the presence o f  RpfB is only limited by the availability o f  a 
carbon source in the minimal medium; however without Rpf, the cells still cannot grow 
even with the addition o f  the carbon source. Thus cells are present which cannot grow 
without Rpf. These cells may be considered to be in a dormant state and unable to leave 
this state in the absence o f  Rpf.
Figure 5.17
M. luteus culture OD600 with and without RpfB. A carbon source (fresh nutrient broth or 
glucose solution) was added to the cultures 21 h into the experiment. In the samples 
containing RpfB, addition o f nutrient broth or glucose was followed by a further 
increase in O D 6oo. No increase in O D 600 was seen in the samples lacking RpfB. All 
controls and test samples were set up in duplicate.
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5.7.2.3 Conclusions: rapid A TP bioluminescence activity test
In this model, RpfB caused an early 4 - 5-fold increase in ATP content o f cultures, 
which was detectable at 4 hours. The model was therefore found to be suitable for use 
as a rapid test o f R pf activity. However, the increase in ATP compared with the 
negative controls (without Rpf) was not as marked as it was in the overnight activity 
test, and so the level o f discrim ination between different batches was not as good. 
Increases in protein and OD6(,(l o f 1.5 - 2-fold were also seen in the cultures containing 
RpfB, com pared with the controls. These rises in ODWju and protein content were 
detectable at 12-24 hours, lagging behind the rise in ATP concentration, as might be 
expected.
Growth o f  cultures containing RpfB was limited only by availability o f  a carbon source. 
Addition o f  nutrient broth or glucose solution allowed the cells to resume growth after it 
appeared to have plateaued at 21 hours. Cultures lacking RpfB appeared to contain cells 
that could not com m ence growth at all, as evidenced by a lower final OD60o and protein 
content. Addition o f a carbon source did not enable these cells to grow, reflecting the 
presence o f  cells requiring RpfB for resuscitation.
5.8 Activity testing of R pf - summary and discussion
Since batches o f  recombinant Rpf vary in activity, and since the proteins appear 
unstable and lose activity quickly with storage, a rapid and objective test o f  their 
biological activity was badly needed in order to further investigate their properties. 
Tests using dormant cultures o f M. bovis BCG appeared reliable, giving useful results. 
The activity o f Rpfsmcl,, hitherto untested, was assessed using this method. Results 
confirm ed it was active, in the fM-pM range. The tiny Rpfsmcu consists only o f  what is 
believed to be the conserved active R pf domain, and these experiments were the first
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time that this domain alone, in a naturally-occurring, as opposed to artificially truncated 
form, had been tested for activity. The results confirm that this domain is the active 
region in the R pf molecules.
Despite giving reliable results, the activity tests using M. bovis BCG took 2-3 weeks to 
give a result. Added to this was the fact that dormant cells o f the organisms must be 
available, and these took 3-6 months to prepare.
The more rapidly growing \ f .  luteus is also responsive to Rpfs, including those from M. 
tuberculosis. Therefore activity testing using this organism was developed instead. 
Tests relying on OD6oo using M. luteus in microtitre plates were too unreliable and 
unreproducible to be useful, because o f  the tendency o f the organism to clump, 
combined with the very small inocula required to dem onstrate the effect o f Rpf. The 
approach devised to find a more rapid test o f activity was to look at the concentration o f 
ATP in cultures o f  stationary phase A/, luteus inoculated at low density into a minimal 
medium. The am ount o f  ATP increases in response to the presence o f  R pf (as would be 
expected, since R pf stimulates growth) and its measurement provided a suitable means 
to assay activity. Based on this, two models were developed -  an overnight assay, and a 
rapid 4 hour assay using a higher starting inoculum.
In the overnight assay the increase in ATP varied from x 5 - x 22 in the presence o f 
RpfB to > x 35 with the positive control. This assay dem onstrated a more marked 
response to Rpf, with better discrim ination between activities, than the rapid assay (a 5- 
fold difference at most). However difference in ATP concentration using the overnight 
assay method was not detectable until 12 hours' incubation at earliest. Thus its 
usefulness was somewhat limited by the fact that it required an overnight incubation, so
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that by the time the result was known for a particular batch intended for use in further 
experiments, that batch could be expected to have lost some o f its activity. The most 
active concentrations o f  RpfB in the range tested (10 pM - fM ) were 1 - 100 nM. The 
range o f  activity o f  RpfB against M. luteus had not been measured previously. Most 
other Rpfs studied have had optimal activity in picom olar concentration (M ukamolova 
2002b). Since RpfB, unlike the others tested, is thought to be membrane bound rather 
than secreted, it was plausible that its optimal concentration for activity might also 
differ. However, RpfB in picom olar concentrations was active against M. boris BCG 
(M ukamolova 2002b). An alternative explanation for the nanom olar optimal activity 
found here could be the different method used to purify the protein in these experiments 
(using Xovagen His-tag columns rather than in-house sepharose columns, with different 
buffers), which might in some way have affected the protein folding process or its 
stability.
In the rapid assay, RpfB in nanomolar concentrations caused a 4-5 -fold increase in 
ATP content o f  cultures containing RpfB com pared with those without. The difference 
was detectable at 4 h -  making it suitable as a rapid test o f  R pf activity. However the 
increases in ATP levels with RpfB were not so marked as in the overnight assay, and 
showed less discrim ination between batches. This test is useful for rapid confirm ation 
that a batch o f  R pf is active. Thus the choice o f  test will depend upon the purpose for 
which it is being carried out, with the overnight assay more appropriate for sensitive 
discrimination o f  activity level between batches, and the rapid assay as a screen to 
ensure active protein is present prior to using the protein in other experiments.
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C H A P T E R  VI
RESULTS: USE OF PHAGE DISPLAY TO IDENTIFY POSSIBLE  
CANDIDATES FOR AN Rpf REC EPTO R
6.1 Introduction
The aim o f the work described in this chapter was to see whether a possible receptor or 
receptors for Rpfs in M. tuberculosis could be identified. The Rpfs are strikingly potent 
cellular signals. This high potency, and the fact that they have an optimum 
concentration for activity above which they are inactive - a phenomenon seen in studies 
o f  ligand-receptor interactions - support the suggestion that they bind to specific 
receptors. One obvious way o f gaining insight into the activity o f  the Rpfs is to identify 
these receptor(s). There are a num ber o f  ways o f doing this. However many o f  the 
straightforward affinity techniques o f  receptor isolation are difficult to do with the 
m ycobacteria due to their slow growth and their pathogenicity. An alternative method is 
to use a genomic technology linked to affinity isolation. The technique o f choice is 
phage display.
6.1.1 Phage display
Phage display is a technique whereby heterologous proteins are expressed on the surface 
o f  phage particles. The phage become vehicles o f  expression which carry within them 
the genomic inform ation for the expressed proteins, and which also have the capacity to 
replicate. Huge numbers o f variant nucleotide sequences can be converted into 
populations o f  variant peptides and proteins which can be screened for desired 
properties. For example, phage display has been used to identify platelet-binding 
domains in fibrinogen-binding proteins o f  Staphylococcus aureus (Heilmann 2002) and 
fibronectin-binding proteins, IgG-binding polypeptides, adhesins, and transport proteins 
in the same organism (Jacobsson 1995, Rosander 2002). It is an extremely powerful tool 
for selecting proteins with specific binding properties from vast numbers o f  variants, 
and has been in use since 1985 (Smith 1985).
In order for a protein to be expressed at the phage surface, the nucleotide sequence 
encoding it is incorporated into a phage or phagem id genome as a fusion to a gene 
encoding a phage coat protein. As phage particles are assembled, the protein to be 
displayed is presented at the surface o f  the mature phage while the sequence encoding it 
is contained within the same phage particle. This physical link between the phenotype 
and genotype o f  the expressed protein, together with the replicative capacity o f  the 
phage, are the basis o f phage display technology (Willats 2002). Libraries o f nucleotide 
sequences o f  billions o f fragments can be converted into populations o f displayed 
variant proteins to be screened. Screening is usually done by an affinity selection (bio­
panning) process during which phage populations are exposed to targets to selectively 
capture binding phage. Through successive rounds o f binding selection followed by 
am plification o f  the selected phage, the original diverse phage population is enriched 
w ith phages w hich bind the desired target.
6.1.1.1 Phage display vehicles
Various different types o f phage display system have been developed. The phage 
normally used are E. coli filamentous phage which infect their host by attaching to F- 
pili, and progeny phage are secreted without killing the host. Five structural proteins 
constitute the phage coat and they are inserted into the E. coli inner membrane before 
incorporation into the phage particle. Most commonly, the minor coat protein (p ill) or 
the major coat protein (pVIII) are used to display the foreign peptides (Jacobsson 2003). 
Different strategies have been em ployed to produce the fusion proteins. The gene fusion 
may be constructed between the nucleotide sequence and the coat protein gene in the 
viral genome. All copies o f the chosen coat protein become fusion proteins -  giving a 
high number o f  expressed foreign proteins, but with the risk o f  affecting phage viability 
if  the functionality o f  the fusion coat protein is affected. Alternatively, hybrid phage
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may be produced in which the gene fusion is an additional element o f  the phage 
genome, so that a wild-type copy o f the gene is retained and phage express both wild- 
type and fusion proteins. Another way to produce hybrid phage is to use a phagem id 
based system (Willats 2002, Rosander 2002, Jacobsson 2003, Heilmann 2002). 
Sequences encoding fusion proteins are carried by plasmids with a phage origin o f  
replication (phagemids). Most o f  the rest o f  the genes required for phage replication are 
carried by helper phage which are co-infected with the phagemids into host bacteria. In 
a hybrid system, fusion to p ill often results in less than one copy o f  the fusion protein 
per phage particle; fusion to pVIII gives multivalent display, the precise num ber o f 
proteins per phage depending on factors such as the size, folding and amino acid 
composition o f  the foreign protein. M ultivalent display may result in more efficient 
selection, but increases the risk o f  weak background interactions (Jacobsson 2003). In 
this work, a hybrid phage system using phagem id pG8H6 (supplied by B. Henderson) 
was used (Jacobsson 1996; derived from Jacobsson 1995), resulting in pVIII fusion 
proteins.
6.1.1.2 Library amplification
The simplest approach is to immobilise target molecules (in this case, recom binant M. 
tuberculosis Rpf) to a support and then expose it to suspensions containing the phage. 
W ashing to rem ove non-binding phage is performed, then bound phage are eluted from 
the target. This can be done by using solutions o f  low pH, high salt, reducing agents or 
enzym atic cleavage. Following elution, the bound phage are then amplified by culture in 
E. coli.
Some expressed sequences may be incompatible with phage propagation, and others 
may be susceptible to proteolysis during propagation. Factors such as this impose
constraints upon the diversity o f  expressed proteins. Also, during amplification, phage 
with lesser avidity for the target but better growth characteristics may be preferentially 
amplified.
6.2 Construction of phage display library
The method used is described fully in M ethods section 2.6.1. Briefly, following 
isolation and purification, M. tuberculosis DNA was cut with blunt-ended restriction 
enzym es Hciellh Rsah A lu l, and H pyC H4V. The aim was to find a concentration o f 
DNA, restriction enzymes and lengths o f  digestion times which would provide a library 
o f fragments between -1 .5  kb and -2 0 0  bp in size. Figure 6.1 shows fragments o f  DNA 
o f the required size range run on an agarose gel, after an appropriate protocol had been 
identified (as described in Methods 2.6.1). Figure 6.2 shows the result o f scaling up the 
reaction tenfold. From this reaction, the 25 min, 35 min and 60 min fractions were 
pooled and then cleaned using the Qiagen gel extraction kit.
The DNA fragm ents were ligated into plasm id pG8H6, then electroporation reactions 
were perform ed using electrocompetent TGI cells. Plasmid DNA was extracted from 
the resulting transformants and digested with H indlll and PstI to check for the presence 
and size o f  inserts in the plasmid, which were found in about 50% o f the transformants. 
Insert sizes ranged from -180 bp to 1500 bp. Figures 6.3 a, b and c show examples o f  
20 clones which were tested when constructing the library, with 50% showing inserts o f  
varying sizes.
Three electroporation reactions were perform ed and the resulting transformants pooled.
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Figure 6.1 Restriction enzyme cutting o f  M  tuberculosis DNA with blunt-ended 
restriction enzymes H aeIII, Rsal, A lu l, and HpyCH4V. 5 pi aliquots o f digested DNA 
were removed at intervals o f 2, 5, 15 and 35 min, heated to 80°C for 20 min to stop the 
reaction, and then run on a 1% TAE agarose gel. No cutting was apparent in the samples 
containing only 1 pi o f diluted enzyme, but a range o f  sizes o f  fragments was obtained, 
as desired, in the samples containing 2 pi o f  diluted enzyme.
1 2 3 4 5 6 7 8 9 10 11 12
« • • • !
500b
Lanes:
1 1 Kb M W  marker
2 uncut M. tuberculosis genomic DNA
3 M  tuberculosis DNA cut with 1 pi o f  diluted enzyme, 2 min
4 66  66 66 66 66 66 £, 5 min
5 “ “ “ “ “ “ ,1 5  min
6 “ “ “ “ “ “ , 35 min
7 M. tuberculosis DNA cut with 2 pi o f  diluted enzyme, 2 min
8 66 66 66 66 66 66 £, 5 min
9 “ “ “ M “ “ ,1 5  min
10 “ “ “ “ “ ,3 5  min
11 Blank well
12 lOObp MW marker
lkb
500b
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Figure 6.2 The reaction shown in 6.1 was scaled up. The reaction was stopped in 3 
pi aliquots at 2 min, 5 min, 10 min, 15 min, 25 min, 35 min and 60 min, then run on a 
1% TAE agarose gel as shown. The 25 min, 35 min and 60 min fractions were pooled 
and cleaned for use in the library.
1 2 3  4 5 6 7 8 9  10
Lanes:
1 1 Kb M W  marker
2 100 bp M W  marker
3 blank lane
4 M  tuberculosis genomic DNA digest at 2 min
5 “ “ “ “ " “ 5 min
6 “ " “ “ “ " 10 min
7 “ “ “ " “ “ 15min
8 “ " “ " * “ 25min
9 “ " " “ M “ 35min
10 “ “ “ “ “ “ 60mm
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Figure 6.3 Figures 6.3a, b and c show examples o f the restricted DNA o f 20 clones 
which were tested when constructing the library. Clones are numbered 1-20, with ‘u ’ 
denoting uncut plasmid and ‘c ’ denoting cut plasmid. 50% o f the clones show inserts o f 
various sizes.
a) lkb lOObp lu  1c 2u 2c 3u 3c 4u 4c 5u Sc 6u 6c
b)
c)
1 kb lOObp 7u 7c 8u 8c 9u 9c lOu 10c
lk b  lOObp 11c 12c 13c 14c 15c 16c 17c 18c 19c 20c
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6.3 Transfection o f phage, PEG precipitation o f phage and titering o f phage 
stocks
The cells containing the phagemid library were transfected with helper phage R408, and 
the phage precipitated as described in the M ethods section.
The phage stocks were titred by adding 10 pi o f 10° - 10"s dilutions o f  the phage stock 
to 200 pi o f TGI cells at O D 6qo 0.5 (see Methods). After incubating for 30 min at 37°C 
the cells were plated out in 100 ul aliquots on plates containing 100 pg/ml ampicillin. in 
duplicate. The colonies were counted the next day and the results are shown in Table 
6 . 1 .
Table 6.1
Dilution o f stock cfu in 100 pi
plate 1 plate 2
10'* 1 1
10" 10 9
10‘6 84 70
10° Semi-confluent Semi-confluent
This was equivalent to a titre o f lO^pfu/ml in the undiluted phage stock.
6.4 Panning for RpfB receptor protein
Fresh recom binant RpfB was used, produced as described in Methods section 2.2 -  2.3. 
The protein was dialysed in PBS to remove urea and imidazole. Panning o f the library 
against RpfB was then performed as described in M ethods 2.6.4. Fractions collected 
from panning were titred in duplicate (M ethods 2.6.3) and plated out in 100 pi volumes 
per plate.
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6.4.1 First round o f panning
The phage titres were obtained in each fraction after the first round o f panning are 
shown in Table 6.2.
Table 6.2
fraction Dilution cfu plate 1 (100 pi ) cfu plate 2 (100 pi ) Titre (pfu/ml)
unbound 10° >1000 >1000
10'6 200 320 > io g
10" 46 39
10"* 23 13
final wash neat 132 136
10"1 30 32 -1 .3  x 10"
10"- 17 18
bound neat -1500 -1500
10"1 450 400
10"2 105 87 -10"
10° 27 24
104 8 _
The results show that most phage did not bind to the RpfB-coated tube, but that a small 
proportion did bind and only came o ff the tube after the elution step.
The bound fraction o f phage was amplified as described in Methods 2.6.2. After 
am plification, titering was carried out again. The results are shown in Table 6.3.
Table 6.3
Dilution o f amplified bound cfu in 100 ui 1
phage from V 1 panning plate 1 plate 2
10'8 57 19
10" 305 397
i t r 6 Semi-confluent Semi-confluent
10° Semi-confluent Semi-confluent
This was equivalent to approximately 3 x 104 - 3.8 x 10!u pfu/ml and showed that the 
amplification process was working well.
6.4.2 Second round o f  panning
After the second round o f panning, only the bound fraction was titred, before it was 
amplified: see Table 6.4.
Table 6.4
Dilution o f bound phage 
from 2nd round o f panning
cfu in 100 pi 
plate 1 plate 2
neat -1800 -1800
10" 46 41
10'- 0 6
10" 1 1
10-4 0 0
This was equivalent to -4 .4  x 10' -  1.8 x 104pfu/ml. In a succesful panning experiment, 
a positive result is usually manifested by a 50 -  1000 fold increase in eluted phage
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compared to the first panning (Jacobsson 2003). This is not seen here. However the 
cycle was continued through am plification to the third round o f panning.
6.4.3 Third round o f  panning
Counts on the bound fraction from the third round o f panning are shown in Table 6.5. 
Table 6.5
Dilution o f bound phage 
from 3rd round o f panning
cfu in 100 pi 
plate 1 plate 2
neat Semi-confluent Semi-confluent
i
10'1 ! 530 389
10- 143 138
10° 35 13
1 0 - 4 0 2
This represents a more satisfactory increase in the number o f  bound phage to 
approxim ately 1 x 1 0 \ Twelve colonies were picked to look for inserts. After overnight 
broth culture DNA was extracted and digested with Pstl and H indlll. The digests were 
examined by gel electrophoresis. Six o f  the twelve colonies contained inserts. All the 
inserts were below 500 bp in size and four o f them had a similar size o f about 400 bp 
(figure 6.4).
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Figure 6.4 1% agarose gel electrophoresis o f  DNA from twelve clones obtained
after three rounds o f  panning the phage library against RpfB. DNA was digested with 
Pstl and HindJXL. Six o f the twelve clones contained inserts o f  below 500 bp in size. 
Four o f  the six inserts had a similar size o f  about 400 bp. 
lOObDlkb
1 kb
500 bp 
400 bp 
300 bp 
200 bp 
100 bp
6.5 Sequencing and analysis of inserts from clones selected by panning
To investigate the clones selected by the three rounds o f  panning, the inserts were 
sequenced, as described in 2.6.5. Three o f  the four inserts which had a similar size o f 
about 400 bp had near-identical sequences; the other clones were different and 
contained no overlapping sequence with the three near-identical ones. The consensus 
sequences o f  the four inserts o f size -400  bp are shown in Figure 6.5, and an alignment 
o f  two o f  the near-identical sequences is seen in Figure 6.6. It was expected that the 
whole o f  each insert should correspond to a fragment o f  the M. tuberculosis genome 
(whether a coding sequence or otherwise). However this did not appear to be the case 
and each insert as a whole did not match with any part o f  the M. tuberculosis genome 
sequence, recorded at http://genolist.pasteur.fr/TubercuList/. Shorter fragments within 
the inserts did correspond to short fragments o f  the M. tuberculosis genome. The 
longest and most notable, highlighted in red in Figures 6.5 and 6.6, was a 17 bp 
sequence present in the three identical inserts, and identified by BLAST searches using 
the whole inserts against the genome, with an E value o f  0.046.
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This 17 bp fragment forms part o f gene Rv0328 , described as coding for a possible 
transcription regulatory protein, perhaps o f the tetR/acrR family. Its co-ordinates within 
the M. tuberculosis genome are 394111 - 394713 and figure 6.7 is a diagram o f  its 
position within the surrounding genome region, taken from 
http://genolist.pasteur.fr/TubercuList/. The entire gene has a length o f 603 bp and the 
protein consists o f 200 amino acids. The nucleotide sequence o f  the gene is shown in 
figure 6.8a and the protein sequence in figure 6.8b. The section represented in the 
inserts from the panning experiments is highlighted in both figures. Although it had 
been thought that the R pf receptor(s) were likely to be membrane-associated proteins, it 
is also possible that R pf might bind inside the cell to a protein such as a transcription 
regulator, given its effect on cell growth. Therefore, since the sequence was present in 
half o f the inserts selected during panning it was decided to clone the gene and express 
the protein, with a view to demonstrating w hether or nor it did bind Rpf.
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Figure 6.5 Consensus sequences o f  four sequenced inserts from clones isolated after 
three rounds o f  panning. The inserts in clones b , c, and d  are near-identical. Green 
highlighted bases are those corresponding to amplified plasmid DNA; red highlighted 
bases are those found in three inserts to be present in M  tuberculosis gene Rv0328. The 
Smal digest site which was used to cut the plasmid is underlined at both ends o f  the 
insert.
Clone a
GCCATGATCGCCGGACCTCGCCAACCGCCCGCGCGAGGCGGAGCAGCTCGCCCGGATCGCC
CTGGCCGAGACGCCGGAGCTGAACCTGCGGCTGGTGCAGATCGTCGCCGGCATCCTGGAGC
GCGGCGGCAAGTCGGTGGAGGCGATGAAGCTGGTGGATAGCGTCACCGCCAGCGGCGACGA
CCTCTCCCTCTTCAGCACGCCCGAGGCGCGCCGGCGCCTGTTGCAGGGCCGCGCCGTCGCCT
C G G C G G T C G A G G G C A T G G C C G A G G C G C A G ^ H M
Clone b
GGACAGGCGAAATCCGCTC
CACGGCGCCGCCTCCCCACCCCCCACGGGCCCGGGCGCGGCACAAAAAAACGCCGGGGAAG
CCTGCTTCCCCGGCGTGTCCCTGGCGGCAGGCGGGCAGTCTCCGCCCTGCCCTGCCCTGCCCT
GGCCGGGCCTTACTCGGCCGGCTGCACCATGGCGGGGGCCTCGGC—
CT GACCTCGAGATCAAACGC
Clone c
GGACAGGCGAAATCCGCTCCACGGCGCCGCCTCCCCACCCCCCACGGGCCCGGGCGCGGCA
CAAAAAAACGCCGGGGAAGCCTGCTTCCCCGGCGTGTCCCTGGCGGCAGGCGGGCAGTCTC
CGCCCTGCCCTGCCCTGCCCTGGCCGGGCCTTACTCGGCCGGCTGCACCATGGCGGGGGCCT
C G G C H H M t ^ ( 1 GG C ® B CAGCGCCCGGTCGAG^^pAGGTCGA®BBHHH
Clone d
^ ■ ^ ^ ■ ^ ■ ■ ^ ■ I H H H H I H H I H H H H ggacaggcgaaatccgctc
CACGGCGCCGCCTCCCCACCCCCCACGGGCCCGGGCGCGGCACAAAAAAACGCCGGGGAAG
c c t g c t t c c c c g g c g t g t c c c t g g c g g c a g g c g g g c a g t c t c c g c c c t g c c c t g c c c t g c c c t
g g c c g g g c c t t a c t c g g c c g g c t g c a c c a t g g c g g g g g c c t c g g c c g g g g c — M
^ ^ B ^ B c a g c g c c c g g t c g a g ^ s g t g c a g g t c g a c c t c g a g a t c a a a c g g g c g g c c g c a
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Figure 6.6 Sequence alignment o f  two near-identical inserts from clones isolated 
after three rounds o f  panning. A 17 bp segment corresponding to a segment in M  
tuberculosis gene Rv0328 is highlighted in red.
Sequence 1 
Sequence 2
lcl|seq_l
lcl|seq_2
Length
Length
227 (1 .. 227)
221 ( 1 . . 221)
Query:
ggacaggcgaaatccgctccacggcgccgcctccccaccccccacgggcccgggcgcggc 60
Sbjct:
ggacaggcgaaatccgctccacggcgccgcctccccaccccccacgggcccgggcgcggc 60
Query:
acnnnnnnncgccggggaagcctgcttccccggcgtgtccctggcggcaggcgggcagtc 12 0
II 
I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 1 I I I I I
Sbjct:
acaaaaaaacgccggggaagcctgcttccccggcgtgtccctggcggcaggcgggcagtc 120
Query:
tccgccctgccctgccctgccctggccgggccttactcggccggctgcaccatggcgggg 180
II IIl l l l l l l l l l l l l l l
Sbjct:
tccgccctgccctgccctgccctggccgggccttactcggccggctgcaccatggcgggg 180
Query: 181 gcctcggccggggc
M i l l
Sbjct: 181 gcctc------ggc
Score = 41.1
Identities
tcagcgcccggtcgag 227
bits
tcagcgcccggtcgag 221
(21), Expect
25/27
1
61
61
121
121
1.1
(92%)
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Figure 6.7 Diagram o f the position o f  Rv0328 within the surrounding genome 
region. Its co-ordinates within the M. tuberculosis genome are 394111 -  394713. Taken 
from http ://genolist.pasteur. fr/TubercuList/.
Ru0316 =3 Ru0^0 udgfl Ry0325 Ru0328
Ru0315 - pep dcd Ru0324Ru0326
384412 i------ •---------- 1---1------ 1------ 1------ 1------ 1------ 1 1 394411
9 1 PQ2 ^ b Ru0323c
Ru03l8c cypl35fll
Rv0331
394412 l.
Ru0332 rmIR 
Rv^333 Rv0336
j 404411
>E6 Ru0338c
aspC
LEGEND
Cod i ng sequences:
— t v i ru1ence,detox, adapt —^  lipid metabo1 i sm
i nf ormat i on pathway ce 1 1 wa 1 1, process
— ► stab 1 e RNfl IS/phage PE/PPE
i ntermedi ary metabo1i sm ™  unknown regu1atory
*— t conserved “ 4  conserved in M. bouis
— *rRNR '▼'tRNR
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Figure 6.8 a Gene sequence o f  M. tuberculosis Rv0328
>M. tuberculosis H37Rv|Rv0328|Rv0328: 603 bp - POSSIBLE
TRANSCRIPTIONAL REGULATORY PROTEIN (POSSIBLY TETR/ACRR-FAMILY)
caagg
agaacacgtcgccgtacttgcgatgcatcgctggcagga
accattcccgaaacctcaggtacagcacgctctgcaggt
agcggggtagccgcggcccgggtggcaggcccgtcgtca
acgtgcttgccatggcggctcccttctgataatcaaatg
tttgatgtaaacgaatgcttatcacgataggatgcagct
1 - gtg caa cag caa ege aca aac ege gac aaa
31 - ctg etc gac ggc get ctg get tgt tta cga
61 - gaa ege ggc tac ggc aac acc age teg ege
91 - gac ate get cgt gcg gca ggg gtg aac ate
121 - gcg teg ate aac tac cac ttc ggt age aag
151 - gac gcg ctg etc gac gat gcg etc ggc egg
181 - tgc ttt teg acg tgg aac cag cgt gtc cag
211 - gag gca ttc gat cac tee ege gcc gcc ggt
241 - ccg gcc ggg cag ate ctg gcg gta etc gaa
271 - gcc acc gtc gat teg ttc gag cag ate ege
301 - ccc gcc gtg tat gcg tgt gtg gag tea tac
331 - get ccg gcg ttg ege tea gag gcc ttg
361 - ctg| gcc |cc gga tat gcc gac gtt
391 - egg cag cat teg gtc gat ctg get ggc get
421 - gcg ctt gcc ggt acc gac ata gca ccg ccg
451 - gag aac ctg teg acc ate gtc teg gtg ttg
481 - atg gcg gtc ate gat ggc etc atg ate cag
511 - tgg ate gcc gat ccg tee gcc acc ccg cga
541 - teg acc gag gta ate cga gcg ctt gcc a g e
571
601 _
ate
tga
ggc gcg gtc gtc acg teg cag ttg egg
accacacggtcgccggatggtctgcactgcgcttgatgc
cgacgtcgatgaagccggcagcgccaagccacgcggcgg
tgtcgagggtggggggcacgcgatagatcgcgggatcga
aacgggccgccagtggttggtcatcggatatcgatgtaa
ggacgagtcgacccccgggccgcagggctcgagcgatgt
cgcaa
Figure 6.8 b Protein sequence o f  M  tuberculosis gene Rv0328
>M. tuberculosis H37Rv|Rv0328|Rv0328: 200 aa - POSSIBLE
TRANSCRIPTIONAL REGULATORY PROTEIN (POSSIBLY TETR/ACRR-FAMILY)
1 - VQQQRTNRDK LLDGALACLR ERGYGNTSSR DIARAAGVNI ASINYHFGSK
DALLDDALGR
61 - CFSTWNQRVQ EAFDHSRAAG PAGQILAVLE ATVDSFEQIR PAVYACVESY
APALRSEALR
121 - ERLAAGYADV RQHSVDLAGA ALAGTDIAPP ENLSTIVSVL MAVIDGLMIQ
WIADPSATPR 
181 - STEVIRALAS IGAWTSQLR
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6.6 Cloning and expression o f Rv0328
Primers were designed to amplify Rv0328 from M. tuberculosis genomic DNA. Primers 
had an Nde\ site at the 5 ’end (primer sequence ATA T C A T A T G C A  ACA GCA ACG 
CAC A) and a H indlll site at the 3 ’ end (primer sequence ATA TAA GCT TCA CCG 
CAA CTG CGA CGT). The PCR reaction was carried out as described in Methods 
2.1.4, and a ~600bp segment o f  genome was successfully amplified (Figure 6.9).
Figure 6.9 Agarose gel showing amplification o f  Rv0328 from M. tuberculosis 
genomic DNA. A ~600bp segment o f  genome was successfully amplified. 50 pi o f  the 
reaction m ixture was run on this gel, for subsequent excision and cleaning.
1 kb 
900 bp 
800 bp 
700 bp 
600 bp 
500 bp 
400 bp
600 bp fragment
100 bp MW
This 600 bp fragment was cloned into TOPO® 2.1 (2.1.5) and transformed into 
competent E. coli DH5a cells (2.1.11 and 2.1.12). After plating onto XGal/IPTG/AplOO 
plates (2.1.13) for blue-white selection, approximately 3 white colonies were obtained 
per 100 pi o f transformants plated (and no blue colonies). O f ten such clones 
subcultured and examined, nine contained the required 600 bp insert (figure 6.10).
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Figure 6.10 Inserts o f cloned Rv0328 from clones o f  TOPO® 2.1 vector transformed 
into E. coli DH5a., after blue-white selection. O f ten clones subcultured and examined, 
nine contained the required 600 bp insert, u = uncut plasmids; lanes 1-10 correspond to 
clones tested, only clone 3 lacks the required insert.
100 bp MW
1 kb
700 
600 
500
The cloned gene was then sub-cloned into pET-21a, using enzymes Ndel and H indlll. 
All the clones obtained again contained the 600 bp insert. Finally this plasmid was 
isolated from D H5a, and transformed again into the expression host E. coli Origami B 
(DE3).
Protein expression was performed under the same conditions as described for the M. 
tuberculosis Rpfs in 2.2.1 and 2.2.2, with extraction and purification as in 2.3.1 and 
2.3.2.2, i.e. using sonication to break up the cells and Quick 900 nickel columns 
(Novagen) to purify the His-tagged protein. In addition, lysozyme was added to the cell 
suspension and left for half an hour prior to sonication, to try and improve the 
extraction. Extraction and purification was first attempted without the use o f urea. The 
yield o f  purified protein in the eluted fraction was low at -4 0  jig/ml. SDS-PAGE 
showed that although a band was visible corresponding to the purified protein, much o f
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the protein remained insoluble in the cell deposit. The extraction was therefore repeated 
using 6M urea: this resulted in a small improvement in solubility (a yield o f ~ 60 pg/ml 
in the eluted fraction). W hether or not this low concentration was sufficient to proceed 
to Rpf-binding experiments was not certain. The logical next step would have been to 
enhance the solubility o f  Rv0328 before perform ing binding experiments. However 
since there was doubt over the relevance o f  the interaction, as highlighted in the 
discussion section, and since further attempts to produce soluble protein might have 
been very lengthy, it was decided not to invest more time in this aspect o f the project. 
See discussion, below, for how this part o f  the work might have been taken further.
6.7 Discussion
Having identified the Rpfs an obvious question is how do they work? As described in 
the Introduction section 1.4.2 two possible mechanisms have been suggested. The most 
obvious is that the secreted or cell surface Rpfs act in an autocrine manner and bind to a 
very high affinity receptor on the cell surface. There are many examples in Gram- 
positive bacteria o f  cell-cell communication using modified oligopeptides that are 
secreted into the medium and accumulate at high cell density. The detectors for these 
oligopeptide signals are two-component adaptive response proteins, and the mechanism 
o f signal transduction is via a conserved phosphorylation/dephosphorylation 
mechanism. A precursor peptide is synthesised, then modified to make the mature 
autoinducer molecule. This is secreted by an ATP-binding cassette (ABC) transporter 
complex. At a critical concentration o f the oligopeptide in the medium, the two- 
com ponent sensory recognition apparatus detects the signal. Sensory information is 
relayed into the cell by phosphorylation and culminates in an appropriate alteration in 
gene expression. The detector for the oligopeptide autoinducer is called the sensor 
kinase, and it transfers the phosphoryl signal to a downstream regulatory component,
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the response regulator. This is a DNA binding protein whose function is usually to 
induce the expression o f density-controlled target genes. Such systems are seen for 
example in Bacillus subtilis, to regulate sporulation, and in Staphylococcus aureus, 
regulating several pathogenicity determinants. Therefore there is a clear precedent for 
this type o f  system to be used for the Rpfs. An alternative explanation is that the Rpfs 
act as enzym es and either by cleaving the cell wall, or by cleaving the cell wall and 
releasing the key mediator, bacteria enter the cell cycle. It was the first hypothesis, 
considered the most obvious, that was being tested here.
Panning o f  the phage library against recom binant RpfB identified an identical 400 bp 
fragment in one in two o f the resulting clones. This fragment contained a 17 bp 
sequence which matches a sequence in M. tuberculosis gene Rv0328, predicted to code 
for a transcription regulatory protein. This gene was successfully cloned but 
unfortunately the expressed protein had low solubility with the expression system used. 
Further efforts to express this protein were not pursued: the fact that only a 17bp 
matching sequence was detected, and that the rest o f the 400bp fragment did not appear 
to match parts o f  the M. tuberculosis genome as it ought, placed the relevance o f  the 
interaction in some doubt. However, the possibility has not been excluded that the 
protein identified, Rv0328, does bind Rpf. The next step would have been to improve 
the solubility o f  the recombinant Rv0328 by using a different expression system. For 
example, a vector enabling a soluble fusion protein to be expressed, such as pET43.1, 
could have been used, as was done in Chapter 4 to improve the solubility o f  RpfsmcsI. 
Once enough soluble protein was available, binding assays with R pf could have been 
performed. One simple way to dem onstrate binding would be to pass the His-tagged 
Rv0328 down a nickel column, followed by recombinant R pf or supernatant o f dormant 
M icrococcus luteus cultures. After saving the unbound fraction, the bound fraction
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could be eluted from the column with imidazole, and subjected to SDS-PAGE, with the 
unbound fraction and Rv0328 run as controls. If  binding had occurred, two bands 
should be seen in the test lane, one corresponding to Rv0328 and the other to Rpf.
Had such experiments failed to show binding o f  R pf to the product o f Rv0328, other 
possible reasons why a receptor for RpfB might not have been identified are 
summarized below. Firstly, the phage display library may not have been extensive 
enough. In a successful panning experiment, a number o f  clones with overlapping 
inserts are desirable, and not all variations o f a protein may be displayed equally well. 
Therefore ideally the size o f the library should exceed the 'm inim um ' number o f clones 
several times, and perhaps the library used here was not large enough. Also, the method 
used to generate the DNA fragments, blunt-ended restriction, does not give truly 
random cleavage o f  the DNA, and perhaps sonication o f the genomic DNA may have 
given a better result (Jacobsson 2003). The insert frequency in the library was at an 
acceptable level (phagemid with insert was found in 50% o f colonies growing on 
ampicillin plates), but higher levels approaching 100% can be achieved using 
phagemids such as pGSSAET. In pGSSAET insertion o f foreign DNA into a cloning 
site is required for expression o f the fusion protein, as without the insertion gene VIII is 
out o f frame with the signal sequence. However, numerous attempts to ligate M. 
tuberculosis DNA into pGSSAET were unsuccessful, for reasons which could not be 
identified. Therefore the library made with pG8H6 was used. It would have been 
informative to test the library to see whether it could identify a known receptor protein 
such as the fibronectin-binding proteins o f the Antigen85 complex (Abou-Zeid et al 
1991) and thus demonstrate that it was indeed functional as a library.
If the library was adequate, then it is a possibility that the R pf was not binding well to 
the polystyrene tube -  since one o f  the problems with recombinant R pf is that it is 
insoluble, the protein may have been aggregating during dialysis to remove urea and 
imidazole. Passive adsorption to the tube relies on establishing a large number o f 
relatively weak bonds between target and support which can result in the target being 
forced out o f  its functional configuration (W ilson 2001). Alternatively, the production 
o f the recom binant protein in the presence o f urea could mean that it was not folded in 
its natural tertiary conformation and so did not bind the receptor as it should.
It may also be the case that selection o f  clones was for some property other than specific 
ligand binding, such as replication or packaging into the phage particle (Jacobsson 
2003). During amplification, phage with inferior avidities for the target but better 
growth characteristics may be preferentially amplified (W illats 2002) and there is 
evidence that this may have occurred in the experiments described here. According to 
Jacobsson's experience, a 'true' selection should be apparent where clones are found 
with different (overlapping) inserts derived from the same gene. Where only identical 
inserts are found (as is the case here), it suggests selection for some other property than 
ligand binding.
Finally, although it was originally supposed that Rpfs have a protein receptor, this may 
not necessarily be the case. The similarity o f  one o f its folds to the active site o f 
lyso/ym e (Cohen-Gonsaud 2004 and 2005) and further bioinformatic analysis 
(Ravagnani, Finan & Young 2005) has raised the possibility that its mode o f action may 
be cleavage o f  an oligosaccharide in the cell wall, not involving a protein two- 
component response system at all. The evidence for this, although at first thought a less
likely mechanism, is now mounting, and is discussed in the Introduction and Discussion 
chapters.
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C H A P T E R  VII
RESULTS: IM M U N O C Y T O C H EM ISTR Y  USING ANTI-Rpf
A NTIBO DIES
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7.1 Introduction
7.1.1 Aim
The question o f whether Rpfs are expressed in M. tuberculosis-infected human tissues 
has not previously been addressed although R pf expression has been shown in mice 
(Tufariello et al 2004). The aim o f the work presented in this chapter was to investigate 
for the first time, by im munocytochemistry using anti-R pf antibodies, whether the 
presence o f  R pf could be detected in M. tuberculosis-infeclQd human tissue sections, 
and if  so, what its distribution was. This would provide the first demonstration that the 
organisms in hum an infection produce Rpfs. The correlation o f R pf with ZN-stained 
bacilli in the sections w as also investigated.
7.1.2 Histobacteriolog}' o f  tuberculosis
In order to m ake sense o f immunocytochemistry aiming to detect proteins produced by 
M. tuberculosis, an understanding o f  the histobacteriology o f  tuberculosis is required. 
An authoritative text on this subject, Le bacille de Koch dans la lesion tuberculeuse du 
poum on , by Georges Canetti, then director o f the Pasteur Institute in Paris, was 
published in 1946, with an English language revised edition following in 1955 (Canetti, 
1955). Canetti studied sections o f human lung from 1500 autopsies and correlated the 
results with clinical and radiological data. He counted the numbers o f acid-fast bacilli 
seen in the various types o f histologic lesions, to try and get a clearer understanding o f 
the evolution o f each lesion. He also drew on Huebschm ann's previous study o f 
histogenesis o f  tuberculous lesions (Huebschmann 1929).
Classically, three main categories o f  tuberculous lesion were considered to exist. Firstly, 
an inflammatory or 'exudative' lesion, consisting o f polymorphs, lymphocytes and 
macrophages; secondly, a 'productive' lesion, in which cellular metaplasias occur, with
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macrophages and histiocytes forming epithelioid cells and then giant cells. The 
epithelioid cells are often arranged in a rounded formation known as a tubercle. Thirdly, 
the caseous lesion, in which tissue necrosis, followed by homogenisation, is seen. The 
homogenised centre may soften.
According to both Huebschmann and Canetti, the majority o f  human pulm onary 
tuberculous lesions start with an exudative-type reaction which is eventually followed 
by caseation. Caseation is followed by the 'productive' reaction with tubercle formation 
and sclerosis at the periphery o f the caseum (this contradicted earlier dogma which had 
the tuberculous process starting as either exudative or productive, with both types then 
progressing to caseation). The evolution o f  a lesion is as follow s: in the pre-exudative 
and exudative phases, the alveoli fill with fibrin, desquamated and swollen alveolar 
cells and white cells. The bundles o f fibrin may be large. The exudative lesions may be 
sub-divided into fibrino-macrophagic, purely fibrinous or polymorphonuclear, 
depending on the proportions o f fibrin and w hite cells present. This appearance is not 
pathognomonic o f  tuberculous infection -  acid-fast bacilli, or small areas o f  caseation, 
must be seen to make a firm diagnosis. In the next stage, caseation begins. The fibrin 
loses its fibrillary structure and swells to fill the alveolus. The alveolar septa lose 
capillaries and become necrotic. The alveolar wall disintegrates so that several alveoli 
are am algam ated into blocks o f necrosis. These may remain solid, and this is what 
occurs in latent infection, and in most active infections. However the caseum may 
soften and this is what leads to clinical tuberculosis: the liquid caseum is expelled via a 
bronchial segment, infecting adjacent areas o f lung and leaving a cavity which is 
difficult to heal. Hence it is the softening o f  the caseum which is the crucial event, 
rather than the formation o f the caseum itself.
The next stage in the evolution o f the lesions is tubercle formation. The tubercles form 
at the peripheries o f the caseum and consist o f  giant cells and epithelioid cells. The giant 
cells are derived from epithelioid cells by atypical division or fusion and may have 
thirty or more nuclei. Later, sclerosis may occur and this may finally be followed by 
calcification.
Canetti performed detailed bacillary counts on sections showing each stage o f the 
evolution o f  a lesion. In the pre-exudative phase (capillary vasodilation, alveolar 
swelling) tubercle bacilli were numerous, and mainly seen in macrophages, often in 
clumps. In the exudative phase, the numbers o f  bacilli seen depended on the numbers o f  
white cells present: if  the alveolitis was almost purely fibrinous bacilli were rarely seen, 
but if  the alveolitis was ’polymorphonuclear' then many bacilli were present. At the 
onset o f  caseation, the sub-type o f exudative lesion again determined the amount o f 
bacilli, with caseation arising from fibrino-macrophagic or polym orphonuclear 
alveolitis showing a huge increase in the number o f  bacilli, but caseation from a 
fibrinous lesion having very few bacilli.
Generalised hom ogeneous caseation followed by necrosis revealed bacilli only very 
rarely. Once necrosis had set in the bacilli appeared to die and they progressively 
disappeared from solid caseum. Similarly, at the periphery o f  the caseum, in the 
tubercle, few bacilli were seen even in the giant cells. Sclerotic and calcified lesions 
also contained no visible bacilli. However, if  the caseum softened, explosive growth o f 
bacilli occured, surpassing the numbers seen in any other lesion and approaching the 
density o f bacilli in pure culture.
7.1.3 Location o f M. tuberculosis in tissue sections
The location o f M. tuberculosis in infected tissues remains the subject o f  debate. The 
mystery o f why so few organisms are seen in the tubercles and giant cells has prompted 
some to consider the possibility o f a non-acid fast form o f M. tuberculosis, perhaps in a 
spore-like form (the organism has genes such as sigF  which is homologous to 
sporulation factors in Streptomyces coelicolor and Bacillus subtilis). Others argue that 
lack o f \ isible acid-fast bacilli is simply down to the lack o f sensitivity o f  histologic 
microscopy. Seiler et al provided persuasive evidence o f a non-acid-fast form (Seiler et 
al 2003;. By analysing tissue sections from both mice and humans infected with M  
tuberculosis Seiler found that whereas ZN-staining bacilli were lost during persistence 
o f  infection, staining with polyclonal antibodies against mycobacterial antigens 
persisted, and bacterial titres remained constant. The authors suggest that this is best 
explained by mycobacterial cell-wall alterations - either loss or re-organization o f cell- 
wall com ponents, which might lead to the loss o f the ability o f the cell to retain 
carbolfuchsin, or, might prevent access o f  the stain to the cell.
Other groups have sought to improve knowledge o f the site o f  the bacilli by using 
methods to detect nucleic acids in tissues in addition to acid-fast staining. One such 
study (H em andez-Pando et al, 2000) found evidence o f M. tuberculosis DNA by in-situ 
and conventional PCR in 15 o f 47 lung specimens taken from Mexican and Ethiopian 
patients who died o f causes other other than TB. There was no histologic evidence o f 
the presence o f  A/, tuberculosis, either as histologic lesions or as visible acid-fast bacilli. 
These individuals were considered to harbour latent tuberculous infection. Furthermore, 
the DNA was found to be present not only in macrophages, but also in type II 
pneumocytes, endothelial cells and fibroblasts. Thus the absence o f visible acid-fast 
bacilli on microscopy certainly does not seem to preclude their presence in the tissues in
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some form. Fenhalls et al (Fenhalls 2002a and 2002b) localised mycobacterial DNA 
and mRNA in human tuberculous granulomas. They considered viable bacilli to be 
those with detectable rpoB  mRNA transcripts, with the presence o f DNA alone 
indicating non-viable cells. In three o f  nine patients tuberculous granulomas were 
present but no acid-fast bacilli could be seen. In the other six cases, those bacilli 
detected by ZN staining were only found in the necrotic regions o f granulomas, whilst 
DNA was found by in-situ hybridization to be present also in giant cells and 
m acrophages on the edges o f granulomas. rpoB  mRNA was also detected in the 
cytoplasm o f  giant cells and macrophages on the outer edges o f certain necrotic 
granulomas and a few granulomas w ithout caseous necrosis. It was not detected within 
the necrotic regions o f granulomas. The authors pointed out that it was possible that 
viable bacteria were present in other areas o f  the granulomas but that rpoB  mRNA was 
at undetectable levels using this technology.
In addition to detection of nucleic acids, evidence o f mycobacterial infection has also 
been sought by staining for specific mycobacterial antigens in human tissues. As 
already m entioned, Seiler (Seiler 2003) used a polyclonal anti-M  bovis BCG serum and 
found that w hereas ZN staining gradually became negative with persistence o f infection, 
staining with the anti-serum remained positive. Another study o f human intracranial 
tuberculom as found that none o f 10 specimens o f tuberculous granuloma were ZN- 
positive, but mycobacterial antigens were found in the cytoplasm o f giant cells and 
m acrophages in all the cases (Radhakrishnan 1991). Hence the presence o f  residual 
antigen deposits in the tissue might provide evidence o f mycobacterial infection when 
bacilli are not visible by ZN staining.
7.2 Method
7.2.1 Determining the correct dilution o f  secondary' antibodies
For a full description o f the method and antibodies used see M ethods 2.7. Purified 
polyclonal anti-Rpf antibodies raised in sheep were obtained from Mike Young 
(M ukam olova et al 2002b). The secondary antibodies used were rabbit anti-sheep 
antibodies (Jackson ImmunoResearch). The first step was to determine the correct 
working dilution o f rabbit anti-sheep secondary antibodies. This was done by binding 
various dilutions o f  the antibodies to sheep anti-factor 8 (Serotec) bound to sections o f 
hum an placenta. The secondary antibody was tested at dilutions o f  1:1000 and 1:5000, 
against dilutions o f the sheep anti-factor 8 (primary) antibody o f  1:100, 1:500, 1:1000 
and negative control (no primary antibody). The outcome is shown in Table 7.1. The 
negative control did not stain; staining o f  all sections using the 1:5000 dilution o f 
secondary antibody were too faint; the best results were obtained using 1:1000 dilution 
o f secondary antibodies against 1:500 and 1:1000 o f prim ary sheep anti-factor 8 
antibody.
Table 7.1
Dilution o f  prim ary antibody Dilution o f secondary antibody (rabbit anti-sheep)
(sheep anti-factor 8) 1:1000 1:5000
1:100 i r T-/  —
1:500
1:1000 "T -r/' -
Negative control “ -
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7.2.2 Determining the optimal dilution o f  an ti-R p f antibodies and imm uno-staining o f  
tissue sections
Sheep anti-factor 8 antibodies were replaced with sheep anti-R pf antibodies, and instead 
o f placental tissue sections, sections o f  a lymph node from the gut, known to contain M  
tuberculosis, were used. The method was again as described in M ethods 2.7. To 
determine the optimal dilution o f anti-R pf antibodies, a dilution o f 1:1000 rabbit anti­
sheep (secondary) antibody was used against the following dilutions o f anti-Rpf 
antibodies: 1:100, 1:500, 1:1000, 1:2000. All were satisfactory but the 1:100 dilution o f 
anti-R pf antibodies gave the clearest result and was the dilution employed in all the 
figures shown. All further experiments described here were performed on consecutive 
sections o f  the same gut lymph node, unless otherwise stated. This came from a patient 
with known tuberculosis o f the gastro-intestinal tract, and the sections were known to 
contain acid-fast bacilli. Features such as lymphoid follicles, granulomas and caseous 
lesions were all clearly visible on each slide o f  this piece o f  tissue. As all the sections 
were taken consecutively from the same tissue their appearances could be easily 
compared and the same lesion could be studied using different stains.
7.2.3 Absorption experiment using recombinant RpfB
In order to confirm  that the staining in the lymph node sections could be ascribed to 
binding o f an ti-R pf antibodies to R pf in the tissues, rather than a non-specific binding 
effect, freshly prepared recombinant R pf was added to the diluted anti-Rpf antibodies 
prior to using them. This should neutralise the anti-Rpf antibodies and lead to a negative 
result. The R pf and the anti-Rpf antibody mixture was allowed to stand at room 
tem perature for 75 minutes before being added to the sections and im muno-staining 
carried out exactly as before.
7.2.4 Staining o f  giant cells in sections not infected with M. tuberculosis
To rule out the possibility that giant cells (rather than Rpfs) cross-reacted with the anti- 
R pf antibody, sections o f  liver were provided by Dr A. Quaglia, Department o f 
Histopathology, Royal Free Hospital. The sections were taken from a patient with a 
liver tumour, the blood supply to which had been interrupted by the procedure o f 
embolisation (i.e. intravascular obstruction o f  the blood vessels, in this case 
deliberately, to kill the affected tissue). Later, the embolised area o f liver had been 
resected. The embolisation had led to an inflamm atory reaction in the liver, in which 
macrophages had fused to form giant cells, histologically very similar and comparable 
to those seen in tuberculous lesions. There was no clinical suspicion or evidence that the 
patient was infected with M. tuberculosis. The sections o f  liver were stained with anti- 
R pf antibodies in exactly the same way as the sections o f gut lymph node.
7.2.5 Ziehl-Neelsen (ZN) staining o f  sections
Cold ZN staining o f  sections was performed in order to demonstrate whether there was 
any correlation between the sites in the sections which contained acid-fast bacilli and 
those which stained positive for Rpf. The im muno-staining was performed first, 
followed by ZN staining. Detail o f the cold ZN staining method used is described in 
Methods 2.7.3.
7.2.6 Staining with anti-LAM antibodies
To com pare the distribution o f  R pf in-situ with that o f  another mycobacterial antigen, 
anti-lipoarabinom annan (LAM) antibodies were obtained from Vladimir K oulchin 's 
laboratory at Chemogen, Portland USA. LAM is a mycobacterial envelope glycolipid 
(Besra et al 1994) that has been implicated in the virulence and pathogenesis o f  M. 
tuberculosis. The antibodies were raised in rabbits and conjugated to horseradish
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peroxidase. They were used at a 1:50 dilution, and with peroxidase-conjugated 
streptavidin as used in the anti-Rpf experiments. The staining method used was identical 
to that already described (see Methods 2.7).
7.3 Results
7.3.1 Staining o f  M. tuberculosis-infected human tissue with anti-R p f antibodies
The lymph node section contained necrotic lesions with caseous centres surrounded by 
a zone o f giant cells and macrophages. Lymphoid follicles were also visible. There was 
no staining o f  the negative control section to which anti-R pf antibody was not applied. 
Figure 7.1 shows the overall appearance o f the section without im muno-staining 
(negative control) at x400 magnification. Areas o f caseating necrosis are seen 
surrounded by zones o f giant cells and macrophages. Figure 7.2a is a xlOOO 
magnification o f  epithelioid giant cells in the negative control (Go). In sections to which 
anti-Rpf antibody was applied, marked im muno-staining was seen, which appeared 
clearly in the giant cells and macrophages in the zones o f tubercle surrounding the 
caseous lesions. Figures 7.2b and c show similar giant cells to those in negative control 
Figure 7.2a, but with anti-Rpf antibodies applied. Dark brown immunoperoxidase 
staining o f  these cells is clearly visible (Gj). Figures 7.3a and b are xlOOO 
magnifications o f  a lymphoid follicle: Figure 7.3a is the negative control and 7.3b, to 
which anti-R pf antibodies were applied, again shows immunoperoxidase staining within 
the follicle. The images are all consecutive sections o f the same infected gut lymph 
node.
7.3.2 Absorption experiment with recombinant R p f
Figures 7.4a and b show' the results o f  the absorption experiment, in w hich recom binant 
R pf had been added to the anti-R pf antibodies prior to staining. No staining o f the
section was seen when R pf had been added, confirming that the addition o f R pf had 
neutralised the anti-Rpf antibodies. Therefore the staining seen with anti-Rpf antibodies 
was specific to those antibodies.
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Figure 7.1 Section of Mycobacterium tuberculosis-infected human gut lymph node, 
unstained negative control, demonstrating areas o f caseating necrosis (C) and 
giant/epithelioid cells (Go). x400 magnification.
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Figure 7.2 Section of human gut lymph node (the same as in Fig 7.1) but at xlOOO 
magnification (a) negative control showing unstained epithelioid giant cells (G o), (b) 
and (c) immuno-stained with anti-Rpf antibodies. Zones of epithelioid giant cells and 
macrophages surround areas of caseous necrosis. Epithelioid giant cells have been 
stained dark brown with immunoperoxidase (G i) .
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Figure 7.3 Lymphoid follicle in section of M. tuberculosis-infected human gut 
lymph node, (a) Fo, negative control; (b) Fj, immuno-stained with anti-Rpf antibodies. 
The lymphoid follicle displays brown immunoperoxidase stain after anti-Rpf has been 
applied.
xlOOO magnification.
(a)
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Figure 7.4 Section of M. tuberculosis -  infected human gut lymph node at xlOOO 
magnification. Blocking experiment in which fresh recombinant Rpf was added to the 
anti-Rpf antibodies prior to immuno-staining. (a) imrnuno-staining after adding Rpf: 
there is no immuno-staining of giant cells (G o) and macrophages, as the anti-Rpf has 
been neutralised by the Rpf. (b) control in which no Rpf was added: a clearly immuno- 
stained giant cell is shown (G |) .
(a)
-
G ,
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7.3.3 Staining o f  giant cells in sections not infected with M. tuberculosis
The appearance o f the embolised liver with or without anti-Rpf antibodies was the 
same. The giant cells in the liver sections did not stain in the presence o f anti-Rpf 
antibodies (figures 7.5a and b). This ruled out the possibility that giant cells cross­
reacted with the anti-Rpf antibody. A positive control made using the gut lymph node 
section did show immuno-staining.
7.3.4 Ziehl-Neelson staining o f  sections
The sections o f human gut lymph node were again immuno-stained with a 1:100 
dilution o f anti-Rpf antibody and then cold ZN-staining was performed. Acid-fast 
bacilli were visible only in the centres o f some o f the necrotic lesions. Immediately 
surrounding the bacilli were areas o f immuno-staining with anti-Rpf antibodies, which 
was not present in the rest o f the necrotic lesion (Figures 7.6a and b). No acid-fast 
bacilli were seen in the areas containing giant cells and macrophages, which were 
positive for Rpf.
7.5.5 Staining with anti-LAM  antibodies
Staining with anti-LAM antibodies revealed that LAM was detectable at the centres o f 
some o f the necrotic lesions in the im m ediate vicinity o f the acid-fast bacilli themselves 
(Figure 7.7 a and b), in a similar distribution to Rpf as described in section 7.3.4. 
However in contrast to the pattern with R pf there was no LAM detectable in the 
macrophages or giant cells surrounding the areas o f caseous necrosis (Figure 7.7c).
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Figure 7.5 Giant cells (Go) in a section o f embolised human liver, uninfected with 
M. tuberculosis, magnification xlOOO. (a) negative control without addition of anti-Rpf 
antibodies (b) the same section immuno-stained with anti-Rpf antibodies. There is no 
immuno-staining of giant cells with anti-Rpf antibodies, indicating that immuno- 
staining is not due to a non-specific cross-reaction with giant cells.
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Figure 7.6 Area of caseous necrosis in a section of M. tuberculosis-infected human 
gut lymph node, after Ziehl-Neelsen staining and immuno-staining with anti-Rpf, 
magnification xlOOO. (a) acid-fast bacilli (AFB) are seen surrounded by areas of brown 
immunoperoxidase staining (IP), (b) the same section, showing the absence of immuno­
peroxidase staining in the necrotic areas distant from acid-fast bacilli.
(a)
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Figure 7.7 (a) Same area of section as seen ZN-stained in Figure 7.6 but immuno-
stained with anti-LAM antibodies. Staining is seen around the areas where acid-fast 
bacilli are located, in a similar way to staining with anti-Rpf. (b) same section with ZN 
and anti-Rpf immuno-staining for comparison, (c) Same section, at edge of area of 
caseous necrosis, including giant cells (G), after staining with anti-LAM. There is no 
immuno-staining, in contrast to the marked staining of giant cells and macrophages seen 
with anti-Rpf. xlOOO magnification.
(a) (b)
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7.4 Discussion
This is the first time anti-Rpf antibodies have been applied to human tissue infected 
with M. tuberculosis. R pf was detected in human tissue for the first time. Acid-fast 
bacilli were present on ZN-staining only in the necrotic centres o f the tuberculous 
lesions. The apparent absence o f  acid-fast bacilli from the macrophages and giant cells 
might be because o f the insensitivity o f acid-fast staining at detecting low numbers o f 
organism s, or because o f the presence o f  non-acid-fast forms o f the organism (see 1.2.2; 
7.1.3), or might reflect a genuine absence. R pf was present in the immediate vicinity o f 
the organism s in the necrotic centres and also in the epithelioid cells/giant cells and 
macrophages. See Figure 7.8 for a diagrammatic representation o f the staining pattern 
seen. The stained cells may either contain secreted Rpf, or entire organisms which were 
not visible on ZN staining. The former possibility is supported by the fact that R pf 
staining within cells appeared granular and diffuse (Gi in Figures 7.2b/c and 7.4b) 
rather than delineating whole bacilli (as seen with other mycobacterial antigens by 
Radhakrishnan et al (1991) and Orrell et al (1991)). The latter possibility is supported 
by FenhalFs findings o f mycobacterial mRNA in these cells even when acid-fast bacilli 
were not visible. In Fenhalls’ studies (Fenhalls et al 2002a and 2002b) ZN-stained 
bacilli were seen only in the necrotic centres but mycobacterial DNA was detectable 
both in the necrotic centres and in the giant cells/macrophages. mRNA was found only 
in macrophages at the periphery o f  the granulomas and not in the necrotic centres. 
Fenhalls suggests that M. tuberculosis may be metabolising more actively in the 
macrophages than in other areas o f the granulomas, and that mRNA may also be present 
at undetectable levels in other areas such as the necrotic centres. This scenario would fit 
with the results presented here, where most R pf was detected in the giant 
cells/macrophages and a smaller amount associated with the ZN-stained bacilli in the 
necrotic area.
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Figure 7.8
Diagrammatic representation o f  a granuloma in human tissue infected with M  
tuberculosis, showing the distribution o f  immuno-peroxidase staining after immuno- 
staining with anti-Rpf antibody. Areas shown in brown are immuno-stained. R pf is 
present in macrophages and multinucleate giant cells, and also in the immediate vicinity 
o f  acid-fast bacilli in the caseous necrotic centre.
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LAM is a mycobacterial envelope glycolipid (Besra et al 1994) that has been implicated 
in the virulence and pathogenesis o f M. tuberculosis and M. leprae infection and has 
been associated with a variety o f  deleterious effects on immune system function. The in- 
situ expression o f LAM in human tuberculous disease does not appear to have been 
studied although several studies have looked at its expression in human leprosy 
(Verhagen et al 1999, van den Bos et al 1999, Lockwood et al 2002). In skin lesions o f 
lepromatous (multibacillary) leprosy, LAM was found in macrophages surrounding the 
granulom a and within the granuloma itself; however in tuberculoid (paucibacillary) 
leprosy, staining with anti-LAM was not seen (Verhagen et al 1999). It is reasonable to 
suppose that tuberculoid leprosy may provide a better approximation o f the distribution 
o f  LAM in hum an M. tuberculosis infection than does m ultibacillary leprosy. Staining 
with anti-LAM revealed that LAM was detectable in the immediate vicinity o f the acid- 
fast bacilli them selves in a similar distribution to Rpf. However in contrast to R pf there 
was no LAM detectable in the macrophages or giant cells. The latter finding is similar 
to that seen in tuberculoid leprosy.
In summary, the expression o f Rpf has been dem onstrated for the first time in human 
tissue sections infected with M. tuberculosis. R pf was detected in the immediate vicinity 
o f  the acid-fast bacilli in the necrotic centres o f  the granulomas, and in the giant cells 
and m acrophages surrounding the caseous lesions. W hether the Rpf in these cells was 
secreted R pf which had entered the cell, or was associated with tubercle bacilli which 
were not visible on acid-fast staining could not be demonstrated. The presence o f  R pf in 
human tuberculous infection lends support to the idea that R pf has a role in controlling 
dorm ancy in human tuberculosis.
CHAPTER VIII 
DISCUSSION
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8.1 Discussion
If medicine is ever to be successful in controlling tuberculosis, then the problem of treating 
persisters and latent infection must be overcome. Several new types of interv entions could 
help target latent tuberculosis. These include improved diagnostic testing for latent 
infection, to replace the tuberculin skin test which has poor sensitivity and specificity; an 
effective post-exposure vaccine that would prevent subsequent reactivation -  already 
achieved with a DNA vaccine in mice (Lowrie et al 1999); and the development o f drugs 
which can effectively and rapidly kill persisters and tubercle bacilli in the dormant state. To 
achieve all these, a better understanding of the dormancy response is necessary. Such 
knowledge could help transform the current approaches to tuberculosis treatment.
In order to identify specific latency drug targets, several lines of research are underw ay. For
example there is a major effort to develop rationally designed inhibitors of the isocitrate
lyase enzyme, and studies of the action of sigma factor could lead to rational inhibitors of a
latency-specific transcription factor. If the biochemical triggers for reactivation from the
dormant state were understood, perhaps this would be prevented in latent tuberculosis; on
the other hand, if  growth deceleration and latency could be blocked then bacilli in the host
could be more readily killed with existing drugs. Therefore the identification of molecules
which caused the reactivation of dormant cells of M. tuberculosis was greeted with great
interest. As well as Rpfs, phospholipids and other small peptides have been implicated as
having a role in M. tuberculosis reactivation (Zhang et al 2001). This group noted that
spent culture supernatant from stationary phase cultures of M. tuberculosis could resuscitate
dormant cells o f the bacillus. They found evidence that a phospholipid and a small 8 kDa
peptide, R vll74c, were responsible for this activity, and pointed out that exogenous
phospholipids could serve as building materials for the cell membrane during their
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replication or repair. Alternatively they might have a role as signalling molecules for 
growth.
The concept o f signalling between bacteria is not a new one. Communities of bacteria
convey their presence to each other by releasing and detecting chemical signalling
molecules called autoinducers. This is known as quorum sensing. Many bacterial
behaviours are regulated by quorum sensing, such as symbiosis, virulence, antibiotic
production and biofilm formation. The first- and best-known example is the case o f the
ocean-dwelling Gram-negative organism Vibrio fischeri. This organism constantly secretes
an autoinducer which at low’ concentrations has no effect, but which at high concentrations
activates the lux operon, resulting in the production of luciferase and the emission o f light
by the organisms. This therefore only occurs when the bacteria are present in large
numbers, so that energy is not wasted on light production when there are too few present to
have an effect. The emission of light gives the bacteria an advantage as it results in a
symbiotic relationship with a squid, w’hich carries the organisms in a light organ. Two
regulatory components are required for the process. The LuxI protein is responsible for
production o f the homoserine lactone (HSL) autoinducer, and the LuxR protein is
responsible for binding the HSL autoinducer and activating transcription of the luciferase
structural operon at high density. HSL/transcriptional activator signalling circuits have
since been found to be the standard mechanism by which many Gram-negative bacteria
communicate (Schauder & Bassler 2001). Other organisms exhibiting inter-cellular
signalling using this method include Pseudomonas aeruginosa (to regulate expression o f
virulence and biofilm formation). Quorum sensing in Gram-positive bacteria, however,
uses modified oligopeptides that are secreted into the medium and accumulate at high cell
density. The detectors for these oligopeptide signals are two-component adaptive response
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proteins, and the mechanism o f signal transduction is via a conserved 
phosphorylatiomdephosphorylation mechanism, as described in section 6.7. This 
mechanism o f action was thought the most likely for Rpf until recently.
Whilst inter-bacterial communication is thus well-described, the idea o f a bacterial 'growth 
factor' is novel. Since Rpfs are present in sporulating organisms such as streptomycetes it 
was suggested that Rpfs might be the trigger for the organism to come out o f the sporulated 
state. Sporulation is itself a protective response to environmental conditions: when the 
environmental conditions are again favourable for growth, some organisms in the 
population might start secreting Rpfs, which might reactivate others in the population. This 
scenario could be extended to apply to the dormant state in genetically related though non­
spore-forming organisms. However the theory leaves many questions unanswered. How are 
the first organisms to start secreting Rpf reactivated? How do they sense that conditions 
have become favourable for growth? Presumably at least one organism must start 
reactivating and secreting Rpf without such a signal. Since Rpfs seem to have cross-species 
reactivity then in an environment such as soil, when one species begins to secrete Rpf, 
organisms o f other species would also be reactivated -  a situation not necessarily beneficial 
to the first organism as there would then be more competition for nutrients.
Recent bioinformatic work has indicated that the high G^-C Gram-positive organisms may
not have a monopoly on Rpf-like proteins (Ravagnani, Finan & Young 2005). Although the
Rpf domain itself is not found in low G+C Gram-positives, an alternative domain dubbed
the Sps (stationary phase survival) domain has been identified, which has very similar
accessory domain structures and genomic contexts, for example in Clostridium sp.. Bacillus
sp.. Listeria sp. and Enterococcus faecalis  (see Introduction 1.4.2). It may even be that
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proteins with a similar function to Rpf are near-universal amongst bacteria, and that they 
may have clinical relevance in many other diseases as well as tuberculosis: if so, for 
example, inhibiting the action o f the Rpf-equivalent proteins might prevent proliferation of 
bacteria in the human host.
The discovery o f resuscitation-promoting factors in M. tuberculosis offers a lead in 
unravelling the mechanisms of dormancy and reactivation in this organism, as well as a 
potential target for drug therapy. However, since 1998, when Rpfs were first identified 
within the M. tuberculosis genome, progress in characterising them and finding their mode 
o f action has been frustratingly slow. This has mainly been a result of their instability and 
insolubility in recombinant form, making work technically difficult and time-consuming 
even for those most experienced in the field. Commercial companies, interested in the 
potential o f Rpfs at first, have for these reasons ceased to prioritise further work on Rpfs 
(Ken Duncan, personal communication). Recent progress in identifying a possible mode of 
action has relied almost exclusively on a bioinformatic approach.
Much of the work described in this thesis was aimed at improving the expression and 
solubility o f mycobacterial (M. tuberculosis and M. smegmatis) Rpfs, using various 
approaches. The best success was achieved in the case o f the small Rpf o f M. smegmatis 
(Rpfsmcg). By expressing Rpfsmeg as a fusion protein with NusA, a much greater quantity o f 
soluble protein could be extracted, without the use of a denaturant. Previous attempts to 
express this protein had resulted in quantities too small to visualise on immunoblotting. 
Quantities sufficient for testing of biological activity were now produced for the first time. 
The use o f a fusion protein with Rpfsmeg was more successful than the strategy o f using
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lower induction temperatures and lower concentrations of inducer with RpfB and RpflE, 
although this too yielded some soluble protein.
The next step was to devise a convenient test for the biological activity of the Rpfs, so that 
batches o f recombinant protein could be shown to be suitable for use in further 
experiments. In order to do this, suitable bacterial cultures containing cells in a dormant 
state were required. Standardised cultures o f A/, bovis BCG were developed which were 
reliable and gave useful results. The activity o f Rpfsmcg, hitherto untested, was assessed 
using these cultures. Results confirmed it was active, in the fM-pM range. The tiny Rpfsmeg 
consists only o f the core 'R pf domain' common to all Rpfs, and these experiments were the 
first time that this domain alone, in a naturally-occurring (as opposed to artificially 
truncated form) had been tested for activity. The results confirmed that this domain is the 
active region in the Rpf proteins.
Despite being reliable, cells from this model o f dormancy in M. bovis BCG took between 3
and 6 months to prepare, and from 1 to 3 weeks to give results in an activity assay.
Therefore attention turned to M. luteus, a much more rapidly growing organism.
Straightforward optical density measurements were not accurate enough because o f the
tendency o f the cultures to clump, and because they were not sensitive enough at the very
low inoculum density required to demonstrate an effect o f Rpf. By measuring the ATP
concentration o f cultures these problems were overcome and rapid (4 hour culture) and
overnight (16 hour culture) tests o f Rpf activity were developed. The latter allowed
accurate quantitative comparisons o f the activity of different preparations o f recombinant
Rpf, whilst the former was more suitable as a rapid qualitative test o f whether a batch had
activity or not. The range of activity of RpflB against M. luteus had not been measured
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previously. The most active concentration o f RpfB was in the nanomolar range. Most other 
Rpfs studied have had optimal activity in picomolar concentration (Mukamolova 2002b). 
Since RpfB, unlike the other Rpfs, is thought to be membrane bound rather than secreted, 
its optimal concentration for activity might also differ; or, it could simply be that the 
different method used to purify the protein in these experiments (commercial rather than in- 
house columns, with different buffers) might in some way have affected the protein folding 
process or its stability (Mukamolova's work found that RpfB in picomolar concentrations 
was active against M. bovis BCG).
The mode o f action o f Rpfs is not yet fully known although bioinformatic analysis over the 
past 12 months has begun to shed some light on this question. Two possible mechanisms 
have been considered. The most obvious is that the Rpfs act in an autocrine manner and 
bind to a very high affinity cell surface receptor. This could be part o f a two-component 
sensory recognition apparatus, the model that would be intuitively expected when drawing 
comparisons with other examples o f quorum sensing in Gram-positive bacteria: or could 
involve other specific protein receptors, such as occurs in eukaryotes, in which growth 
factors bind tyrosine kinases. An alternative explanation is that the Rpfs act as enzymes and 
either by cleaving the cell wall, or by cleaving the cell wall and releasing the key mediator, 
bacteria enter the cell cycle. The first hypothesis was tested here by means of a phage 
display system.
Panning o f the phage display library against recombinant RpfB identified an identical 400
bp fragment in 25% of the clones which contained a 17 bp sequence matching a sequence
in M. tuberculosis gene Rv0328. This gene is predicted to code for a transcription
regulatory protein, and was successfully cloned. Unfortunately the expressed protein had
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low solubility with the expression system used. Because of time constraints a different 
expression system could not be tried, nor binding experiments performed to see whether 
Rv0328 did bind Rpfs. The possibility that Rv0328 does bind Rpf was therefore not 
excluded. Had the time been available to improve the protein's solubility, binding assays 
with R pf could have been performed, for example by passing the His-tagged Rv0328 down 
a nickel column, followed by recombinant Rpf or supernatant o f dormant M. luteus 
cultures.
Since this attempt to identify a protein receptor was made, evidence has been mounting that 
Rpf may in fact act as an enzyme, facilitating cleavage o f the cell-wall peptidoglycan, and 
not by binding to a specific protein receptor at all. This was first suspected when the 
similarity o f one o f the folds of Rpf to the active site o f lysozyme was noted (Cohen- 
Gonsaud et al 2004). See Introduction 1.4.2 for a review o f this work. Hence, although the 
overall sequence conserv ation between Rpf and c-type lysozymes is low, it was suggested 
that the function o f Rpfs may be to cleave oligosaccharide in the cell wall. Mike Young's 
group's recent publication, in which the Sps domain was also identified, supports this view 
(Ravagnani, Finan & Young 2005). The group suggests that the walls o f dormant 
organisms may be considered similar to a 'cocoon', requiring the muralytic enzymes to 
cleave certain residues so that growth and cell wall expansion can resume. Inter-cellular 
signalling might still be involved, mediated perhaps by the release o f a small molecule as a 
result o f the cleavage of peptidoglycan by Rpf.
W hatever the mode of action, the role o f Rpf in human tuberculosis infection -  if any -
remains uncertain. To discover whether or not Rpfs are in fact expressed in infected human
tissue, paraffin-embedded tissue sections taken from human cases o f tuberculosis were
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investigated by performing immunocytochemistry with anti-Rpf antibodies. Expression of 
Rpf in human tissue was successfully demonstrated for the first time. Although acid-fast 
bacilli were present on ZN-staining only in the necrotic centres of the tuberculous lesions, 
Rpf appeared to be present not only in the immediate vicinity of the organisms, but also in 
the epithelioid cells/giant cells and macrophages in the zone surrounding the caseous 
necrotic lesions. These cells may either contain secreted Rpf, or entire organisms which 
were not visible on ZN staining. This was consistent with the results of Fenhalls' studies of 
mycobacterial nucleic acids in such lesions (Fenhalls 2002a and 2002b), in which ZN- 
stained bacilli were seen only in the necrotic centres (as here) but mycobacterial DNA was 
detectable both in the necrotic centres and in the giant cells/macrophages, and mRNA was 
found only in macrophages at the periphery o f the granulomas and not in the necrotic 
centres. M. tuberculosis may be metabolising more actively in the macrophages than in 
other areas o f the granulomas, with most Rpf/mRNA detected in the giant 
cells/macrophages and smaller (Rpf) or undetectable (mRNA) amounts associated with the 
ZN-stained bacilli in the necrotic area. The presence of Rpf in human tuberculous infection 
means that the possibility of a role for the Rpfs in controlling dormancy in human disease 
remains very much a possibility.
8.2 Further Work
Technical challenges still face researchers studying Rpfs. Difficulties with solubility and
measuring activity still need to be more completely overcome. O f the strategies assessed
here to improve solubility, that of expression using a NusA fusion protein was by far the
most successful. Production o f clones expressing all the Rpfs of M. tuberculosis with such
a fusion protein would be worthwhile, with subsequent manipulation of induction
temperatures to further enhance solubility. The reliable production o f sufficient quantities
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o f soluble Rpfs would greatly assist further efforts to assess their effects both in vitro and in
vivo.
The most successful experiments described in this thesis were those involving the 
immunocytochemistry of human M. tuberculosis- infected tissue using anti-Rpf antibodies. 
This approach merits further work. Different human tissues should be stained, particularly 
lung tissue, to demonstrate the presence and location of expressed Rpfs. Tissues from 
patients with clinically active disease should be compared with those from cases with latent 
tuberculosis, to see whether there is a difference in the pattern of Rpf production between 
these two groups. If specific antibodies to each individual Rpf could be raised then the 
expression and location of each could be analysed individually. Such specific antibodies 
with no cross-reactivity with other Rpfs might be very difficult to produce but an 
alternative approach would be to stain tissues from mice infected with Rpf knock-out 
mutant strains o f M. tuberculosis (Downing 2005), for comparison.
If little is known about the function o f Rpfs, less still is yet known about their effect on 
virulence or pathogenesis in the host. Mutants o f M. tuberculosis lacking three o f the rp f  
genes {rpfA, rpfB and rpfC  or rp f A, rpfC  and rpfD) were significantly attenuated in a mouse 
infection model (Downing 2005). Further work in this area could be very enlightening. 
Purified recombinant Rpfs, or Rpf analogues, could be administered to mice infected w'ith 
such attenuated strains of M  tuberculosis, and M. tuberculosis H37Rv, to see whether, and 
how, this influenced the disease process. What would be the consequence of infection with 
a mutant lacking all five Rpfs, if construction o f such a mutant were possible? 
Alternatively, what would be the effect o f administering anti-Rpf antibodies, or synthetic 
Rpf antagonists, to mice infected with wild-type M. tuberculosis?
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The study of dormancy in general, and Rpfs in particular, remain key areas in which a 
better understanding may yet transform the treatment and prognosis of the one third of the 
world's population infected with tuberculosis. If the full mechanism of action o f Rpfs could 
be determined, and their role in human infection characterised, there could be a choice of 
approaches to take in combating human disease. Either suppressing their activity to prevent 
reactivation o f dormant organisms, or mimicking them to prevent persisters developing and 
to activate latent organisms and make them treatable, might be possible. Furthermore, Rpfs 
have potential for use in diagnostic culture o f slow-growing mycobacteria. The ability to 
allow very small innocula to grow, and to shorten the lag phase of a culture could both be 
extremely helpful as ways to make rapid culture systems both faster and more sensitive. 
Some preliminary work in this field has been attempted (Freeman et al 2002). On a broader 
scale, Rpfs may only be one enzyme group o f many similar involved in the growth kinetics 
o f different bacteria, as is hinted at with the identification o f the Sps-domain proteins. The 
idea of a 'cocoon'-like state with cell wall alterations, if confirmed, might for example be 
relevant to organisms in biofilms, where an ability to penetrate the biofilm and cleave the 
cell wall enzymatically might allow more effective antibiotic treatment of these refractory 
infections. Many common pathogens may be found to have other similar systems, which 
could be harnessed as an important adjunct to antibiotic therapy, and which might assume 
great importance in an age of ever-increasing antibiotic resistance.
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DNA sequence of M. tuberculosis Rv0867 (rpfA)
>M. tuberculis bacteria i RvOo’oVc i rpfA: 122. bp -
gaggg
attccgaccgcggatggaggcgggggacccaccaggtcc 
gccgagatcggaccggagccgcatacggctccttggggt 
gaagccaacgtcgttcgccgatgtacgaccgcggccggg 
tgatcctctccacggcgaatccaacccgaacccgacagc 
tgacctcgtaggcgtgtaccgagaggaattacctaacgt
1 - atg agt gga ege cac cgt aag ccc acc aca
31 - tcc aac gtc age gtc gcc aag arc gcc ttt
61 - acc ggc gca gta etc ggt ggc ggc ggc ate
91 - gcc atg gcc get cag gc<5 acc geg gcc acc
121 - ggg gaa tgg gat ni- rt ^ ^ gcc ege +-^ ^ w
151 - gag teg ggc ggc aac tgg teg ate aac P C C
181 - ggc aac ggt tac etc ggt ggc ttg cag ttc
211 - act caa age acc tgg gcc gca cat ggt ggc
241 - ggc gag ttc gcc ccg teg get cag ctg gcc
271 - age egg gag cag cag att gcc gtc ggc gag
301 - egg gtg ctg gcc acc cag ggt ege ggc gcc
331 - tgg ccg gtg tgc ggc ege ggg t ta fr* e- ex aac
361 - gca aca ccc ege gaa gtg ctt ccc get teg
391 - gca geg atg gac get ccg ttg gac geg qcc
421 - geg gtc aac ggc gaa cca gca ccg ctg gcc
451 - ccg ccg ccc gcc gac ccg geg cca ccc gtg
481 - gaa ctt gcc get aac gac ctg ccc gca ccg
511 - ctg ggt gaa ccc etc ccg gca get ccc gcc
541 - AS/' 13 -- w ccg gca cca ccc <— f-T^ - -3 gca cca
571 - ccc geg ccc gcc gac gtc geg cca ccc gtg
601 - gaa ctt gcc gta aac gac ctg ccc gca ccg
631 - ctg ggt gaa ccc etc ccg gca get ccc gcc
661 - gac ccg gca cca ccc gcc gac ctg gca cca
691 - ccc geg ccc gcc gac ctg geg cca ccc geg
721 - ccc gcc gac ctg geg cca ccc geg ccc gcc
751 - gac v, ~ VJ gca cca ccc gtg ga3 ctt gcc aa
781 - aac gac ctg ccc geg ccg ctg ggt gaa C C C
811 - etc ccg gca get ccc gcc gaa ctg geg cca
341 - ccc gcc gat ctg gca ccc geg tcc gcc gac
871 - ctg geg cca ccc geg ccc gcc gac ctg geg
901 - cca ccc geg ccc gcc gaa ctg geg cca ccc
931 - geg ccc gcc gac ctg gca cca ccc get geg
961 - gtg aac gag Caa acc geg ccg ggc gat cag
991 - ccc gcc aca get cca ggc ggc ccg gtt ggc
1021 - ctt qcc acc qat ttq gaa etc ccc gag ccc
1051 - gac ccc caa cca get gac gca ccg ccg ccc
1081 - ggc gac gtc acc gag geg ccc gcc gaa acg
1111 - ccc caa gtc teg aac ate gcc tat acg aag
1141 - aag ctg tgg cag geg att egg gcc cag gac
1 1 7 1 - gtc t* rrr* IS ^ ggc aac g a fts ^  ^ geg *3 ^ L. t- / -rr etc
1201 - gca cag ccg tac gtc ate ggc
tgacgggctgaggccggactttaaaccgaacccacccat
tcgtcggtaccgtcctcgaagaactggtgcttccacacg
ggaagccgcgccttgatggtctccaccaggtgcgcacag
gtgccaaacgccgcccgccggtgateggcggcaaccgcc
gccaccagggcggcctccccgacctgcaagacgccgatc
cggtg
Amino acid sequence encoded by M. tuberculosis Rv0837 (RpfA)
> M . tubercuiis bacteria,Rvu8o7c,RpfA: 407 a a  - POSSIBLE RESUSCI TATION-? ACM 
1 - MSGRHRKPTT SNVSVAKIAF TGAVLGGGGI AMAAQATAAT DGEWDQVARC ESGGNWSINT
61 - GNGYLGGLQF TQSTWAAHGG GEFAPSAQLA SREQQIAVGE RVLATQGRGA WPVCGRGL5N
121 - ATPREVLPAS AAMDAPLDAA AVNGEPAPLA PPPADPAPPV ELAANDLPAP LGEPLPAAPA
181 - D PAP PAD LAP PAPADVAPPV EIAYNDL P AP LGEPLPAAPA DPAPPADLAP D?,’DADIAI5DA
241 - PADLAPPAPA DLAPPVELAV NDLPAPLGEP LPAAPAELAP PADLAPASAD LAPPAPADLA
301 - PPAPAELAPP APADLAPPAA VNEQTAPGDQ PATAPGGPVG LATDLELPEP DPQPADAPPP
361 - GDVTEAPAET PQVSNIAYTK KLWQAIRAQD VCGNDALDSL AQPYVIG
Composition Analysis of Rv0867 RpfA of M. tuberculosis
P r ed ic ted  Stru ctu ral C la s s  o f  th e  W h o le  P ro te in : R D e le a g e  & 
M od ification  o f  N ish ik a w a  & O oi 1 9 8 7
A nalysis W hole Protein
M olecu lar  W eig h t 3 6 7 5 1 .0 0  m .w .
L en gth 3 7 4
1 m icrogram  = 2 7 .2 1 0  p M o le s
M olar E xtinction  c o e ff ic ie n t 3 2 6 5 0  + /- 5%
1 A ( 2 8 0 ) = 1 .1 3  m g/m l
I so e le c tr ic  P o in t 3 .4 3
C h a r g e  a t  pH 7 - 3 8 .9 5
Number %by %by
Amino Acid(s) count weight frequency
Charged (RKHYCDE) 64 22.02 17.11
Acidic (DE) 48 15.79 12.83
Basic (KR) 9 3.67 2.41
Polar (NCQSTY) 55 16.76 14.71
Hvdrophobic (AILFWV) 156 38.34 41.71
AAla 89 17.22 23.80
CCys 3 0;84 0.80
D A sp 28 8.77 7.49
EGlu 20 7.03 5.35
F Phe 2 0.80 0.53
GGIy 26 4.04 6.95
H His 1 0.37 0.27
I lie 5 1.54 1.34
KLys 2 0.70 0.53
LLeu 37 11.40 9.89
M Met 1 0.36 0.27
NAsn 11 3.42 2.94
P Pro 78 20.61 20.86
QGIn 15 5.23 4.01
RArg 7 2.98 1.87
S Ser 10 2.37 2.67
TThr 13 3.58 3.48
VVal 18 4.85 4.81
WTrp 5 2.53 1.34
YTvr 3 1.33 0.80
BAsx 0 0.00 0.00
ZGIx 0 0.00 0.00
X X x x 0 0.00 0.00
. Ter 0 0.00 0.00
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DNA sequence of M. tuberculosis R vl009 (rpfE)
v . 1.1: ■ I  . • u I i 1 ‘ ; o r i  1 v 1 i1: Y'1 1 -; ■ • 7 ; .06* : r —
g c c e a t a a c a c e c g c g e g e e g g a g t t . g c t c a a e a t .  t g q c  
e g g t I c g t  L a c c g t  c t t g t g a t  c g a a c g g g t g g g q c c t  e 
t a g g t t t c g g a g g g c c c a t  t t t g c t t t t t g t t c g c t g t g  
t a g g t g g t t g a g t g t t g c c g a g g t c g g g g a t a t a g c g c g  
t t g a c t c t a c t t a c c a a a c t t c a t c a g a c c c a a t c a c c g
1 - a t g t t g eg e c t g g t a g t c g gt geg c t g c t g
31 - c t g g t g t t g g eg t t c g c c g g t g g c t a t geg
61 - g t c g c c gca t g c aaa ac g g t g acg t t g ac c
91 - g t c gac gga a c c ge g a t g eg g g t g a c c acg
121 - a t g aaa t e g egg g t g a t  c g a c a t e g t c gaa
151 - gag aac ggg t t c t e a g t c g ac ga c e g e gac
181 - gac c t g t a t c c c geg g c c g gc g t g cag g t c
211 - c a t gac g c c g a c a c c a t e g t g c t g egg c g t
241 - age c g t c c g c t g cag a t e t e g c t g g a t g g t
271 - c a c gac g e t aag cag g t g t g g a cg a c c ge g
301 - t e g acg g t g g a c gag ge g c t g g e e caa e t c
331 - ge g a t g a c c ga c a cg g e g cc g g c c geg g e t
3 61 - t c t eg e g c c ag e e g e g t c c c g c t g t c c ggg
391 - a t g geg e t a c c g g t c g t c age g c c aag acg
421 - g t g cag e t c aa c gac g g c ggg t t g g t g eg e
4 51 - acg g t g ca c t t g c c g g c c c c c a a t g t c geg
4 81 - ggg c t g c t g a gt ge g g c c gg c g t g c c g c t g
0  -  - - t t g caa age ga c c a c g t g g t g c c c g c c geg
5 41 - acg g c c c c g a t e g t c gaa g g c a t g cag a t e
571 - cag g t g a c c e g e a a t eg g a t e aag aag g t c
601 - a c c gag egg c t g ccg c t g cc g cc g a ac geg
631 - c g t c g t g t c gag ga c c c g gag a t g a ac a t g
6 61 - age egg gag g t c g t c gaa ga c c c g ggg g t t
691 - cc g ggg a c c ca g g a t g t g a cg t t c ge g g t a
721 - g e t gag g t c aa c ggc g t c gag a c c gg c c g t
7 51 - t t g c c c g t c g c c aac g t c g t g g t g a c c cc g
781 - g c c c a c gaa g c c g t g g t g eg g g t g gg c a c c
811 - aag c c c g g t a c c gag g t g c c c c c g g t g a t e
841 - ga c gga a ge a t e t g g Q 3. C ge g a t e g c c gg c
871 - t g t gag g c c g g t ggc a ac t g g geg a t e aac
90 i - a c c ggc aac ggg t a t t a c g g t g g t g t g cag
931 - t t t gac ca g gg c a c c t g g gag g c c aa c g gc
961 - ggg c t g egg t a t gca c c c e g e g e t g a c c t  c
991 - g c c a c c eg e gaa gag cag a t e g c c g t t g c c
1021 - gag g t g a c c cga c t g c g t caa g g t t g g gg c
1051
1081
g c c  t g g  c c g  g t a  t g t  g e t  gca  cg a  ge g  g g t  
geg  e g e
t g a c c a t c c g g c t g c t c g g g c g c a c t g a g a t o a g g e g g e  
t g g c c a a a g a g c t c g a c t t t .  c . g g c c g c g c a a a t c t c t  eg  
g a c a g a a c t t c g t g c a c g a c g e c a a c a c g g t g c g a c g g g  
t g g t t g c c g c c t c c g g q g t c a g c c g t t c c g a c c t g g t L t  
t g g a g g t c g g g c c g g g c c t g g g a t c g c t g a c c c t g g c a c  
t gc  t c
Amino acid sequence encoded by M. tuberculosis Rvl009 (RpfB)
> M . tuberculis bacteria i Rvi 009 J k p f S : 362 a  a  -  PioDab-.e resuscitaticr.-prcr 
M L R L W G A L L  LVLAFAGGYA VAACKTVTLT VDGTAMRVTT MKSRVIDIVE ENGFSVDDRD
DLYPAAGVQV HDADTIVLRR SRPLQISLDG HDAKQVWTTA STVDEALAQL AMTDTAPAAA
SRASRVPLSG M A L P W S A K T  VQLNDGGLVR TVHLPAPNVA GLLSAAGVPL L Q S D H W P A A
TAPIYEGMQI QYTRNRIKKY TERLPLPPNA RRYEDPEMNM SREVYEDPGY PGTQDVTFAY
AEVNGVETGR L P V A N V W T P  A H E A W R V G T  KPGTEVPPVI DGSIWDAIAG CEAGGNWAIN
TGNGYYGGVQ FDQGTWEANG GLRYAPRADL ATREEOIAVA EVTRLRQGWG AWPVCAARAG
AR
61 - 
1 2 1  -  
181 - 
241 - 
301 - 
3 61 -
Composition Analysis of Rv1009 RpfB of M. tuberculosis
P r e d ic te d  Stru ctu ral C la s s  o f  th e  W h o le  P ro te in : R D e le a g e  & R o u x  M od ification  o f  N ish ik a w a  & O o i 1 9 8 7
Analysis Whole Protein
Molecular Weight 35937.40 m.w.
Length 341
1 microgram = 27.826 pMoles
Molar Extinction QQCOO +/ COA
coefficient oyozu  ■ / O /O
1 A (280)= | 0.91 mg/ml
Iso electric Point 5 19
Charge at pH 7 l -7.30
Number %by %by
Amino Acid(s) count weight frequency
Charged 82 30.71 24.05(RKHYCDE)
Acidic (DE) 39 13.19 11.44
Basic (KR) 31 12.93 9.09
Polar (NCQSTY) 72 21.87 21.11
Hydrophobic 133 36.36 39.00(AILFWV)
A Ala 45 8.90 13.20
CCys 3 0.86 0.88
DAsp 21 6.73 6.16
EGlu 18 6.47 5.28
F Phe 3 1.23 0.88
G Gly 31 4.93 9.09
HHis 5 1.91 1.47
I lie 12 3.78 3.52
KLys 7 2.50 2.05
L Leu 22 6.93 6.45
M Met 7 2.56 2.05
NAsn 12 3.81 3.52
P Pro 23 6.21 6.74
QGIn 13 4.63 3.81
RArg 24 10.43 7.04
S Ser 13 3.15 3.81
TThr 27 7.60 7.92
VVal 45 12.41 13.20
WTrp 6 3.11 1.76
YTyr 4 1.82 1.17
BAsx 0 0.00 0.00
ZGIx 0 0.00 0.00
X X xx 0 0.00 0.00
. Ter j 0 0.00 0.00
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DNA sequence of M. tuberculosis Rvl884 (rpfC)
c c t  g a a t a a t .  e g g  a t  g e t  g t  a g c a g a  11t. q q a g t e a c *  g 
g a g t t t q c t g t c c q c g c c q t c c t g e g c c g e c e a a e t c g a  
c c g c g e c a a a c g c g a c a t a g t g c g g t c c c g c c a c c t c g a  
t a g c c t c t a t c a a c g g g e e e t g a c g a c a g c a a c a e a g t c  
g t a t t g c c a g g c c c t a c c g c c g g c c t g a t e a a t e e g g t t
1 - g t g c a t c c t t t g c c g g c c g a c c a c g g c e g g
31 - t e g e g g t g c a a t a g a c a c c c g a t e t e a c c a
61 - e t c t c t e t a a t e g g t a a c g e t t e g g c c a c t
91 - t e e g g c g a t a t g t e g a g e a t g a c a a g a a t e
121 - g c c a a g c c g e t c a t e a a g t c c g c c a t g g c c
151 - g c a gg a e t c g t c a c g g c a t c c a t g t e g e t c
181 - t c c a c c g c c g t t g c c c a c g c c g g t c c c a g e
211 - c c g a a c t g g g a c g c c g t c g e g c a g t g c g a a
241 - t c c g g g g g c a a c t q g g e g g c c a a c a c c g g a
2 71 - a a c g g c a a a t a c g g c g g a c t g c a g t t c a a g
301 - c c g g c c a c c t g g g c c g c a t t c g g c g g t g t c
33 1 - g g c a a c c c a g c a g e t g c c t c t e g g g a a
361 - c a a a t e g c a g t t q c c a a t e g g g t t e t c g e e
391 - g a a c a g g ga t t g g a c g e g t g g c c g a c g t g c
4 21 - g g c g c c g c c t c t g g c c t t c c g a t e g c a c t g
4 51 - t g g t e g a a a c c c g e g c a g g g c a t  c a a g c a a
4 81 - a t e a t e a a c g a g a t e a t t t g g g c a g g c a t t
51 1 - c a g g c a a g t a t t c c g e g e
t g a c g g t t g g c g g c g t g t g c g g t c t  a t g a c c a g g t .  e g a e  
g t a t g t g t t .  t g g a  t c a g g t  c a t g g a a g g t  t c g g c c a e a g  
1 1 c a c a t g g c a g c g c e g e e g g a e a a g a t  c.t g g a  c a t  t g a  
t c g c g g a t g t c c g c a a t a c c g g c c g g t t e t e g c c g g a a a  
c c t t c g a g g e e g a g t g g c t t g a c g g t g c c a c e g g c c e e g  
e g  c l  t
Amino acid sequence encoded by M. tuberculosis Rvl884 (RpfC)
ii:-'jjr ..klk . Ga.--.:lati'.t. M.-'. .4.\ -..Ja.li A.G.
61 - STAVAHAGPS PNWDAVAyOF. SGGNWAANTG NGKYGG,,eKK 1’A 1WAAFGGV GKi 
.21 - QIAVANRV1.A EQGLDAKPTC GAASGLPIA1, WSKPAOG.: K Q  I INKT IV.'AGT QA;
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Composition Analysis of Rv1884 RpfC of M. tuberculosis
P r e d ic te d  S tructural C la s s  o f  th e  W h o le  P ro te in : A lp ha  
D e le a g e  & R o u x  M od ifica tion  o f  N ish ik a w a  & O o i 1 9 8 7
Analysis W hole Protein
Molecular Weight 11141.10 m.w.
Length 109
1 microgram = 89.758 pMoles
Molar Extinction coefficient 35660 +/- 5%
1 A (280)= 0.31 mg/ml
Isoelectric Point 7.98
C harge at pH 7 0.85
Amino Acid(s)
Number
count
%by
weight
%by
frequency
Charged (RKHYCDE) 16 18.83 14.68
Acidic (DE) 6 6.70 5.50
Basic (KR) 7 8.81 6.42
Polar (NCQSTY) 26 25.95 23.85
Hydrophobic (AILFWV) 46 43.22 42.20
A Ala 20 12.76 18.35
CCys 2 1.85 1.83
DAsp 2 2.07 1.83
EG lu 4 4.64 3.67
FPhe 2 2.64 1.83
GGIy 16 8.20 14.68
HHis 0 0.00 0.00
I lie 9 9.14 8.26
KLys 4 4.60 3.67
LLeu 5 5.08 4.59
M Met 0 0.00 0.00
NAsn 7 7.17 6.42
P Pro. 8 6.97 7.34
QGIn 7 8.05 6.42
RArg 3 4.21 2.75
S S er 6 4.69 5.50
TThr 3 2.72 2.75
W a l 4 3.56 3.67
WTrp 6 10.03 5.50
YTyr 1 1.46 0.92
BAsx 0 0.00 0.00
ZGIx | 0 0.00 0.00
x Xxx i 0 0.00 0.00
Ter J 0 0.00 | 0.00
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DNA sequence of M. tuberculosis Rv2389 (rpJD)
' M . cub' :-i c a  1 i c b a c  ’ . ■: :. i ’ Kv . ' • A • :t l o t  bp -
g a o a , .
t c g g g t g g c e a c c c a c q g g a r c g t c g t g g c g g c g t c g g t  
c a a a t  c a g e  c a  c c a  c g a  a c a a  ggt.  a g t g g t  c c t  g a t g t  c 
c a  t c g a c c a g t c g g t c a g c a a c c g g a a c a g c c o a a o g c e  
g c a g a t c g a c c g c a g t e g g a t c a a g g t g a t c a t g g a c a a
g g t g a a c g g c c g c t g g c t g g c c a g c a a g g t g g a g c t g c t
1 - a t g a c a c c g g g t t t g c t t a c t a c t g e g g g t
31 - g e t g g c c g a c c a c g t g a c a g g t g c g c c a g g
61 - a t e g t a t g c a c g g t g t t c a t e g a a a c c g c c
91 - g t t g t c g e g a c c a t g 1 1 1 g t c g e g t t g t t c
121 - g g t c t g t c c a c c a t e a g e t e g a a a g c c g a c
151 - g a c a t e g a t t g g g a c g c c a t e g e g c a a t g c
181 - g a a t c c g g c g g c a a t t g g g e g g c c a a c a c c
211 - ggt. a a c g g g t t a t a c g g t g g t c t g c a g a t e
241 - a g e c a g g e g a c g t g g g a t t c c a a c g g t g g t
2 7 1 - g t c ggg t e g c c g g e g g c c g e g a g t c c c c a g
301 - c a a c a g a t e g a g g t c g c a g a c a a c a t t a t g
331 - a a a a c c c a a g g c c c g g g t g e g t g g c c g a a a
361 - t g t a g t t c t t g t a g t c a g g g a g a c g c a c c g
3 91 - c t g g g c t e g e t c a c c c a c a t e c t g a c g t t c
421 - e t c g e g g c c g a g a c t g g a g g t t g t t e g g g g
45 1 - a g e a g g g a c g a t
t g a g g t g t g c c t g c g t t a c a t t g c t g g c c a c c c t a g c t g  
g t a c g c g c t a t g e g a t g a t 1 1 g g c a t g g t a t  t  t c g g c a g  
g c a c c a g t t g a g c t g c c c g g c c t g g c g c c c a t g c c c g g a  
c a a c c g t t e g g g g t c t a c c t g c a c g t c c c g t t c t g c c t g  
a c c c g t t g c g g g t a c t g c g a c t t c a a t a c c L a c a c c c c g  
g c c c a
Amino acid sequence encoded by Rv2389 (RpfD)
~ X : .*■ :i../I”.’Ai: APRi R./RCAk . V_’r V ‘b K T A  W A  i . A .i*■ I .. aiK.AI' DIPV." A LA-,
61 - E S G G N W A A N T  GNGLYGG1.QI S Q A T W D S N G G  V G S  F.*\AAH Pp s.X>l EVAI-NIM KTgGFGAvvPK
121 - C S S C S Q G D A P  L G S L T H I L T F  I.AAETGGCSG 5R D 2
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Composition Analysis of Rv2389 RpfD of M. tuberculosis
P re d ic te d  S tru c tu ra l C la s s  o f th e  W h o le  P ro te in : A lp h a  
D e le a g e  & R o u x  M o d ific a tio n  o f  N is h ik a w a  &  D oi 1 9 8 7
Analysis Whole Protein
Molecular Weight 10629.20 m.w.
Length 105
1 microgram = 94.080 pMoles
Molar Extinction coefficient 24520 +/- 5%
1 A(280)= 0.43 mg/ml
Isoelectric Point 3.66
Charge at pH 7 -9.04
Number %by %by
Amino Acid(s) count weight frequency
Charged (RKHYCDE) 21 23.98 20.00
Acidic (DE) 12 13.39 11.43
Basic (KR) 3 3.88 2.86
Polar (NCQSTY) 35 35.15 33.33
Hvdrophobic (AILFWV) 32 31.73 30.48
A Ala 13 8.70 12.38
C Cys 4 3.88 3.81
DAsp 9 9.75 8.57
GGIu 3 3.64 2.86
FPhe 1 1.38 0.95
GGIy 16 8.60 15.24
H His 1 1.29 0.95
I lie 6 6.39 5.71
KLys 2 2.41 1.90
LLeu 6 6.39 5.71
M Met 1 1.23 0.95
NAsn 5 5.37 4.76
P Pro 5 4.57 4.76
QGIn 8 9.64 7.62
RArg 1 1.47 0.95
SSer 11 9.01 10.48
TThr 6 5.71 5.71
VVal 2 1.86 1.90
WTrp 4 7.01 3.81
YTvr 1 1.54 0.95
BAsx 0 0.00 0.00
ZGIx 0 0.00 0.00
x Xxx 0 0.00 0.00
. Ter 0 0.00 0.00
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DNA sequence of M. tuberculosis Rv2450 (rpfE)
>M. tuberculis bacteriaiRv2450cirpfE: 51c op -
cgtgc
gagcggagccggggacggctgaatcggttggccgacccg
caggcggcggctagcagccgcgccgggcagatcaagcgc
tccgctgccgtgccggaccgagacggcacgtcccacgca
gcaccctcgaatgcacctggcagctaacccatgcccgtg
ggttggctttggcgcgcgcgcaccgcgaaaggaacaacg
1 - ttg aag aac gcc cgt acg acg etc ate gcc
31 - gcc geg att gcc g g g acg ttg gtg acc acg
61 - tea cca gcc ggt ate gcc aat gcc gac gac
91 - geg ggc ttg gac cca aac gcc gca gcc ggc
121 - ccg gat n r* rrbrr rtnr-■=) "d — tt t ccg a a ctg
151 - ccg ccg gcc ccg gac get gca ccc gtc gat
181 - act ccg ccg get ccg gag gac geg ggc ttt
21 1 - gat ccc aac etc ccc ccg ccg ctg gcc ccg
24 1 - gac ttc ctg tcc ccg cct geg gag gaa geg
2 7 1 - cct ccc gtg ccc gtg gcc tac age gtg aac
30 1 - tgg gac geg ate geg cag tgc gag tcc ggt
3 31 - gga aac tgg teg ate aac acc ggt aac ggt
3 61 - tac tac ggc ggc ctg egg ttc acc gcc ggc
391 - acc tgg cgt gcc aac ggt ggc teg ggg tcc
42 1 - geg gcc aac geg age egg gag gag cag ate
451 - egg gtg get gag aac gtg ctg cgt teg cag
4 61 - ggt ate ege gcc tgg ccg gtc tgc ggc ege
5 1 1 - ege ggc
tgaccaccgcgaaaagacgcaaaagctcccaaatccggt 
cggatttgggagcttttgcgtctgctcgcgcaccccgga 
gtagcgtcaaacccgtgaccgctacgccgcgtgaattcg 
acatcgtgttgtacggggcgaccggcttcgtcggcaagc 
tgaccgccgaatacctggcccgggccgggggagatgccc 
gga tc
Amino acid sequence encoded by Rv2450 (RpfE)
>M. tuberculis bacteria i  Rv2450c i RpfE: 172 aa - PROBABLE RESUS* 
1 - LKNARTTLIA AAIAGTLVTT SPAGIANADD AGLDPNAAAG PDAVGFDPNL
61 - TPPAPEDAGF DPNLPPPLAP DFLSPPAEEA PPVP'vAYSVN WDAIAQCESG
121 - YYGGLRFTAG TWRANGGSGS AANASREEQI RVAENVLRSQ GIRAWPVCGR
: iT A T I O N - P r v _ T b
PPAPDAAPVD
GNWSINTGNG
RG
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Composition Analysis of Rv2450 RpfE of M. tuberculosis
P r e d ic te d  S tru ctu ra l C la s s  o f  th e  W h o le  P ro te in : R  D e le a g e  & 
R o u x  M od ification  o f  N ish ik a w a  & O oi 1 9 8 7
Analysis Whole Protein
Molecular Weight 14904.20 m.w.
Length 145
1 microgram 67.095 pMoles
Molar Extinction 
coefficient 26840:1:5%
1 A(280) 0.56 mg/ml
Isoelectric Point 3.93
Charge at pH 7 -10.13
Number % by %by
Amino Acid(s) count weight frequency
Charged (RKHYCDE) 31 27.61 21.38
A cidic (DE) 18 14.56 12.41
Basic (KR) 8 8.38 5.52
Polar (NCQSTY) 30 22.29 20.69
Hydrophobic (AILFWV) 50 33.59 34.48
A Ala 23 10.97 15.86
CCys 2 1.38 1.38
DAsp 11 8.49 7.59
EGlu 7 6.06 4.83
FPhe 4 3.95 2.76
GGIy 17 6.51 11.72
HHis 0 0.00 0.00
l lie 4 3.04 2.76
KLys 0 0.00 0.00
LLeu 7 5.32 4.83
M Met 0 0.00 0.00
NAsn 10 7.66 6.90
P Pro 21 13.68 14.48
QGIn 3 2.58 2.07
RArg 8 8.38 5.52
S S er 8 4.68 5.52
TThr 4 2.71 2.76
VVal 8 5.32 5.52
WTrp 4 .5. 00 2.76
YTvr 3 3.28 2.07
BAsx 0 0.00 OJDOl
ZGIx 1 0.86 0.69
XXXX 0 0.00 0.00 j
. Ter 0 0.00 0.00 |
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APPENDIX ii
M edia and solutions.
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Culture media
Sauton  '.v medium agar 
To make 1 litre:
0.5 g potassium dihydrogen orthophosphate 
0.5 g M agnesium sulphate
4.0 g L-asparagine 
6 ml glycerol
0.05 g ferric ammonium citrate
2.0 g tri-sodium  citrate 
0.1 ml 1% Zinc sulphate
M ake up to 900ml with distilled water. To make agar, add lg  agar per 100ml.
Adjust pH to 7 w ith potassium  hydroxide. Autoclave, cool, then add 2.5 ml 20% 
Tween-80 and 100 ml ADC.
M iddlebrook agar
M iddlebrook 7H9 broth (Difco): prepared according to m anufacturer’s instructions. 1% 
agar added.
Luria-Bertani (LB) medium  
BactoTryptone 
BactoYeast extract 
NaCl
For solid m edia add 1% agar 
Nutrient Broth E
Nutrient broth E (Lab M) 13g/l. For solid media add 1% agar. Autoclave.
Nutrient broth 2
Nutrient Broth 2 (Oxoid) 25g/l, autoclave.
Nutrient Agar
Nutrient Agar (Oxoid) 28g/l, autoclave.
10g/l 
5 g/1 
10g/l
. Adjust to pH 7.0 with sodium hydroxide, autoclave.
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4g 
4g
70mg 
1 mg 
0.5mg 
0.1ml 
40mg 
20mg 
5mg 
lOOmg
Adjust pH to 7.5 with sodium hydroxide, autoclave.
Before use, add 5g/l L-lactate and filter sterilise
* Trace elem ents solution stored at 4°C: 
per 10ml:
Z n S 0 4 x 7H 20 5mg
H 3BO 3 5mg
C u S 0 4 x 5H20 2.4mg
N a2M o 0 4 2.5mg
h 2s o 4 0.05ml
SOB
Bacto Tryptone 2%
Bacto Yeast extract 0.5%
NaCl lOmM
KC1 2.5mM
M gCl2 lOmM
M g S 0 4 lOmM
Autoclave.
Lactate m inimal media (LMM)
Per 1 litre:
Potassium dihydrogen orthophosphate
Ammonium chloride
M agnesium sulphate
Ferrous sulphate
M anganese chloride
Trace elements*
Thiamine
L-m ethionine
Biotin
Inosine
Yeast-peptone induction medium  
15g select peptone 
1 Og yeast extract 
5g NaCl 
Adjust pH to 7.2. Autoclave.
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Buffers -  DNA
TAE buffer 
50x stock:
Tris base 242 g
EDTA 0.05 M
Glacial acetic acid 57.1 ml
H20  To 1 1
Loading buffer
Bromophenol blue 0.25%
X ylene cyanol 0.25%
Ficoll type 400 in H20  57 .1ml
EDTA lOmM
Buffers -  protein
PBS
NaCl 8g
KC1 0.2g
N a2H P 0 4 2.88g
k h 2p o 4 0.48g
Charge buffer
Nickel sulphate 50mM
8M
40m M 
500 mM
Binding buffer-with urea
Urea (heat gently until dissolved)
Tris HC1 pH 8.0
NaCl
Binding buffer -  without urea
Tris HC1 pH 8.0 40mM
NaCl 500mM
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Elution buffer
Imidazole 1M
NaCl 0.5M
Tris HC1 pH8.0 40mM
Strip buffer
EDTA lOOmM
NaCl 0.5M
Tris HC1 pH 8.0 40mM
Wash buffer
M ake up by adding 3ml elution buffer to 47ml binding buffer: contains 60mM 
im idazole
Binding buffer -  large-scale (21) extractions
Tris-H Cl pH 8.0 25mM
NaCl 0.5M
10% glycerol
Elution buffer -  large-scale (21) extractions 
Im idazole 0.5M
NaCl 0.5M
Tris-HCl pH 8.0 25mM
10% glycerol
Sample buffer
Tris-HCl 0.0625M
Glycerol 0.5%
SDS 2.3%
Bromophenol blue 1%
Freeze in 10ml aliquots. Add mercaptoethanol 2%  before use
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Running buffer
Tris base 0.025M
Glycerol 0.192M
SDS 0.1%
Transfer buffer fo r  immunoblotting 
Tris base 48mM
Glycine 39mM
M ethanol 20%
pH 8.1-8.4
TBS
Tris-HCl pH 8.0 lOmM 
NaCl 150mM
Blocking buffer
TBS containing 5% Marvel milk powder
SD S-PAG E -  12.5% separating gel
For 2 gels:
A A-M BA  
Tris-H Cl pH 8.8
H ;0
TEM ED
APS
3.275 ml 
1.86 ml 
2.725 ml 
15 pi 
10 pi
SDS-PA GE stacking gel
For 2 gels:
AA-M BA 0.5 ml
T risH C lp H  6.8 0.75 ml
H20  1.7 ml
TEMED 15 pi
APS 15 pi
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APPENDIX iii 
Table of clones referred to in the thesis
Clone Insert Vector Host
AD1 rpJDf TOPO® DH5u
AD2 rp fiy TOPO® DH5a
AD 3 rpJD pET-2 la DH5a
AD4 rpfD pET-2 la Origami B (DE3) pLysS
AD5 rpJB pET-19b Origami B (DE3) pLysS
AD6 rpJC pET-19b Origami B (DE3) pLysS
AD 7 rpfA pET-19b Origami B (DE3) pLysS
ADS rpJE pET-19b Origami B (DE3) pLysS
AD9 rpfP pET-15b. tev DH5a
ADI 1 rpJE pET-15b. tev Origami B (DE3) pLysS
CA1261 f /^smeg pSDY5 XL2-Blue
CA1272 - pET-43. lb XL2-Blue
CA1002 rpJB pET-19b HMS174
CA1318 r/^ /smcg pET-43.lb Origami (DE3)
.
+ mutation at Xho\ site 
1 no mutations
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Vector maps
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Vector map of pET 15.b (Novagen)
Aat 11(5635) 
Ssp 1(5517)
EcoR 1(5706) 
Cla 1(24)
Sea 1(5193) 
Pvu 1(5083)
Pst 1(4958)
Bsa 1(4774) 
Ahd 1(4713)
AJwN 1(4236)
BspLU11 1(3820)
Sap 1(3704) 
B st1107 1(3591) 
Acc 1(3590) 
BsaA 1(3572) 
Tth111 l(3565)
,Bpu1102 1(267)
. BamH 1(319) 
-Xho 1(324)
Nde 1(331)
-NCO 1(389)
-Xba 1(428)
■ Bgl 11(494)
■ SgrA 1(535)
• Sph 1(691) 
■EcoN 1(751)
p E T -1 5 b
(5708bp)
A'V , Mlu 1(1216) V~ Bel 1(1230)
$CD BstE 11(1397)i
^Apa 1(1427)
A
a / |
/BSSH 11(1627) 
^ -H p a  1(1722)
PshA 1(2061)
Bpu10 1(2926) 'B sm  1(2704) 
MSC 1(2791)
Eag 1(2284) 
Nru 1(2319) 
BspM 1(2399)
Sgtll
T7 promoter primer #69348-3 
T7 promoter lac operator Xba I rbs
A . i ' " :-jA* ’ CGCGAAATTAATACGACT CACTATAGGSSAAnGTGAGCGGA'AATAATTCCCCTCT4G4AATAA'T'"GTTTAACTIIAAGAAuGAGA
Nco I Hls«Tafl Nde I Xbol SamHI
r at -a T ~ ~  ... l'jtcatcatjatca'ta agcagcgcc ‘tggtg cc gc gc gg ca gc ca t at gc  t ; ta' :: tgc tgc taacaaagc tcga
! ■■ : ■ ■ 
gpulKC1 thrombin T7 terminator
AAGGAAGCTGAGT'GGCIGCTGCCACCGC'GAGCAATAAC !A3CATAACCrCTTGGG3CCTCTAAACGGGTCT'TGAGGGGTHT, \
L v s G I l A I a S !u..euA j A :a A .o l h ^ . I o G I u G i n d
T7 terminator primer #89337-3
pET-15b cloning/expression region
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Vector map of pET 19.b (Novagen)
pET-19b
(5717bp)
B sa 1(4783)
Earn 1105 l<4722)
B p u 1102  1(267) 
BamH 1(319) 
Xho 1(324)
1(544)
S ph  1(700)
EcoN  1(760)
Drd 11(948)
Mill 1(1225) 
Bel 1(1239)
A lw N  1(4 24 5)
11(1406) 
Bm g 1(1434) 
Apa 1(1436)
BspLU11 1(3829)
Sap 1(3713)
B s t1 107  1(3600) 
A cc 1(3599) 
B saA  
Tth111
BssH  11(1636) 
Hpa 1(1731)
BsaX  1(1884) 
PshA  1(2070)
Eag 1(2293) 
Nru 1(2328) 
BspM 1(2408)
B p u io  1(2935) B sm  1(2713) 
M sc 1(2800)
Aat 11(5644) 
S s p  1(5526)
S e a  1(5202) 
Pvu 1(501—
Rst 1(4967)
T7 promoter pnmer #69348-3
Sgl|| T7 p rom oter ^  _________ l>c o perato r__________ xftal _rtos_
aGATC "C GAT CCCSC GAAATTAA T AiGAC TC ACT AT ACGGGAAI TG“GAbCGGA IAAC AA TTCCCCTC1 AGAAATAATTT"GT TTAAC TTI AAGAAGuAbA
Nco I H 'w T a g  Nda I  X f to i_ S a m H  I
:  ■ ■ • . . r  : .■ • . . .  .  : . . . .  . a  . . .  . -  a -
HetG ly H i sH i sH i sH ' s Hi s H i s»HlsH i s Mi sH i sSer Ser 6 ' vh i s i  I c AspAsoAbpAspLyaH ■ sHetLeuG 1 uAsoProA 1 aA taA »n-ys 
Hpu110 2 1   Enterofclnase 1 T7 term inator________
iiCCCGAAAbbAAGCTGAGT TGGCTGC TGCCACCGC TGAGCAATAAi " AGCATAACCCCTTGGGGCC TCT AAACGGGTCTTGAGGGGT T T TT Tb 
AlaA rqi ysb  u AI aG lu leu A  ! oAl oAloThrA I 06 I uG I n£ndM---------------
T7 terminator primer #69337-3
pET-19b cloning/expression region
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Vector map of pET 21a-d (Novagen)
,B p u 1102  l(80)
BssH I l{1475) 
EcoR V(1514)
Dra 111(5201)
AtwN 1(3581)
B spL U 11 1(3165)
S a p  1(3049)
B s t1 107  1(2936)
Tth 111 1(2910)
S ty  1(57)
B spG  1(2691)
1(158) HISS) 
Not 1(166) 
Eag 1(166) 
Hind 111(173) 
Sal 1(179) 
S a c  1(190) 
EcoR  1(192) 
BamH 1(198)
N he 1(231)
N de 1(238)
Xba 1(276)
Bgl 11(342)
SgrA  1(383)
S e a  1(4538) 
Pvu 1(4428) 
P st 1(4303)
B sa  1(41
 
Hpa 1(1570)
PsnA  1(1909)
PpuM  1(2171) 
P sp 5  11(2171) 
B p u io  1(2271)
Mlu 1(1064) 
Bel 1(1078)
BstE  11(1245) 
Bm g 1(1273) 
1(1275)
T7 promoter
Tl\,4Ti . . ,a AA*1AaTA: »A." I f  ACTATAOJG .AATIUTfiAGCGCATAA M U C tC . ! _ TAG~ AAT AAT T' TGTT TTUCT'TAAGAAGGAG*
AT Al A T vUl IaO 'A I j -  : T . A _ 4g>. AAA* . ,*G r ■ ■ A ' . .»AA' ! i GAU 1L. G . »• A A - I  G C ti i. Gi AT TC6AGC AT. A t A CA, Ai 1 A’ t liA 
'TetA a' ■ •• 'lo tT h r G ly .,. y . .r ij  ’ .KctU V Ar qli i , Ser GI 1 e \ .  Ar qA -oSI - A o f  y sG I y A r q lh  ArqA u -> or f oP roP roP r oL eo
c l  ' -2 1 b ■GT . • SAa; M  TCt.. ,a AA.'.i" G a.' G ACTCGAuvA. ;a< Ai Ai CACCAt iA
•- i ' M 1 ’ H i
. AC C A 1 GijC IA bC 
■ • ■
p C 1-2 1 c  o AA i . . 
i Ar q ! i cAr q l I ••Ar .p  I .y  S .  r -  Jr • V r  I **^ArqPr sh • • c  5 e  • f lv  r V  I hr I hr I hr U  r .»! -i
, ,s :a „ G .  'C . TAA-.i'-AU. 'L'GAAAG&aaG- T5*eir&4i;iS(t8CCAC:ai1.8A6CAAr4ACTAG:ATAAC<,CCtTCa8St.TCTiUAC6tW TL'fSAiU86IT*T:T0
pET-21 a-d(+) cloning/expression region
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V ector m ap of pE T  43.1 a-c (Novagen)
Dra 111(7033)
Sea 1(6140)
AlwM 1(5427)-----
BspLU11 1(5011) 
S ap  1(4395) 
Tth111 1(4756)
Avr II (463)
Pac I (503)
Xho I (530)Ahd 1(6621) Pml I (576)r g ^ 6 8 1 5 - 7 2 6 2)Bgl 1(6503) tag I (592)Bgl 11(943)
Bsm 1(967) 
Msc 1(1075) 
StU 1(1128)
Fsp 1(6398) Not I (592)
Hind 111 (599)
Kpn I (624)
Sal I (626)
P st I (639)BspM 1(1277) Sse8387 I (639)
A sc I (641)Nco 1(1403) BsrG I (646)
EcoR I (654)
BamH I (660)
S ac  I (672)
PshA I (661)pET-43.1 a +)
(7275 bp)
Sm a I (721)
S ac II (797)
S pe I (626)
lac operator  
T7 prom oter Nde 1(2317)
Xba 1(2355)
Sptl 1(2622) 
ECON 1(2682)
BstE 11(3328)
Apa 1(3358)
Bpu10 1(4117) 
P sp5 11(4017)
Hpa 1(3653)
Promoter pnmer __
TGTGAGCGGATAACAATTC
CCCTCTAOAAIkTAATTTrSTTTIUwrrmUkaAAOOAflATATXCATA1
Nu»*Tao primer caK-3_
TGAACAAAOAAATTTTOGCT. . .lSSfbD. . . OCCGAACAGOGCATTGATGATCT03CTGATATCGAAOOGTTGACCGAC
Met Ly» Ju low Acs * 4 8 o a  Alo Gk> ( in  Gty Ik* Abo k jp  L«u Ala Atp |la» Gu Gly Le. rKr <ep
HtyTaq Sac I s-T»»
ly« Ao Gly A )  l+ o  II** Hct Ao Ala At j  Atn t • 
S*T»ci 16m*r pnm«r
. I' p  Che Gly Aup G i Ala Thr 'nr Gly Sar Qy
lAACtVXAJCACATOQACTCOCCACaaCCA
PCATCACCATCACCATCACTCCGCQOGTAAAOAAACCQCTOCTGCGAAATrr
i Sot Ala Gly _yr. Glti Try Aio A a Alo .yv P^e
S a c  I BerrM  I ScoR  I QtrQ  I A sc  I
Emg l
hknd  III N ot I
AGTCCGGAOCTCGTOGATCCCAATTCTOTACAGGCGOJC p£T-43.1b(*)
ie r  fv© Gkj L+* roi Ajp Pro A_n Gor Vbl GJr. Ato Vtj 
AaTCCOAGCTCGTOaATCCOAATTCTOTACAOOCOCOCC pET-43 1c(*)
> r  Tor G y Tro lU  t r y  jUt Lou Ty> Arq Af.-j Alo
HSV*T»q hi-T»9
'rT^A51Ai?3T53AC^5TAi:CArCt^TA5GCGT^QAAGCnt3CGOCCOCACAGCrCTATACACCrrCCAAGCCACCCAGAACTCOCTCCTC»AAGACCCAGA/5afcTCTCCAOCACCACCACCACCACCACTAA p £ T -4 H « ( .)v Alo Gly A- 9 Arq Arq ty> Hb A^  j  Tyi Alo Phc GK. Alg Cyy Gly Art) Thr Alo 'jbl Tyr Ihr Gyt. Ly< V c  A a Arc) hr Arq S f E n d
TJCA^GACGTCGACGGTACCATCGATACaCtfTTCaAAOCTTOCOOOGOCACA
Cy» V 9  V  S y  T>y Vol P t»  T er Hr? Arq Vr* Arq 5<>- Arq N o  Hr. {
CoiiOOWN prtmor
A w  II .  470B45.3
TsH1AATrAAS'rr3t3GCC7rrCCrAI39Cr^TAAAACA5AATTTOCCTtX3COOCAOTA(3COCGOT(X!TCCCACCraACCCCATOCCGAACTCACAACTCSAAACOCCCTAGCOCCGATC<»rAtfT3TCiC!GGTCTCC pET-43.1«(*)
rrTAATTOAaTTOOGCOTTCCTAOOCTOATAAAA pET-43 1b<*)
TTAATTAAjTTGGGCGTTCCrAGGCTGATAAAAC |>ET-43 1 c (.)
Vo • n d
pET-43.1a(+) cloningyexpression regions
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M ap of plasm id pLysS (Novagen)
p L y s S
(4886bp)
T7 lysozy^ ®
Earn 1105 k3850) 
Drd 11(3819)
B st1107  1(596) 
Xmn 1(639)
S a c  11(835)
P m e 1(2449)
BsrO 1(4874), | E coR  1(1)
NCO 1(4586) 
S e a  1(4474)
8  m g 1(4422)
T th111 1(4343)
Drd 1(4343)
B su 36  1(4234)
Bel 1(4183)
B saB  1(4087)
Ava 1(3581)
BspM 1(3190) 
ApaB 1(3188)
Nru 1(3110) 
E ag 1(3075)
S a l 1(2787)
E coN  1(2762) 
S p h  1(2702)
BsrG 1(2454)
Xba 1(1424) 
Ear 1(1452)
Tc promoter 
Cla 1(1518) 
Hind 111(1523) 
E coR  V(1681 )
B sa  1(1992) 
Afl 11(2057)
Att 11(2323)
1(2388)
1(1926) 
1(1935)
p L y s E
(4886bp)
APPENDIX v
M PN table
Values o f  the MPN for 5 tubes inoculated from each o f three successive 10-fold
dilutions (Taylor 1962)
Numbers of 
turbid tubes 
observed at three
successive m.p .n .
dilutions (per inoculum of the
/ JL —% f i rst  dilution)
o I o o - i 8
I 0 o 0 - 2 0
I I o 0 - 4 0
2 0 0 0 4 5
2 o I 0 - 6 8
2 I o 0 - 6 8
2 2 o 0 9 3
3 0 0 0 - 7 8
3 0 I I I
3 1 o 1 1
3 2 0 >•4
4 0 o 1-3
4 0 I 1 7
4 I 0 1-7
4 I I /  2 1
4 2 0 2-2
4 2 I 2- 6
4 3 0 2 7
Numbers of 
turbid tubes 
observed at three
successive m . p . n .
dilutions (per inoculum of the
first dilution)t
5 0 0 2 3
5 0 I 3-1
5 1 0 3 3
5 1 I 4 6
5 2 0 4 9
5 2 1 7 0
5 2 2 9 5
5 3 0 7-9
5 3 1 1 1 0
5 3 2 14-0
5 4 0 1 3 0
5 4 1 1 7 0
5 4 2 2 2- 0
‘5 4 3 2 8 0
5 5 0 2 4 0
5 5 I 3 5 0
5 5 2 54-1°
5 5 3 9 2 - 0
5 5 4 1 6 0 0
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APPENDIX vi
Results of viable counts from flask o f M  bovis BCG in Sauton's medium containing 
200 ml o f liquid culture with a headspace:broth ratio of 5:1 and constantly agitated
Age o f culture (days) Cfu/ml on agar MPN in liquid medium MPN with Rpf
0 20
36 1 0 6
60 10 '
76 6 xlO 6
92 2.6 x 10 6
97 1 0 6
109 < i o - ’ *
111 < 10 4 ’ 1.2 x 10 - 4.6 x 10 -
132 0 > 8 x 1 0 5" > 8 x 10 5
151 3 x 10- 4.6 x 10 6 1.2 x 1 0 6
154 5 x 10-
165 1.75 x 10 6 8 x  10 6
168 1.1 x 1 0 6 8 x 1 0 b
176 3.4 x 10 -
183 1 0 b
*Maximum value -  i.e. no growth was seen at the dilutions plated (not possible to 
ascertain the cfu/ml, as low er dilutions w^ere not plated).
**Minimum value -  Growih occurred in all the MPN tubes
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S t  From Luciferase to  Lazarus 
a wake-up call for tuberculosis
Angharad Davies
My friend's father, Ken, had to  strip naked and lie u n d e r  a bright light 
for an h o u r  a day (thirty minutes back, thirty minutes  front)  for tw o  
years. W o rs e ,  my grea t  aun t  as a young w o m a n  suffered t h e  humiliation 
o f  m on ths  on w h a t  was  th e n  known as th e  'venereal  diseases '  ward,  
being told she must have b e e n  a bad girl and tha t  as pun ishm en t  she  
w ou ldn ' t  be  able t o  have babies. In fact she, like Ken, had tuberculosis  
(TB) -  pelvic in h e r  case -  in t h e  days before  it could be  t rea ted .
So feared vvasTB o n c e  th a t  John Bunyan called it " the  Captain o f  th e s e  m e n  o f  dea th" .  
Then, in th e  1940s, d rug  t r e a tm e n ts  b e c a m e  available, and eventually, m any believed, th e  
disease w ould  be eradicated .
In fact, today, o n e  third o f  th e  w o r ld 's  popu la tion  rem ains infected with th e  bac te r iu m  th a t  
causes TB -  M ycobacterium  tuberculosis .  N a tu r e  has m a d e  a concession -  n o t  all th o s e  
carrying th e  disease will actually b e c o m e  ill. Instead, th e  bacteria  lie d o r m a n t  in th e  body, 
evading th e  im m une system, as if biding th e ir  t im e  and  stealthily waiting for  th e  o p p o r tu n i ty  
to  at tack  w h e n  th e  t im e is right.
In a fo r tu n a te  nine o u t  o f  te n  peop le ,  this n e v e r  happens.  In so m e  cases, however; 
w eaken ing  o f  a pe rso n 's  immunity can cause  th e  bac teria  to  reactivate -  fo r  instance, 
during c h e m o th e ra p y  for cancers, HIV infection, o r  simply old age. H o w  this w orks ,  and 
w h a t  contro ls  it, is n o t  yet known.
W h y  n o t  identify all th e  p e o p le  w h o  a re  carrying th e T B  bacte rium  in th e ir  bodies, and 
t r e a t  th e m  with anti-tuberculosis drugs, b e fo re  th e y  b e c o m e  ill? U nfo r tuna te ly  this is n o t  as 
easy  as it so unds .T he  d o r m a n t  bac te r ia  a re  m uch  less responsive to  drugs than  the ir  
wakeful c o u n te rp a r t s .T h e  chemical p ro ce sses  th a t  go  on  inside all living o rganism s have 
b e e n  s low ed  right d o w n  -  o r  even, s o m e  believe, s to p p e d  a l to g e th e r  This m e a n s  th a t  th e  
drugs, which act by interfering with th e s e  chemical processes ,  are  unable to  d o  the ir  job. It's 
r a th e r  like trying to  sab o tag e  a car  by putting sugar in th e  petro l tank  -  if th e  engine isn't 
running, nothing actually happens.
Similarly, th e  ability o f  th e s e  bac te r ia  to  b e c o m e  d o r m a n t  accoun ts  for th e  lengthy 
t r e a tm e n t  n e e d e d  for th o s e  w h o  d o  b e c o m e  ill w ithTB. Even today, t r e a tm e n t  takes a 
m in im um  o f  six m o n th s  -  a tall o r d e r  for a w ell-funded and  d e v e lo p e d  health  system, let 
a lone  th o s e  in p o o r e r  p a r ts  o f  th e  w o rld  w h e r e  TB is rife. It is o n e  o f  th e  W o r ld  Health  
O rgan isa tion 's  s ta ted  aims to  find ways o f  decreas ing  th e  length o f  t r e a tm e n t  forTB .To do  
this, a b e t t e r  unders tand ing  o f  th e  d o rm a n c y  p h e n o m e n o n  is badly n ee d ed .
Recently, scientists a t  th e  University o f  W ales, A berys tw yth ,  have m a d e  a b rea k th ro u g h  in 
this field. Mike Young and  his t e a m  have d iscovered  small p ro te in  molecules, p ro d u c e d  by
)03 Max Perutz essay prize
TB bacteria ,  which a p p e a r  to  switch th e  d o r m a n t  bac teria  back on. Mike raised th e  
tantalising possibility th a t  this might b e  a m e an s  o f  com m unica tion  b e tw e e n  th e  bac teria  - if 
o n e  o f  th e m  senses th a t  condit ions a re  right to  c o m e  o u t  o f  th e  d o r m a n t  s tate ,  it 
p ro d u c e s  th e s e  p ro te in s  as a 'w ake-up  call' to  a le r t  th e  o th e rs  -  a s o r t  o f  biological alarm 
clock.
T he  intriguing possibility o f  com m unica t ion  b e tw e e n  bac teria  is s u p p o r te d  by ev idence  
f rom  th e  oceans. C e r ta in  aquatic  bac te r ia  can p ro d u c e  th e  pro te in  luciferase, making th e m  
glow b lue-green.This benefits th e i r  host, th e  squid, at night. In re tu rn  for this illuminating 
activity, th e  squid allows th e  bac te r ia  to  live in a special light organ. Since glowing is such an 
energy-consum ing  fo rm  o f  rent, t h e  bac te r ia  only p ro d u c e  luciferase w h e n  th e y  d e t e c t  th a t  
th e r e  a re  enough  o f  th e m  a ro u n d  to  m ake  th e  effect w orthw hile .T h is  is kn o w n  as 
'q u o ru m  sensing'. So, w h e re a s  in th e  p as t  scientists co ns idered  each single bac te r ium  to  b e  
a com ple te ly  se p a ra te  individual, existing independen tly  o f  all th e  o thers ,  it is n o w  know n 
th a t  in fact they  d o  p ro d u c e  signals to  c o m m u n ic a te  with and influence o n e  a n o t h e r  An 
analogy could  be  m a d e  with a colony o f  ants  -  each a n t  is a sep ara te  se lf-contained living 
o rganism  bu t  also behaves  a lm os t  like a cell in th e  larger entity which is th e  colony.
Mike d u b b e d  th e T B  'w ake-up ' p ro te in s  'Resuscitation P rom oting  F ac to rs ' .T he  aim o f  my 
re se a rch  is to  fu r th e r  investigate th e s e  resuscita tion  p ro m o tin g  factors, an d  t o  study 
w h e t h e r  by using th e m  to  'w ake up' d o r m a n t  TB bac te r ia  in th e  labo ra to ry  I can r e n d e r  
th e  b ac te r ia  m o r e  susceptible to  th e  ac tion  o f  anti- tuberculosis  drugs. A t first sight, 
resu r rec t ing  this par t icu lar  Lazarus may se e m  th e  last thing th a t  n eeds  to  be  d o n e .  
N e v e r th e le s s  it may b e  th a t  to  hit th e  b ac te r ia  hard  w ith  drugs, w e  n e e d  to  switch th e m  
back o n  first. T h e  result could b e  s h o r t e r  t r e a tm e n t s  an d  th e  curing o f  d o r m a n t  disease.
Ken says h e 's  all fo r  it.
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